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Summary 
Epigenetics deals the heritable changes in gene regulation which is not related with the changes of 
DNA sequence itself.  Among several molecular mechanisms that mediate epigenetic phenomena, 
DNA methylation and histone modifications are well known markers. CpG islands (CGIs) are the key 
epigenomic elements in mammalian genome. CGIs are defined as the segments of the genome that 
show increased level of CpG dinucleotides and GC content. These CGIs are enriched at genes, about 
60% of all genes in the human genome containing a CGI upstream. DNA methylation at CGIs is one of 
the most intensively studied epigenetic mechanisms. It is fundamental for cellular differentiation and 
control of transcriptional potential. DNA methylation is involved also in several processes that are 
central to evolutionary biology, including phenotypic plasticity and evolvability. Furthermore, histone 
modifications in CGIs are associated with the changes in chromatin states and with transcription 
activity. Changes in gene expression play a crucial role in adaptation and evolution. Considering the 
role of DNA methylation and histone modifications in gene expression changes, our aim was to 
explore the relationship between these two epigenetic marks and selective pressure in human 
genome. 
 
In the first step, we explored a relationship between CpG islands methylation and signatures of 
selective pressure in Homo sapiens, using a computational biology approach. For this we analyzed 
methylation data of 25 human cell lines from the Encyclopedia of DNA Elements (ENCODE) 
Consortium. To define regions under selective pressure, we used three distinct signatures that mark 
selective events from different evolutionary periods. We compared the DNA methylation of CpG 
islands in genomic regions under selective pressure with the methylation of CpG islands in the 
remaining part of the genome. We found that CpG islands in the regions under selective pressure are 
undermethylated than the CpG islands of the other group. 
 
In the second step, we have studied, using a computational biology approach, the relationship 
between histone modifications in CGIs and selective pressure in Homo sapiens.  We considered three 
histone modifications: histone H3 lysine 4 trimethylation (H3K4me3), acetylation of histone H3 at 
lysine 27 (H3K27ac) and trimethylation of histone H3 at lysine 36 (H3K36me3), and we used the 
publicly available genomic-scale histone modification data of 23 human cell lines. To define regions 
under selective pressure, we used the similar approach as used in the first step. We found that, CGIs 
under selective pressure showed significant enrichments for histone modifications.  
 
In conclusion, our overall findings suggest that CpG islands that experienced selective pressure are 
characterized by distinct epigenetic signatures. 
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Chapter 1: Background 
Epigenetics and its mediators 
Epigenetics has been one of the most thrilling terms in the field of biological research. Literally the 
term “epigenetic” means “in addition to changes in genetic sequence.” Conrad Waddington in 1942 
first mentioned ‘‘Epigenetics’’ to interpret the process during development by which genotype gives 
rise to phenotype (Waddington 1942). Since the term was introduced to the scientific community, 
various researches suggested that gene function could be altered by more than just the changes in 
gene sequence. The modern and generally accepted definition of epigenetics is the study of changes 
in gene function that are stably heritable and that do not entail a change in DNA sequence (Berger et 
al. 2009). Over the last few years, the development of several genomic and proteomic technologies 
like next-generation sequencing (NGS), chromatin immuno precipitation (ChIP-Seq) have provided a 
broader view of the epigenome which refers to the complete description of these potentially heritable 
changes across the genome (Park 2009; Dunham et al. 2012).  
 
Several molecular mechanisms mediate epigenetic phenomena including DNA methylation, histone 
modification, chromatin remodeling and micro RNA (Tammen et al. 2012).  Among those, DNA 
methylation and histone modifications (table 1.1) are the most studied epigenetic mediators. The 
role of epigenetics in various diseases especially in cancer is well studied (Dawson and Kouzarides 
2012). However, studies concerning the link between epigenetics and evolution are still limited (see 
the paragraph epigenetics and evolution). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1: Chromatin modifications, readers, and their functions (Dawson and Kouzarides 2012). 
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DNA methylation 
In mammalian cells, DNA methylation is a chemical modification by a methyl (-CH3) group added by 
the enzymatic family of DNA methyltransferases (DNMTs) on C5 position of cytosine in DNA molecule 
that results 5-methylcytosine (Figure 1.1). It occurs almost exclusively at CpG dinucleotides where a 
cytosine nucleotide occurs next to a guanine nucleotide (Bird 2002; Jones and Liang 2009). In human 
somatic cells, ~70–80% of cytosine in CpG sites is methylated (Chen and Riggs 2011).  
 
 
 
 
 
 
 
 
 
                      Figure 1.1: DNA methylation; addition of methyl group in 5C of cytosine 
 
Although most CpG dinucleotides are methylated, the genome also contains CpG islands (CGIs), a 
short CpG-rich genomic regions, which are usually unmethylated (discussed below). Though 
methylation in other sequences has been reported in mammals (Lister et al. 2009), the function of 
non-CpG methylation is currently unknown. DNA methylation is involved in several key processes like 
X chromosome inactivation, genomic imprinting and silencing of germline specific genes and repetitive 
elements (Bird 2002; Jones and Liang 2009), and is essential for normal development (Eckhardt et al. 
2006). Methylation at CGIs promoter is often associated with the shutdown of respective genes and 
aberrant DNA methylation is found to occur in various types of cancer, leading to silencing of some 
tumor suppressor genes (Bird 2002; Dawson and Kouzarides 2012; Lopez-Serra and Esteller 2012). In 
mammal, three different DNMTs namely DNMT1, DNMT3a, and DNMT3b catalyze and  maintain DNA 
methylation throughout the cell cycle (Jones and Liang 2009). Among the three enzymes DNMT1, 
which has preference for hemimethylated CpG sites, is mainly involved to copy pre-existing 
methylation patterns to the newly synthesized strand during the cell cycle (Jones and Liang 2009) 
probably with the help of the protein UHRF1 which binds hemimethylated sites. In addition, both 
DNMT3a and DNMT3b are de novo methyltransferases and they have no affinity for hemimethylated 
CpG substrates in vitro (Okano et al. 1998; Gowher and Jeltsch 2001). DNMT3a/3b are reported to be 
responsible to establish methylation patterns during early development (Okano et al. 1999). De novo 
methylation by DNMT3a/3b also contributes to the maintenance of DNA methylation patterns (Liang 
et al. 2002; Chen et al. 2003), perhaps by methylating CpG sites overlooked by DNMT1 (Riggs and 
Xiong 2004; Jones and Liang 2009). 
 
Histone modification 
Chromatin is a complex of DNA and proteins (histones). Histone proteins help packaging the DNA by 
forming nucleosome around which 147 base pairs of DNA are wrapped. Nucleosome is a basic unit of 
DNA composed of an octamer consisting two copies of four core histones: H3, H4, H2A and H2B (Luger 
et al. 1997).  
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Histone proteins can be modified covalently by different molecules in their N-terminal tails (Table 1.1). 
Mainly studied covalent modification of histones includes acetylation of lysines, methylation of lysines 
and arginines, phosphorylations of serines and threonines (Figure 1.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Covalent modifications of the N-terminal tail of the canonical core histones. 
Phosphorylations are shown as yellow circles, acetylations as red squares, and methylations as 
bluehexagons (Lund and Van Lohuizen 2004). 
 
These modifications can either activate or repress transcription of associated genes depending on the 
types of amino acids and modifications (Kouzarides 2007; Blomen and Boonstra 2011). The best-
characterized sites of histone modifications are those that occur on lysine residues. Methylation of 
some lysine residues (e.g. H3K4, H3K36 and H3K79) is often associated with active genes, whereas 
others (H3K9, H3K27 and H4K20) are associated with inactive genes. In general, acetylation of lysine is 
linked to transcriptional activation (Barski et al. 2007; Kouzarides 2007).  
 
In our study, we are particularly interested on histone H3 lysine 4 trimethylation (H3K4me3), histone 
H3 lysine 27 acetylation (H3K27ac) and histone H3 lysine 36 trimethylation (H3K36me3) considering 
their role in gene activations. 
 
H3K4me3: H3K4me3 is functionally important histone mark, associated with transcription activation 
(Kouzarides 2007). It is found that H3K4me3 clearly peak at 5' ends of annotated human genes 
(Guenther et al. 2007). It is intriguing to find the co-occurrence of the activating H3K4me3 with the 
repressive H3K27me3 mark in embryonic stem cells (ESCs) on silent transcription state (Bernstein et 
al. 2006; Mikkelsen et al. 2007). These bivalent domains are poised between the states, active 
transcription or stable repression. Upon differentiation, losing H3K27me3, they can become active or 
be subject to more stable transcriptional repression (Deaton and Bird 2011). Like DNA methylation, 
H3K4me3 mark plays a crucial role in mammalian development (Bernstein et al. 2006). Alteration of 
this mark is found to be associated with cancer and other diseases (Kaneda et al. 2009; Ke et al. 2009; 
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Sandgren et al. 2010). In mammals, the trimethylation of H3K4 is maintained by different histone 
methyltransferases, such as MLL1 or ASH1L (Dou et al. 2006; Gregory et al. 2007). The discovery of 
histone lysine demethylase enzymes indicates that histone methylation is a biochemically dynamic 
state (Shi et al. 2004). Lysine demethylase enzymes for H3K4me3 have been found on active 
promoters indicating that methylation of H3K4me3 on active genes may display a cyclic behavior. 
KDM5B/Jarid1B/PLU1 belonging to the JmjC domain-containing family of histone demethylases, is an 
H3K4me3/me2-specific lysine demethylase (Lloret-Llinares et al. 2012) 
 
H3K27ac: The acetylation of lysine residues is a major histone modification involved in transcription, 
chromatin structure, and DNA repair (Dawson and Kouzarides 2012). Among all lysine acetylations 
H3K27ac is known as promoter mark associated with transcriptional activation (Wang et al. 2008). 
H3K27ac is a evolutionarily conserved mark among species (Woo and Li 2012). Also this mark is an 
important enhancer mark that can distinguish active from poised enhancer elements (Creyghton et al. 
2010). Acetylation of H3K27 is catalyzed by the acetyltransferases p300 and CBP (Tie et al. 2009; Pasini 
et al. 2010). p300 and CBP are important  transcriptional and epigenetic regulators (Kalkhoven 2004) 
and dysregulation of their functions is associated with leukemia and other types of cancers. 
Consequently, p300 and CBP are generally considered  as anti-cancer drug target (Wang et al. 2013). 
The NuRD (nucleosome remodelling and deacetylation complex), which is required for lineage 
commitment of pluripotent cells, mediates deacetylation of histone H3K27 and recruits Polycomb 
Repressive Complex 2 (PRC2) that in turns is necessary for subsequent H3K27 trimethylation at NuRD 
target promoters. It seems that NuRD controls the balance between acetylation and methylation of 
histones, thus precisely directs the genes expression crucial for embryonic development (Reynolds et 
al. 2011).  
 
H3K36me3: H3K36me3 is a gene body mark (Barski et al. 2007), evolutionary conserved between 
human and mouse (Kolasinska-Zwierz et al. 2009). This mark generally is associated with gene 
activation (Wang et al. 2008) specifically transcriptional elongation (Li et al. 2007).  H3K36me3 is also 
found to be associated with alternative splicing, transcriptional repression, dosage compensation, 
DNA replication and repair, DNA methylation and the transmission of the memory of gene expression 
from parents to offspring during development (Wagner and Carpenter 2012). In mammalian cells, 
histone methyltransferase SETD2 is thought to be the only trimethylase of H3K36 (Edmunds et al. 
2007). Loss of SETD2 is found to be involved in the development of sporadic clear renal cell carcinoma 
(Duns et al. 2010). SETD2 has also been hypothesized to be a tumour suppressor in breast cancer 
(Newbold and Mokbel 2010). Histone demethylase JHDM3A (jumonji C (JmjC)-domain-containing 
histone demethylase 3A; also known as JMJD2A) is capable of removing trimethylation of H3K36 
(Klose et al. 2006). 
 
CpG island (CGIs), a platform for epigenetic gene regulation 
CGIs are considered as the key epigenomic elements in mammalian genome. CGIs were first defined 
as the fraction of genome characterized by low level of DNA methylation (Bird et al. 1985). Later, 
based on the CpG content of the DNA sequence, CGIs were defined as the segments of the genome 
that show increased level of CpG dinucleotides and GC content (Gardiner-Garden and Frommer 1987; 
Takai and Jones 2002). CGIs are considered to be the promoter mark of vertebrate genome since 
approximately 70% of annotated gene promoters are associated with a CGI (Saxonov et al. 2006). This 
association suggests the regulatory role of CGIs. It is well established that CpG sites in promoter CGIs 
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are undermethylated in expressed genes, while hypermethylation of promoter CpG sites is associated 
with gene silencing  (Jones 2012).  Almost all the housekeeping genes, some tissue-specific genes and 
developmental regulator genes are associated with CGIs (Larsen et al. 1992; Zhu et al. 2008).  
 
CGIs that do not co-localize with annotated promoters have been found in intragenic, 3', and 
intergenic regions (Medvedeva et al. 2010). These kinds of CGIs were termed as ‘‘orphan’’ CGIs in 
another study (Illingworth et al. 2010).  Though the functions of orphan CGIs is not well understood 
yet, it has been reported that some orphan CGIs might represent alternative promoters of nearby 
annotated genes (Maunakea et al. 2010). A subset of intergenic orphan CGIs having peaks of 
H3K4me3 are assocoated with  transcription start sites (TSSs) for long noncoding RNAs (Guttman et al. 
2009). 
 
Using evolutionary modelling, Cohen et al. reclassified CGIs as hypo deaminated CGIs, ~80% of these 
are present within 10 kb of an TSS and show strong overlap with H3K4me3; and those that had arisen 
as a by-product of biased gene conversion (BGC), are typically constitutively hypermethylated (Cohen 
et al. 2011). Recently, another study identified non-polymorphic species-specific CpG dinucleotides 
(termed “CpG beacons”) as a distinct genomic feature associated with CGI evolution, human traits and 
disease (Bell et al. 2012). 
 
CGIs can either be permissive or repressive for transcription mediated by epigenetic state. By building 
a chromatin-based atmosphere CGIs are thought to contribute to the functional output of related 
genes (Blackledge and Klose 2011). 
 
Permissive state 
Though CGIs are associated with mammalian gene promoters but still it is not completely understood 
how CGIs execute their role in gene regulation. Earlier studies reported that high levels of histone H3 
and H4 acetylation which are the marks of active chromatin, are associated with CGIs (Tazi and Bird 
1990; Birney et al. 2007; Wang et al. 2008; Su et al. 2010). There is a robust  correlation between the 
active promoter mark, H3K4me3 sites and CGIs (Clouaire et al. 2012). CpG density in CGIs positively 
correlates to H3K4me3 level mediated by Cfp1 (CxxC finger protein 1), that recognizes non-methylated 
CpG is a fundamental component of the Setd1 H3K4 methyltransferase complex (Voo et al. 2000; Lee 
and Skalnik 2005; Illingworth et al. 2010). Several transcription factors like Sp1, CREB (Mancini et al. 
1999) and CTCF (Renda et al. 2007) contain CpG in their binding site but CpG methylation often blocks 
their recognition sites. 
 
Histone mark H3K36me2, known to inhibit transcriptional initiation (Strahl et al. 2002; Li et al. 2009), 
is found to be depleted in CGI chromatin compared to the non-CGIs promoters and gene body. 
Depletion of H3K36me2 was also found to be linked to the appearance of the H3K36me3 state 
(Blackledge et al. 2010) which is a gene body histone mark and associated with actively transcribed 
genes (Mikkelsen et al. 2007). The histone demethylase Kdm2a, a CxxC domain protein that binds 
particularly to unmethylated CpG, mediates demethylation of H3K36me2 (Tsukada et al. 2006; 
Blackledge et al. 2010). Hence, reduction of H3K36me2 may contribute to a transcriptionally 
permissive state at CGIs. Both modifier proteins Cfp1 and Kdm2a depend on CpG density to influence 
chromatin modification (Figure 1.3).  
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Repressive state 
CGIs promoter can be silenced by DNA methylation and polycomb-mediated mechanism (Figure1.3). 
CGIs are not methylated when located at transcription start sites (TSSs). Usually CGIs are 
unmethylated compared to the other heavily methylated genome. It is well known that some CGIs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. The chromatin state at CGIs. (A) Transcriptionally permissive unmethylated CGIs, marked 
by histone acetylation (H3/H4Ac) and H3K4me3, which is directed by Cfp1, and show Kdm2a-
dependent H3K36me2 depletion. Nucleosome deficiency and constitutive binding of RNAPII may also 
contribute to this transcriptionally permissive state. (B) DNA methylation associated stable long-term 
silencing of CGI promoters mediated by MBD proteins, which recruit corepressor complexes 
associated with HDAC activity, or may be due to directed inhibition of transcription factor binding by 
DNA methylation. (C) Polycomb mediated silencing of CGIs. An unknown CGI-binding factor could be 
responsible to recruit PRC2 to CGIs that trimethylates H3K27. This H3K27me3 is recognized by PRC1 
complexes that act to inhibit transcriptional elongation, thereby silencing genes. (Deaton and Bird 
2011). 
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acquire methylation during normal differentiation, which leads to the stable silencing of the 
associated promoter (Stein et al. 1982; Mohn et al. 2008; Payer and Lee 2008). DNA methylation can 
destroy permissive chromatin environment by inhibiting the ZF-CxxC domain proteins that specifically 
recognizes CpG dinucleotides (Blackledge et al. 2010; Thomson et al. 2010). Also methylated CpG acts 
as binding sites for methyl CpG binding domain proteins (MBDs) that recruit repressors of 
transcription, histone deacetylase (HDAC) complexes (Figure 1.3) (Meehan et al. 1989; Nan et al. 1998; 
Klose and Bird 2006; Clouaire and Stancheva 2008). 
 
The mechanism of susceptibility of this CGI subset to DNA methylation is not still clear. Studies from 
cancer tissues reported that a polycomb-silenced intermediate state may facilitate the constitutively 
repressed and acquisition of DNA methylation state (Viré et al. 2005; Schlesinger et al. 2006). Unlike 
CGIs at the promoter of annotated genes, orphan CGIs are frequently methylated. CGIs in gene bodies 
are sometimes methylated in a tissue-specific manner (Illingworth et al. 2010; Maunakea et al. 2010; 
Deaton et al. 2011). Elevated methylation of intragenic CGI is found to be correlated with silencing of 
the associated gene.  
 
In addition to DNA methylation, polycomb group proteins (PcG) mediate silencing of CGI promoters 
through two distinct complexes: polycomb repressive complex 1 (PRC1) and PRC2. PRC2 mediates 
H3K27me3, and this mark is recognized by PRC1, which is thought to inhibit transcriptional elongation, 
thus contribute to genes silencing (Figure 1.3). It is noteworthy that the transcriptionally permissive 
and polycomb-repressed states can coexist at CGIs with bivalent domain, predominantly in totipotent 
embryonic cells (Deaton and Bird 2011). 
 
Epigenetics and evolution  
The role of epigenetic modifications in the regulation of gene expression is crucial in eukaryotic 
biology as well as in evolution. Epigenetic states can be influenced by environmental cues to affect 
phenotype for multiple generations. Epigenetic changes in gene expression not only creates heritable 
phenotypic diversity within an individual, but also within populations, independent of genetic 
variation (Richards 2006; Richards 2008). Changes in the regulation of gene expression levels have 
long been thought to play a vital role in evolution and adaptation (Britten and Davidson 1969). It has 
been hypothesized that epigenetic variant could be a novel substrate for natural selection and thus 
participate in the adaptation of species in changing environment (Jablonka and Lamb 1989). 
 
Several studies have reported the association between DNA methylation and epigenomic variation. In 
higher eukaryotes, individuals largely differ each other in their epigenomic chromatin signatures. 
Intra-species epigenomic variation has been found at DNA methylation level in Arabidopsis thaliana 
(Vaughn et al. 2007; Zhang et al. 2008). A recent study showed progressively increased prevalence of 
an epigenetic trait in mice (dietary methyl donors supplemented) in the population over five 
generations. Withdrawal of the dietary supplement resulted loss of that trait after one generation, 
supports the idea that beside genetic variation natural selection can act on epigenetic variation. Their  
finding also suggests that epigenetic changes could underlie rapid adaptation of species in response to 
natural environmental change  (Cropley et al. 2012). In humans, several studies reported the  inter-
individual differences of DNA methylation (Fraga et al. 2005; Flanagan et al. 2006; Gibbs et al. 2010; 
Zhang et al. 2010). Another study showed DNA methylation patterns are associated with genetic and 
gene expression variation in human cell lines (Bell et al. 2011). Comparative studies found significant 
interspecies methylation level differences across tissues between human and other primates (Gama-
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Sosa et al. 1983; Enard et al. 2004). Llamas et al. showed the stability of cytosine methylation patterns 
in DNA from ancient specimens by bisulphite allelic sequencing of loci from late Pleistocene bison and 
suggested that cytosine methylation in ancient DNA provides a powerful means to study the role of 
epigenetics in evolution (Llamas et al. 2012). Whole-genome sequencing of other ancient samples has 
also been demonstrated (Miller et al. 2008; Green et al. 2010; Reich et al. 2010) that open the 
opportunity to explore precisely the correlation of DNA methylation patterns with evolution over 
evolutionary time-frame. 
 
Beside DNA methylation, histone modifications could also contribute to the epigenetic variation. In a 
comparative study, 15 genomic regions in humans associated with histone acetylation were found to 
be conserved for the same epigenetic status in 10 of the orthologous regions in mouse (Roh et al. 
2007). On a larger scale comparison for different histone modifications between human and mouse 
for the chromosomes 21 and 22 and the syntenic chromosomes, reported that genomic locations of 
those epigenetic markers at orthologous loci are strongly conserved, even in the absence of sequence 
conservation. Interestingly, the conservation of histone modification patterns was highest in genomic 
regions proximal to annotated orthologous genes (Bernstein et al. 2005; Wilson et al. 2008). Cain et al. 
proposed that differences in gene expression levels among primates are associated with the changes 
in H3K4me3 (Cain et al. 2011). A recent study identified human-specific changes in H3K4me3 levels at 
TSSs and related regulatory sequences in comparison with chimpanzees and macaques (Shulha et al. 
2012). Using a chemical perturbation of yeast cell model, a recent study found the persistence of 
acetylation variation at some nucleosomes, stabilized by a DNA variance and alteration in other 
nucleosomes, might have experienced  environmental perturbations (Abraham et al. 2012). 
 
Genetic information also affects gain and loss of epigenetic marks in the form of either cis- or 
transacting variation. For instance, trans-acting genetic variation in the genes that encode enzymes 
(e.g. DNA methyltransferase or histone methyltransferase) responsible to add epigenetic marks, could 
contribute to epigenetic variation, while cis-acting variation in the nucleotide sequence at the target 
locus might also play a role in epigenetic regulation (Murrell et al. 2004; Heijmans et al. 2007).  
 
Rapid production of genomic and epigenomic data will facilitate refine our understanding of 
epigenetic mechanisms and connections between these mechanisms and evolutionary change at the 
population level.  
 
Selective pressure and signatures of natural selection 
Selective pressure is the phenomena which alters the behaviour and fitness of living organisms within 
a certain environment. It is the driving force of natural selection and evolution. The recent history of 
the human population is characterized by huge environmental change and emergent selective agents 
(Sabeti et al. 2002). Dramatic changes in environment and lifestyle likely resulted in powerful selective 
pressures for new genotypes that were better suited to the novel environments (Pickrell et al. 2009).  
 
The ability to identify the molecular signature of natural selection provides a powerful tool for 
identifying loci that have contributed to adaptation. Several methods have been developed that 
identify signals from both recent and ancient selection event  in human genome on a genome-wide 
scale (Voight et al. 2006; Sabeti et al. 2007; Pickrell et al. 2009; Green et al. 2010; Pollard et al. 2010). 
These tools could further facilitate the study of the relationship between epigenetic modification and 
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selective pressure in a genomic perspective. Since one of the main effects of selection is to modify the 
levels of variability within and between species, these methods could be roughly classified into two 
groups: the methods in the first group use a population genetic approach, while the second group use 
a comparative approach. Population genetic approaches are mainly used to detect recent selection 
events occurring in a population, comparative approaches, on the other hand, deal data from multiple 
different species, are suitable to detect more ancient selections (Nielsen 2005).  
 
Aims 
Considering the crucial role of epigenetics modifications in gene regulation, our aim was to explore 
the relationship between epigenetic modifications and selective pressure in human genome. In 
particular: 
 
1. In the first step we focused the relationship between cytosine methylation in CpG 
islands and signatures of selective pressure in human genome. 
 
2. In the second step we focused to explore the relationship between histone 
modifications (HeK3me3, H3K27ac and H4K36me3) and signatures of selective 
pressure in human genome. 
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Chapter 2: CpG islands are undermethylated in the genomic regions 
under selective pressure 
 
Introduction 
DNA methylation at CpG sites is one of the most intensively studied epigenetic mechanisms (Pelizzola 
and Ecker 2011). CpG sites are DNA regions where a cytosine nucleotide occurs next to a guanine 
nucleotide. Cytosines in CpG dinucleotides can be methylated to form 5-methylcytosine. Human 
genome contains about 30 million CpGs that exist in a methylated or unmethylated state. A part of all 
CpG sites present in the genome are clustered into CpG islands that are defined as genomic regions 
with increased CpG density. These CGIs are enriched at genes, about 60% of all genes in the human 
genome containing a CpG island upstream (Bird 2002). The methylation status of CGIs can influence 
gene expression (Illingworth and Bird 2009; Pelizzola and Ecker 2011). The hypermethylation at 
promoter CGIs typically results in a decreased transcription of downstream genes (Stein et al. 1982). 
Further, aberrant DNA methylation has been often reported to cause various human diseases (Handel 
et al. 2010; Petronis 2010; Duthie 2011).  
 
Three DNA methyltransferases, namely DNMT1, DNMT3a, and DNMT3b (Jones and Liang 2009) are 
involved in the maintenance of DNA methylation during the cell cycle. When the two parental DNA 
strands are separated in the S-phase of the mitosis, two hemimethylated strands are produced. 
DNMT1 is a component of a protein complex with high affinity with hemimethylated DNA, 
subsequently restoring methylation on the daughter strands (Sharif et al. 2007).  
 
Also demethylation is an important biological mechanism, as illustrated, for example, by the 
demethylation of the paternal and maternal genomes in the zygote after fertilization (Haaf 2006) or 
by the reprogramming of pluripotency cells to differentiated cells (Mikkelsen et al. 2008). 
Nevertheless, the molecular mechanism of DNA demethylation in mammals is disputed, one 
possibility being that cells demethylate their genome by passive demethylation.  
 
Several evidences suggest a dependence of DNA methylation on local sequence content (Bock et al. 
2006). DNA methyltransferases within eukaryotic cells are not free, but they are compartmentalized 
by interaction with nuclear components (Jeong et al. 2009). Thus it is likely that chromatin structure of 
a genomic region will have an important impact on the maintenance of methylation of that region. It 
could be hypothesized that there are genomic regions somehow ‘‘protected’’ in vivo from methylation 
but yet readily accessible to exogenously added soluble DNA methylases (Lin et al. 2007). 
Nonetheless, a complete understanding of the role of DNA methylation and the mechanisms 
responsible for its establishment and maintenance remain elusive (Pelizzola and Ecker 2011). 
 
Many studies focused on the interplay between epigenomic regulation and evolution, because DNA 
methylation is involved in several processes that are central to evolutionary biology, including 
phenotypic plasticity and evolvability (Johnson and Tricker 2010). Changes in the regulation of gene 
expression levels have long been hypothesized to play an important role in evolution (Britten and 
Davidson 1969). Nevertheless, studies specifically addressed to the relation between promoter 
methylation and selective pressure in Homo sapiens are still lacking. 
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Several tools are needed to study the relation between CGIs methylation and selective pressure in a 
genomic perspective. First, we need tools that recognize genomic signals of selective pressure. Many 
methods have been developed to exploit signatures left by natural selection, each signature providing 
distinct information about selective events (Nielsen 2005). Since one of the main effects of selection is 
to modify the levels of variability within and between species, these methods could be roughly 
classified into two groups. To the first group belong the methods that use a population genetic 
approach, while to the second group belong methods that use a comparative approach. While 
population genetic approaches aim to detect recent selection events occurring in a population, 
comparative approaches, involving data from multiple different species, are suitable for detecting 
more ancient selections (Nielsen 2005). By these methods, hundreds of such regions putatively under 
selective pressure have been identified. They are typically as large as few hundreds of kilobases to 
megabases, and may contain many genes. The second requirement to study the relation between 
CGIs methylation and evolution is the availability of methylation data at genomic scale. Recent 
advances in high-throughput sequencing technologies are enabling epigenetics to progress rapidly 
into an ‘omic’ science (Fouse et al. 2010). In particular, the Encyclopedia of DNA Elements (ENCODE) 
Consortium (Meissner et al. 2008; Celniker et al. 2009) is providing masses of methylation data that 
may be accessed and used by the entire scientific community. The analysis of these relevant datasets 
by computational methods could complement experimental approaches to further our understanding 
of DNA methylation (Bock and Lengauer 2008; Soojin and Goodisman 2009). 
 
In this study, we explored the relationship between CGIs methylation and signatures of selective 
pressure in Homo sapiens, using a computational methodology. We compared the CGIs methylation 
level in genomic regions under selective pressure with CGIs localized in the remaining genome. We 
evaluated DNA methylation levels both by direct analysis of CpG methylation in cell lines and by an 
indirect approach that uses the analysis of genetic variation inside CGIs. To define genomic regions 
under selective pressure, we used three different methods oriented to provide information about 
selective events happened in different periods of human evolution. Independently of the methods 
used both to evaluate CGIs methylation and to estimate selective pressure, we found evidences of 
undermethylation of CGIs in human genomic regions that undergone selection. 
 
Results 
DNA methylation in cell lines and signatures of selective pressure 
Based on datasets available in public repository we estimated the CGIs methylation in 25 cell lines. 
Genomic coordinates of 28691 CGIs were obtained from UCSC Genome Browser ‘‘CpG Islands’’ track. 
As known, USCS CGIs file contains also data related to sequence for alternative haplotypes (present 
mainly in chr 6, for the inclusion of alternative versions of the MHC region). Of course, in our analysis 
we filtered the file excluding these duplicated data. Excluding CGIs corresponding to sequences for 
alternative haplotypes, we obtained 27718 unique CGIs.  
Cell line methylation data were obtained by downloading them from UCSC Genome Browser ‘‘HAIB 
Methyl RRBS’’ track. This track reports the percentage of DNA molecules that show cytosine 
methylation at specific CpG dinucleotides in several cell lines. The 25 cell lines that we used could be 
roughly divided in three groups: cancer transformed cells (n= 6), EBV transformed cells (n= 2) and 
normal untransformed cells (n= 17). The complete list of the cell used, with their characteristics are 
shown in Supplimentary table 2.1. We extracted only the methylation values of those CpGs that were 
localized inside CGIs (order 105 per cell line). 
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To estimate the methylation of each CpG island we calculated the mean of all CpGs methylation 
values into a CpG island. We were able to estimate the methylation status of about 104 CGIs for each 
cell line. Supplimentary table 2.2  lists, for each cell type, the description of the CpGs analyzed. As 
expected, the CGIs mean methylation values were higher in Cancer Transformed (mean = 26.91, SE =  
2.84) and lower in Normal Untransformed cells (mean = 14.34, SE = 0.57), EBV transformed cell 
showing intermediate levels (mean = 18.93, SE = 1.46) (Figure 2.1). 
 
 
 
 
 
 
 
 
 
Figure 2.1: Histogram of CGIs mean methylation values (y-axis) and their Standard Errors for each cell 
line group: Cancer Transformed (CT), EBV transformed (EBV), and Normal Untransformed (NU). 
 
To explore the possible relationship between CGIs methylation and selective pressure we compared 
the methylation of the CGIs inside genomic regions showing signature of selective pressure with the 
methylation of the CGIs in the remaining genomic regions.  
 
To obtain genomic regions with signatures of selective pressure, we used three different approaches. 
As first approach, we used the per-continent Integrated Haplotype Score (iHS) (Voight et al. 2006). 
This score belongs to the Extended Haplotype Homozygosity (EHH) statistic ‘‘family’’ (Sabeti et al. 
2002). The iHS measures the decay of identity, as a function of distance, of haplotypes that carry a 
specified ‘‘core’’ allele at one end and it is considered a measure of recent positive selection. The 
normalized iHS scores (see materials and methods) were obtained from UCSC Genome Browser 
‘‘HGDP iHS’’ track. 
 
To define genomic regions putatively under selective pressure by this method, we scanned normalized 
iHS scores across the whole genome and selected the genomic intervals where iHS score values ≥ 2. 
Once detected such compact regions, we extended their boundaries to the nearest loci where iHS was 
exactly vanishing. According to these criteria, 586 regions were identifies. We denoted these regions 
as ‘‘High iHS regions’’ (HIR). Supplimentary table 2.3 reports the HIRs that we identified and their 
boundaries. Next we identified CGIs localized within HIRs. We found that 2545 CGIs were localized 
inside HIRs whereas the remaining 26146 were placed outside. We compared the methylation of CGIs 
inside HIRs with the methylation of CGIs localized outside these regions. 
 
Figure 2.2 shows the results obtained. In all cell lines analyzed, the CGIs inside HIR regions were less 
methylated than the CGIs in the remaining part of the genome. The differences were highlystatistical 
significant (Bootstrap p-value≤10-4) in all cell lines analyzed. Supplimentary table 2.4 reports in detail 
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the results of this analysis. The Bootstrap procedure adopted to evaluate the difference between 
means of distributions is described in Materials and Methods. 
 
An additional method able to detect regions putatively under selective pressure is represented by the 
Selective Sweep Scan (S) score, which is based on the comparison of Homo Sapiens DNA with 
Neanderthal DNA (Green et al. 2010). This score, when positive, indicates more derived alleles in 
Neanderthal than expected, given the frequency of derived alleles in human. On contrary, a negative 
score indicates fewer derived alleles in Neanderthal, and may suggest an episode of positive selection 
in early humans, after divergence with Neanderthal and before human populations divergence. We 
used the 212 regions with S scores in the lowest 5% of the distribution (5% Lowest S Regions, 5LSR) 
contained in the UCSC Genome Browser (see materials and methods). Supplimentary table 2.5 reports 
the regions used with their relative boundaries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Methylation of HIR CGIs compared to methylation of CGIs in other genomic regions. For 
each cell line, the mean methylation value of CGIs inside HIR regions (open bars) and of the CGIs in the 
remaining part of the genome (closed bars) are reported. Inset shows the same data summarized by 
cell group (Cancer Transformed = CT, EBV transformed = EBV, Normal Untransformed = NU). Values 
are means +/− Standard Error (SE). 
 
We found that 348 CGIs were localized inside 5LSRs and the remaining 28343 outside them. Figure 2.3 
shows the results obtained by comparing the methylation of CGIs inside 5LSRs with the methylation of 
CGIs localized in the other regions of the genome. 
 
Also for this different measure of selective pressure, in all cell lines analyzed, CGIs inside regions under 
selective pressure were less methylated than the remaining CGIs. The differences were highly 
statistical significant (Bootstrap p-value<10-3) in 17 cell lines analyzed, but did not reach this 
significance in 8 cell lines (p<0.05). Nevertheless, combining the results of all 25 cell lines by means of 
the test statistic - 2 log (p1, p2 … p25), where p1, p2 … p25 are the p-values of the individual tests, we 
reached a combined statistical significance much less than 10-3. Supplimentary table 2.6 reports in 
detail the results of the analysis. 
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Figure 2.3: Methylation of 5LSRs CGIs compared to methylation of CGIs in other genomic regions. 
For each cell line, the mean methylation value of CGIs inside 5LSRs regions (open bars) and of the CGIs 
in the remaining part of the genome (closed bars) are reported. Inset shows the same data 
summarized by cell group (Cancer Transformed = CT, EBV transformed = EBV, Normal Untransformed 
= NU). Values are means +/− SE. 
 
To check if the results could be due to the same CGIs identified by both methods, we searched for 
CGIs that are both within HIRs and within 5LSRs. We found only 70 CGIs in common between these 
two groups, indicating that the results obtained by the two methods are driven by different sets of 
CGIs. In addition, excluding these 70 CGIs from the analysis, the result continued to be highly 
significant both for HIRs and 5LSRs (data not shown). It is intriguing to note that these 70 CGIs were 
less methylated when compared both to the remaining HIR CGIs and 5SLR CGIs, but the differences 
were not statistical significant (data not shown). 
 
To further define regions under selective pressure, we decided to use a third and last approach that 
looks for sequences that are conserved across species (Pollard et al. 2010). By this approach, 
conserved regions are defined as genomic regions with a reduced rate of evolution compared to what 
is expected under neutral drift. Several methods for detecting conserved regions in multiple 
alignments have been described. We used data downloaded from UCSC Genome Browser 
Conservation (cons46way) Track, which lists 725627 Conserved Elements (CEs) that were predicted to 
be conserved among primates (Siepel et al. 2005). 
 
We Identified 26936 CEs located inside 14391 CGIs, by filtering all genomic CEs by CGIs. Excluding CGIs 
corresponding to sequences for alternative haplotypes, we obtained 13288 unique CGIs containing 
25362 CEs. We named ‘‘CE CpG islands (CE CGIs)’’ those CGIs that contain at least one conserved 
element. For each cell line, we compared the methylation of CE CGIs with the methylation level of the 
remaining CGIs not containing conserved elements. 
In all the cell lines analyzed, CE CGIs were less methylated than CGIs that do not contain conserved 
elements (Figure 2.4). The differences were highly statistical significant (Bootstrap p-value<10-4) in all 
lines analyzed. Supplimentary table 2.7 reports in detail the results of this analysis. 
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Since the number of CE CGIs is higher than that of HIR CGIS and 5SLR CGIs, it could be possible that all 
HIR CGIs and 5SLR CGIs are contained in the CE CGI group. In this case the results we found with HIR 
and 5SLR could be due to CE only.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Methylation of CE CGIs compared to methylation of CGIs that do not contain conserved 
elements. For each cell line, the mean methylation value of CE CGIs (open bars) and of the CGIs that 
do not contain conserved elements (closed bars) are reported. Inset shows the same data summarized 
by cell group (Cancer Transformed = CT, EBV transformed = EBV, Normal Untransformed = NU). Values 
are means +/− SE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Venn diagram showing the overlaps among CGIs localized in the regions under selective 
pressure detected by the three methods used. 
 
To check this possibility, we estimated the overlaps between the CGIs lists obtained by the different 
methods (Figure 2.5). We found that 1385 CGIs were in common between CE and HIR (HIR+CE CGIs) 
and 205 were in common between CE and 5SLR (5SLR+CE CGIs).  
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If the phenomena underlying the three signatures (CE, HIR and 5SLR) contributed independently to 
lower the CGIs methylation, we expected that CGIs in regions with two signatures of selective 
pressure showed lower methylation when compared to CGIs in regions with one signature only.  
 
We found that, in all cell lines analyzed, HIR+CE CGIs were less methylated than the remaining CE 
CGIs. The differences were highly statistical significant (Bootstrap p-value< 10-3) in 14 cell lines 
analyzed, but did not reach this significance in 11. In these eleven cell lines the differences were 
significant only at p<0.05 (Figure 2.6, Supplementary table 2.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Histogram of the percentages of methylation of HIR+CE CGIs (open bars) compared to CE 
CGIs (closed bars) for each cell line. Error bars represent standard errors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Histogram of the percentages of methylation of 5SLR+CE CGIs (open bars) compared to CE 
CGIs (closed bars) for each cell line. Error bars represent standard errors. 
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Also 5SLR+CE CGIs were less methylated when compared to the remaining CE CGIs, in all cell lines 
analyzed. The differences were highly statistical significant (Bootstrap p-value, 10-3) in 17 cell lines, 
but did not reach this significance in 8. In these eight cell lines the differences were significant only at 
p<0.05 (Figure 2.7, Supplementary table 2.9). Also in these two cases the joint analysis of all cell lines 
yielded a combined statistical significance much less than 10-3.  
 
In the genome, CGIs are located in 5’, 3’ or in other gene regions, as well as in intergenic regions. We 
decided to estimate the methylation of CGIs located in these different locations to assess if the CGIs 
undermethylation that we found in regions under selective pressure is restricted to CGIs with a 
specific localization. We used the 4 classes of CpG islands described by Medvedeva et al. (Medvedeva 
et al. 2010): 5’ CGIs (in 5’-flank region, 5’ UTR-exon , 5’UTRintron, initial coding exon and initial 
intron), intragenic CGIs (in internal exons and internal introns), 3’ CGIs (in final exons, final introns, 3’ 
UTR exons and 3’ UTR introns) and intergenic CGIs (located at least 3 kb from any known gene 
upstream and downstream). In particular, 5’ CGIs are located in regions that, starting 3 kb upstream 
Transcription Start Site, extend till the first intron. Considering all cell lines, 5’ CGIs showed the lowest 
methylation level (weighted mean = 9.01), intragenic and 3’ CGIs showed the highest values 
(respectively, weighted mean = 55.21 and 42.59) and intergenic CGIs showed intermediate 
methylation values (weighted mean = 21.31). For each cell line, the differences among CGIs 
methylation of different genomic regions were high statistical significant (Kruskal-Wallis Test, p-value 
≤ 2.2 10-16) (Supplementary table 2.10).  
 
Next we divided CGIs with signature of selective pressure according the above described classes. 
Unfortunately, for intragenic and 3’ classes, we did not obtain a number of HIR CGIs and 5LSR CGIs 
sufficient to perform a consistent statistical analysis. In particular, in these classes we found about 80 
HIR CGIs and less than 10 5LSR CGIs. 
 
We were able to perform statistical analysis only by using CE as signature of selective pressure. In all 
cell lines but 2 (which were both cancer cell lines), 5’ CGIs in CE regions were undermethylated when 
compared to 5’ CGIs located outside CE regions (Bootstrap p-value,10-4). Intragenic and 3’ CGIs 
located in CE regions showed no differences in methylation when compared to intragenic and 3’ CGIs 
outside CE regions. In all cell lines, intergenic CGIs in CE regions were severely undermethylated when 
compared to intergenic CGIs located outside CE regions (Bootstrap p-value <10-4) (Supplementary 
table 2.11). 
 
This first set of experiments suggested that, in different cell lines, the GCIs localized in genomic 
regions under selective pressure are undermethylated. CGIs in regions with two signatures of selective 
pressure (in which CE is involved) showed lower methylation when compared to CGIs in regions with 
one signature only. Furthermore, at least for CE, the CGIs undermethylation that we found in genomic 
regions under selective pressure is specifically due by CGIs located at the 5’ and in the intergenic 
regions. 
 
Genetic variation inside CpG islands and signatures of selective pressure 
We decided to estimate the CGIs methylation by a different, indirect approach. It is well settled that 
5-methylcytosine is the initial molecule in the deamination reaction that generates thymine; thus, 
methylation may be required for increased mutation rates at CpG sequences. We predicted that CGIs 
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localized in regions under selective pressure, being less methylated, would be less likely to mutate. 
Under this hypothesis, these CGIs should show a lower degree of genetic variation among individuals. 
 
To evaluate the degree of genetic variation in CGIs, we calculated the frequency of SNPs present in 
each CGI. Among the 26033053 SNPs from dbSNP (build 131), we selected the 199514 SNPs that were 
located inside CGIs. To obtain a normalized value of SNP frequency for each CGI, we divided the 
number of SNPs present in each CGI by its size. By this method we were able to calculate the SNP 
frequencies for 25558 CGIs. 
 
We found that, on average, each CGI contained 1.04 SNP/100 bp (range 0.04–63.28). Then we 
compared the SNP frequency of CGIs inside the regions under selective pressure with the SNP 
frequency of CGIs localized in the other regions of the genome.  
 
Figure 2.8 reports the results obtained. The 2345 CGIs localized in HIRs showed a mean of 0.89 
SNP/100 bp in comparison with 1.05 of the other 23213 CGIs (Bootstrap p-value < 10-4).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: SNP content of CGIs in genomic regions under selective pressure compared with CGIs 
localized in other genomic regions. The mean SNP frequencies (SNPs/100 bp) of CGIs in genomic 
regions under selective pressure (open bars) and of CGIs localized in other genomic regions (closed 
bars) are reported. The regions are: A = HIR, B = 5SLR and C = CE). Values are means +/− SE. 
 
The 309 CGIs localized in 5LSRs showed a mean of 0.67 SNP/100 bp in comparison with 1.04 of the 
other 25249 CGIs (Bootstrap p-value < 10-4). The 13286 CE CGIs showed a mean of 0.76 SNP/100 bp in 
comparison with 1.34 of the other 12272 CGIs (Bootstrap p-value < 10-4). 
 
Also for this approach we checked if CGIs in regions with two signatures of selective pressure (HIR+CE 
or 5SLS+CE) showed differences compared to CGIs in regions showing only a signature (CE). We found 
that the 205 5SLR+CE CGIs contained less SNPs than the remaining 13081 CE CGIs (mean= 0.61 
SNP/100 bp vs. 0.76 SNP/100 bp, Bootstrap p-value < 10-4). On contrary, the 1386 HIR-CE CGIs did not 
show any difference in SNP content in comparison with the remaining 11900 CE CGIs (mean= 0.74 vs. 
0.76, Bootstrap p-value = 0.36). 
 
In summary, we demonstrated that the CGIs localized in regions showing signatures of selective 
pressures contain less SNPs than CGIs in other regions of the genome. When compared to CGIs in 
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regions with one signature only, CGIs in regions with two signatures of selective pressure showed 
differences in the case of 5SLR but not for HIR. 
 
Discussion 
One of the most studied epigenetic modifications is the DNA methylation, which is evolutionarily 
ancient and associated with regulation of gene transcription (Law and Jacobsen 2010). DNA 
methylation could be central both to the ability of a population of organisms to change its phenotype 
in response to changes in the environment and to its ability to generate genetic diversity and evolve 
through natural selection (Johnson and Tricker 2010). The evolutionary conservation and divergence 
of epigenetic mechanisms in eukaryotes have started to be revealed by genetic and genomic studies 
of various organisms (Law and Jacobsen 2010). A general scenario that seems to emerge is that the 
epigenetic marks and the mechanisms that establish these marks are basically ancient and conserved, 
but the precise details of how these marks function within genomes is far to be completely clarified. 
An intriguing question is how evolutionary forces have adapted epigenetic mechanisms to the needs 
of the specific organism and, within a species, to the needs of a specific population.  
 
In this study we searched for possible differences in DNA methylation between genomic regions under 
selective pressure and the remaining genome. We focused on CpGs inside CpG islands and on the 
species Homo sapiens. We chose a genome-wide approach using computational biology methods. 
 
One of the difficulties in this kind of study concerns the methods to be used to detect signatures left 
by natural selection. Despite the many methods that have been developed, up to now no method 
could be considered the ‘‘best one’’. Each method apparently provides distinct information about 
selective events (Nielsen 2005). To overcome this limit we decided to use three different approaches. 
The first one, the iHS score (Voight et al. 2006), is a population genetic approach. The general idea of 
this method is to search for haplotypes longer than expected, the so-called ‘‘long-range haplotype’’. 
An allele under selection increases in frequency so rapidly that long-range associations with 
neighboring polymorphisms are not disrupted by recombination. Generally this approach is thought to 
provide evidence for recent positive pressure (Voight et al. 2006), ‘‘recent’’ meaning after the human 
population separation. The second method defines as ‘‘under selective pressure’’ the regions of the 
human genome with a strong signal for depletion of Neanderthal-derived alleles. The presence of 
these signals may mark an episode of positive selection in early humans, after the separation from 
Neanderthal (Green et al. 2010). The third and last method belongs to the comparative approaches, 
involving data from multiple different species. Methods for detecting signatures of selection from 
rates and patterns of substitution have a long history in the field of molecular evolution (Petronis 
2010). The method that we used (Pollard et al. 2010) is aimed to identify conserved elements in 
primates allowing to test hypotheses about selective pressures on this particular evolutionary lineage. 
We decided to use these three methods because they provide information about selective events 
happened in different evolutionary times. 
 
Independently of the method that we used, CGIs localized inside regions under selective pressure 
were less methylated than CGIs in other genomic regions. In addition, we found that CGIs in regions 
with two signatures of selective pressure (in which CE is involved) showed lower methylation when 
compared to CGIs in regions with one signature only. This finding suggests that each signature is 
providing distinct information about selective events.  
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We observed CGIs undermethylation in all cell lines analyzed, including different types of normal 
cultured cells (fibroblasts, epithelial cells, myocytes etc.). It is well known that, in a multicellular 
organism, different cell types acquire various functional capabilities by distinct epigenetic 
modifications. Acquired during early development, the cell type-specific epigenotype is maintained by 
cellular memory mechanisms. It is quite surprising that different cells showed similar methylation 
differences. This finding may suggest that the regions under selective pressure are somehow more 
‘‘protected’’ from methylation, independently of the cell type-specific epigenotype. This 
interpretation could be further supported by the analysis of EBV transformed and cancer derived cells. 
Epigenetics of cancer has been deeply studied, and the loss of DNA methylation at CpG dinucleotides 
was the first epigenetic abnormality to be identified in cancer cells (Feinberg and Tycko 2004). The 
role of hypomethylation in activating oncogenes, as well as hypermethylation affects tumor-
suppressor genes has been well established (Feinberg and Tycko 2004). We found that genomic 
regions under selective pressure are relatively less methylated in cancer cells too. This difference 
persists even in a scenario of global hypermethylation that characterizes cancer cells in our 
experiments.  
 
To confirm the results obtained in cell lines, we checked the possible existence of undermethylation in 
regions under selective pressure by a different approach. It is well established in scientific literature 
that the 5methylcytosine present in some CpG sites is subject to mutational pressure by spontaneous 
deamination to thymine (Holliday and Grigg 1993). A fraction of CpG sites in the genome are clustered 
into CpG islands that are thought to be mainly unmethylated (Bird 1986). Since 5-Methylcytosine is 
the initial molecule in the deamination reaction that generates thymine, CpG sequences within CpG 
islands, which are not methylated, would be less likely to mutate. Tomso et al. (Tomso and Bell 2003) 
found a general underrepresentation of polymorphisms in CpG islands, strongly supporting the idea 
that decreased methylation in CpG islands leads to decreased variation at island CpGs. Using the same 
way of reasoning, we predicted that, if CGIs in regions under selective pressure were 
undermethylated, they would show less polymorphisms than the CGIs in the remaining genome. 
 
Independently of the method used to define the regions under selective pressure, we found that CGIs 
inside regions under selective pressure contain less SNPs than the CGIs in the remaining genome. 
When we compared CGIs in regions with two signatures of selective pressure to CGIs in regions with 
one signature only, we found that CGIs showing both 5SLR and CE signatures contained less SNPs than 
CGIs showing CE signature only. On the contrary, when we compared CGIs showing both HIR and CE 
signatures to CGIs showing CE signature only, we found no differences in SNP content. A possible 
explanation is that the selective pressure that acted on HIRs was very recent. Its effect could be 
evident in cell CGIs methylation but not (or not yet) in genetic variation. 
 
CGIs can be located inside the genes or outside them. CGIs located inside genes can be divided, 
according their position, in CGIs in 5’ region, CGIs in the 3’ regions and CGIs in internal exons or 
introns. CGIs located near 5’ region of genes are known to influence gene expression but also CGIs 
located outside these regions can be involved in important biological processes (Smilinich et al. 1999; 
Ramser et al. 2008; Illingworth and Bird 2009). We decided to analyze the methylation of CGIs, 
categorized by their position, to assess if the CGIs undermethylation that we have found in regions 
under selective pressure was a general phenomenon or it was restricted to CGIs with a specific 
localization. We were able to analyze only CE CGIs because, after classification, the number of HIR 
CGIs and 5LSR CGIs in intragenic and 3’ regions was too low to perform a reliable statistical analysis. 
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We found that, at least for CE, the CGIs undermethylation in regions under selective pressure 
specifically involved CGIs located at the 5’ and in the intergenic regions. For the 5’ regions, the finding 
was quite expected because of their well established role in gene regulation. The functional role of 
intergenic CGIs is less clear. There is a growing evidence of the role of CGIs methylation in the 
regulation of microRNAs (Han et al. 2007). In particular, it has been demonstrated that 80% of the 
promoters of ‘‘intergenic’’ microRNAs contain CGIs. In addition, these regulatory regions show signals 
of evolutionary conservation (Wang et al. 2010). We also cannot exclude that some CGIs categorized 
as intergenic, may be related to yet unidentified genes. 
 
Bock et al. (Bock et al. 2006) developed a computational epigenetics approach to discriminate 
between CpG islands that are prone to methylation from those that remain unmethylated on the 
basis of a set of 1,184 DNA attributes.  One of these attributes was the evolutionary conservation that 
the authors found to be uncorrelated with CpG island methylation. It should be noted that in this 
study (published in 2006) only CGIs on chromosome 21 were analyzed. Further, the methods to 
evaluate evolutionary conservation and for the statistical analysis are not the same that we used. 
 
Our study has some limit. The most important one is the estimation of CGIs methylation. For each CGI 
we have data only on a limited number of CpGs, and from their methylation values we estimated the 
total CGI methylation. It should be noted that the dataset that we used is the largest genome-wide 
dataset available and that, in any case, this could be considered a systematic error that could cause a 
general noise only.  
 
Another limit is that we analyzed the DNA methylation only. Epigenetic control of transcription 
involves a complex network of signals, including transcription factors, noncoding RNAs, DNA 
methylation, and histone modifications (Bonasio et al. 2010). In this study we looked only to a part of 
these mechanisms. Further studies are needed to analyze the other component of this machinery. 
 
Another possible limit concerns the method used to define regions under selective pressure. Other 
methods have been described and our choice could not be exhaustive. A final caveat concerns 
possible cell-culture induced DNA methylation. It is well established that in vitro culture can cause 
changes in epigenetic marking of the genome (Bork et al. 2010; Saferali et al. 2010), probably due to 
the adaptation of the cells to the in vitro conditions. Therefore it should be underlined that, 
concerning DNA methylation, cell lines could be not representative of their relative primary tissues.  
 
In conclusion, in this paper we demonstrated, in several cell lines, that CpG islands in regions showing 
signatures of selective pressure are undermethylated in comparison with the other regions of the 
genome. Additionally, by analyzing SNP frequency in CpG islands, we demonstrated that CpG islands 
in regions under selective pressure show lower genetic variation among individuals. 
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Materials and Methods 
Data and evolutionary scores 
All the data and the scores that we used were downloaded from annotation tracks in the UCSC 
Genome Browser (Sanborn et al. 2011). A brief description is provided below. Further and more 
detailed information about the dataset used can be found at http://genome.ucsc.edu/. 
 
CpG island coordinates 
CGIs genomic coordinates were obtained from the UCSC GB CpgIslandExt track. In this track CpG 
islands were predicted by searching the sequence one base at a time, scoring each dinucleotide (+17 
for CG and 21 for others) and identifying maximally scoring segments. In this dataset, to define a CpG 
island the following criteria were used: i) to have a GC content of 50% or greater, ii) to have a length 
greater than 200 bp, and iii) to show a ratio greater than 0.6 of observed number of CG dinucleotides 
to the expected number, calculated on the basis of the number of Gs and Cs in the segment under 
analysis. 
 
DNA methylation data 
 Methylation profiles from each cell sample were downloaded from the UCSC GB HAIB Methyl RRBS 
Track. These tables report the percentage of DNA molecules that show cytosine methylation at 
specific CpG dinucleotides in several cell lines. To obtain these data, researchers belonging the 
ENCODE Consortium assayed DNA methylation at CpG sites with a modified version of Reduced 
Representation Bisulfite Sequencing (Meissner et al. 2008). We used data from 25 cell lines, which 
were the first ones to come out from the moratorium period (expiration of moratorium period =2011-
04-13). The data set contains, for each cell line at least two replicas each containing, on average, 
about 1.5 million of CpG methylation values. To exclude unreliable data, only methylation signals 
identified by a number of reads ≥10 were used for further analyses. After this filtering, we computed, 
for each CpG the mean value between two replicas, obtaining methylation values of genomic CpGs 
per cell line in the range (5–8) 105. We next selected methylation values of CpG dinucleotides in CGIs, 
filtering them by the CpG Islands track of UCSC-GB. The final CGI methylation value was obtained by 
calculating the mean methylation of all CpGs contained in the CGI. 
 
Integrated haplotype score (iHS) 
The normalized his scores were obtained from UCSC Genome Browser ‘‘HGDP iHS’’ track. The per-
continent integrated haplotype score (iHS) (Voight et al. 2006) is a measure of recent positive 
selection. The scores present in the UCSC Genome Browser were calculated using SNPs genotyped in 
53 populations worldwide by the Human Genome Diversity Project in collaboration with the Centre 
d’Etude du Polymorphisme Humain (HGDP-CEPH). 
 
Samples from 1043 individuals from different geographical regions were genotyped for 657000 SNPs 
at Stanford. The 53 populations were divided into seven continental groups: Africa (Bantu populations 
only), Middle East, Europe, South Asia, East Asia, Oceania and the Americas. 
 
iHS was calculated for each population group and then normalizing the resulting unstandardized iHS 
scores in derived allele frequency bins as described in (Voight et al. 2006). Per-SNP iHS scores were 
smoothed in windows of 31 SNPs, centered on each SNP. The final score is 2log10 of the proportion of 
smoothed scores higher than each SNP’s smoothed score. 
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We converted genome coordinates from assembly NCBI36/hg18 to assembly GRCh37/hg19 by using 
Batch Coordinate Conversion (liftOver) utility (UCSC Genome Browser). We scanned normalized iHS 
scores across the whole genome and selected the genomic intervals where iHS values ≥2. Once 
detected such compact regions, we extended their boundaries to the nearest loci where iHS was 
exactly vanishing. 
 
Selective Sweep Scan: 5% Smallest S scores 
Green et al. identified polymorphic sites among five modern human genomes and determined 
ancestral or derived state of each single SNP (Green et al. 2010). The human allele states were used to 
estimate an expected number of derived alleles in Neanderthal in the 100000-base window around 
each SNP. The measure called S score compare the observed number of Neanderthal alleles in each 
window to the expected number. An S score significantly less than zero indicates an increase of 
human-derived alleles not found in Neanderthal, suggesting positive selection in the human lineage 
since divergence from Neanderthals. Regions with S scores in the lowest 5% (strongest negative 
scores, ‘‘5% Lowest S’’ track of UCSC Genome Browser) were used in our analyses. 
 
Conserved Elements 
Conserved elements were downloaded from the UCSC GB Conservation (cons46way) Track. In this 
track conserved elements were predicted using the methods phastCons and phyloP. Both phastCons 
and phyloP are phylogenetic methods that rely on a tree model containing the tree topology, branch 
lengths representing evolutionary distance at neutrally evolving sites, the background distribution of 
nucleotides, and a substitution rate matrix. Pairwise alignments with the human genome were 
generated for each species using blastz from repeat-masked genomic sequence. The conserved 
elements were predicted using 10 primate species. Primate species used are: Homo sapiens 
(reference species), Pan troglodytes, Gorilla gorilla gorilla, Pongo pygmaeus abelii, Macaca mulatta, 
Papio hamadryas, Callithrix jacchus, Tarsier syrichta, Microcebus murinus, Otolemur garnettii. 
 
Statistical analysis 
In order to test the null hypothesis that two distributions have the same means we use a 
‘‘bootstrapping approach’’. In particular we take the mean of the smaller sample, hereafter denoted 
by m, and compare this value with the probability distribution of mean, p(m), obtained from a large 
number (104) of randomly sampled cohorts of the same size taken from the larger sample. Type I error 
to reject the null hypothesis even if it is true, denoted as ‘‘Bootstrap p-value’’ of the test, by definition 
is the sum of p(m) for m≥m. Since we have 104 cohorts of the larger sample the precision of our 
‘‘Bootstrap p-value’’ is 10-4, which is however small enough since we have fixed the threshold of 
statistical significance at 10-3. All statistical analyses were carried out with Galaxy 
(http://galaxyproject.org/) and R ver. 2.10.1 (R Foundation for Statistical Computing, Vienna, Austria; 
http://www.r-project.org/). 
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Chapter 3: CpG islands under selective pressure are enriched with 
H3K4me3, H3K27ac and H3K36me3 histone modifications 
 
Introduction 
CpG islands (CGIs) are unmethylated segments of a genome that have an increased level of CpG 
dinucleotides and a high GC content (Bird et al. 1985; Illingworth and Bird 2009). In the human 
genome, most CGIs are either inside or close to the promoter regions of genes (Larsen et al. 1992). 
Typically these CGIs occur at or close to  transcription start sites (TSSs) (Illingworth et al. 2010). It is 
well established that CpG sites in promoter CGIs are undermethylated in expressed genes, while 
hypermethylation of promoter CpG sites is  associated with gene silencing (Jones 2012). Others CGIs 
that are distant from known TSSs have been found in intergenic, 3' and intragenic regions 
(Medvedeva et al. 2010).   
 
There is an extensive literature demonstrating that  structural modifications to chromatin, along with 
CGI methylation, contribute to the functional output of related genes (Blackledge and Klose 2011). 
The N-terminal tails of histone proteins can be modified covalently by small molecules (for example, 
phosphorylation, acetylation, methylation) and by macromolecules (for example, ubiquitination, 
sumoylation etc.). The precise environment of the CGI chromatin that controls gene regulation is not 
definitively established. The general understanding is that by altering the state of the CGI chromatin, 
histone modification can regulate access of the transcription machinery to particular DNA sequences 
(Li et al. 2007). Of all the possible histone modifications, methylation of the lysine or arginine residues 
has received the main attention. These modifications can activate or repress the associated genes 
depending on which lysine or arginine residues are methylated (Kouzarides 2007). Methylation of 
histone H3 at lysine 9 (H3K9) or lysine 27 (H3K27) is considered to be a repressive mark (Kouzarides 
2007). In contrast, H3K4me3, perhaps the best established epigenetic marker, is robustly associated 
with activation of transcription (Kouzarides 2007). In mammals, the trimethylation of H3k4 can be 
catalyzed by different histone methyltransferases, such as MLL1 or ASH1L (Dou et al. 2006; Gregory et 
al. 2007). The majority of H3K4me3 sites overlap with the 5' ends of annotated human genes 
(Guenther et al. 2007) and several studies have reported the inverse correlation between two 
epigenetic marks, DNA methylation and H3K4me3 (Okitsu and Hsieh 2007; Balasubramanian et al. 
2012). The H3K4me3 mark also plays a crucial role in mammalian development (Bernstein et al. 2006), 
and its alteration has been found  to be associated with cancer and other diseases (Kaneda et al. 
2009; Ke et al. 2009; Sandgren et al. 2010). In addition, both H3K27ac and H3K36me3, which are 
known as a promoter mark (Wang et al. 2008) and a gene body mark (Barski et al. 2007), respectively, 
are associated with transcriptional activation (Wang et al. 2008; Wagner and Carpenter 2012).   
 
Alterations in gene regulation are thought to play an important role both in adaptation and evolution 
(Britten and Davidson 1969). A recent report proposed that differences in gene expression levels 
among primates are associated with the changes in H3K4me3 (Cain et al. 2011). Moreover, another 
recent study identified human-specific changes in H3K4me3 levels at TSSs and related regulatory 
sequences in comparison with chimpanzees and macaques (Shulha et al. 2012). Besides, the 
Encyclopedia of DNA Elements (ENCODE) project is studying different functional elements of human 
genome including regions of histone modifications. In particular they assayed chromosomal locations 
for 12 histone modification in 46 different cell types (Dunham et al. 2012). In a previous study 
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(Cocozza et al. 2011), we  demonstrated that CGIs under selective pressure are hypomethylated 
compared to the CGIs in other regions of the genome. In this study, we explored the relationship 
between selective pressure signatures of and histone modification (H3K4me3, H3K27ac and 
H3K36me3) enrichment in CGIs. We used the genome-wide histone modification data of thirteen 
human cell lines produced by the ENCODE consortium (Celniker et al. 2009; Ernst et al. 2011). To 
define regions under selective pressure we used three distinct methods (Cocozza et al. 2011) that are 
able to detect both recent and ancient selective pressure events (Nielsen 2005). 
 
Results 
We analyzed thirteen cell lines from the ENCODE/Broad Institute, derived from nine normal and four 
cancer tissues, respectively. A list of features for each considered cell line is presented in 
Supplementary table 3.1. For each cell line, we downloaded histone modification data for H3K4me3, 
H3K27ac and H3K36me3 marks. We used the “Peaks Signal” (PS), representing regions of statically 
significant enrichment of a specific histone modification (see Materials and Methods). We 
downloaded genomic coordinates of 27718 unique CGIs defined according to criteria described in the 
University of California Santa Cruz Genome Browser (UCSC GB) (http://genome.ucsc.edu/) (see 
Materials and Methods). For each cell line, we estimated the number of CGIs containing at least one 
PS of histone modification and found, on average, 15478, 11903 and 10182 CGIs containing PSs of 
H3K4me3, H3K27ac and H3K36me3, respectively.  
 
To identify genomic regions that may have undergone selective pressure we used three different 
approaches that are sensitive to selective pressure events that occurred in distinct evolutionary 
epochs.  
 
The first method uses the per-continent “integrated Haplotype Score” (iHS) (Voight et al. 2006) and 
marks recent positive selection (see Materials and Methods). Using the iHS we identified 586 genomic 
regions that have putatively undergone recent selective pressure. We denoted these regions as ‘‘high 
iHS regions’’ (HIRs). Within the HIRs regions we found 2545 CGIs.  
 
The second approach is based on a comparison between Homo sapiens and Neanderthal genomes 
(see Materials and Methods).  The selective sweep scan score (S score) was used to identify regions of 
the human genome with a strong signal for depletion of Neanderthal-derived alleles. This score, when 
negative, may indicate an episode of positive selection in early humans  (Green et al. 2010). We found 
212 genomic regions with a significant negative score (5% lowest S regions, hereafter denoted as 
5LSRs) containing 348 CGIs.  
 
In the third approach, we looked for sequences that were conserved across ten primate genomes. 
These sequences are the so-called “Conserved Elements” (CEs) (see Materials and Methods) and they 
mark ancient selective pressure events. We downloaded 725627 CEs and used them to search for CGIs 
that contain CEs (Siepel et al. 2005). We identified 13288 unique CGIs that contained at least one CE. 
 
We computed the fraction of CGIs containing histone modification marks that show signatures of 
natural selection (HIRs, CEs and 5LSRs), and compared it with an analogous quantity computed for 
CGIs shown to have no signals of selective pressure. The presence of a possible 
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enrichment/diminishment, defined as the ratio of the percentages of the above two groups, was 
assessed by means of a hypergeometric test (see Material and Methods). 
 
Overall Analysis 
We found a significant enrichment of H3K4me3 and H3K27ac markers for all three signatures of 
selection in almost all cell lines (Figure 3.1, Figure 3.2 and Supplementary table 3.2) while for 
H3K36me3 the enrichment reached significance only for the CE signature (Figure 3.3 and Table 3.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Enrichment of H3K4me3 modification in CpG islands under selective pressure. Black bars 
represent the fraction of CGIs containing histone modification marks within regions that show 
signatures of natural selection (HIRs, CEs and 5LSRs). Grey bars represent the fraction of CGIs 
containing histone modification marks within regions that do not show signatures of selective events. 
The X-axis indicates the analyzed cell lines. An asterisk (*) above a bar indicates a statistically non-
significant difference. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Enrichment of H3K27ac modification in CpG islands under selective pressure. Same 
notation as in Figure 3.1. 
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Figure 3.3: Enrichment of H3K36me3 modification in CpG islands under selective pressure. Same 
notation as in Figure 3.1. 
 
Position Analysis 
We investigated whether or not these differences were dependent on the position of the CGIs in 
various genomic regions. To do this we followed the same approach described by Medvedeva et al. 
(Medvedeva et al. 2010) dividing the CGIs into four groups according to their positions with respect to 
genes: at the 5' end of a gene, in the intragenic region, at the 3' end of a gene, and in the intergenic 
region. Results of this analysis are presented in the Supplementary table 3.3 and summarized below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Enrichment of H3K4me3 modification in 5' CpG islands under selective pressure. Same 
notation as in Figure 3.1. 
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Analysis of 5' CGIs demonstrated the same significant enrichment pattern as seen in the overall 
analysis with significant enrichment of H3K4me3 and H3K27ac (Figure 3.4 and Figure 3.5), in almost all 
cell lines for all signatures of selection, and significant enrichment of H3K36me3 in all cell lines for the 
CE signature only (Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Enrichment of H3K27ac modification in 5' CpG islands under selective pressure. Same 
notation as in Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Enrichment of H3K36me3 modification in 5' CpG islands under selective pressure. Same 
notation as Figure 3.1. 
 
Both intragenic and 3' CGIs were significantly enriched for H3K36me3 in the majority of cells lines 
(nine and ten out of the thirteen, respectively) for the CE signature (Figure 3.7 and Figure 3.8), while 
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analysis of the other markers did not reach significance in almost all other cases (Figure 3.9, Figure  
3.10, Figure 3.11 and Figure 3.12) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Enrichment of H3K36me3 modification in intragenic CpG islands under selective 
pressure. Same notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Enrichment of H3K36me3 modification in intragenic CpG islands under selective 
pressure. Same notation as Figure 3.1. 
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Figure 3.9: Enrichment of H3K4me3 modification in intragenic CpG islands under selective pressure. 
Same notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Enrichment of H3K4me3 modification in 3' CpG islands under selective pressure. Same 
notation as Figure 3.1. 
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Figure 3.11: Enrichment of H3K27ac modification in intragenic CpG islands under selective pressure. 
Same notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: Enrichment of H3K27ac modification in 3' CpG islands under selective pressure. Same 
notation as Figure 3.1. 
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Finally, regarding intergenic CGIs we found a significant enrichment in all cell lines for all considered 
markers for the CE signature and in twelve out of thirteen cell lines for H3K4me3 in the HIR signature 
(Figure 3.13, Figure 3.14 and Figure  3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Enrichment of H3K4me3 modification in intergenic CpG islands under selective 
pressure. Same notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Enrichment of H3K27ac modification in intergenic CpG islands under relective pressure. 
Same notation as Figure 3.1. 
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Figure 3.15: Enrichment of H3K36me3 modification in intergenic CpG islands under selective 
pressure. Same notation as Figure 3.1. 
 
 
Evolutionary forces analysis 
Two major evolutionary forces result in enriched CpG content: one is based on low levels of DNA 
methylation and, consequentially, deamination; and the other is biased gene conversion (BGC), which 
acts to repair TG mismatches caused by the deamination of methyl-cytosine (Cohen et al. 2011). 
According to the role that these two forces play in CGI maintenance, CGIs can be classified as hypo-
deaminated CGIs or BGC CGIs. We examined whether or not the relationship that we found between 
selective pressure and histone mark enrichment was present in both classes. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: Enrichment of H3K4me3 modification in hypo-deaminated CpG islands under selective 
pressure. Same notation as Figure 3.1. 
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We found that both hypo-deaminated and BCG CGIs showed an enrichment of all markers in the CE 
signature in all cell lines, while only BGG CGIs showed significant enrichment of H3K4me3 and 
H3K27ac in the HIR signature in all cell lines (Figure 3.16, Figure 3.17, Figure 3.18, Figure 3.19, Figure 
3.20, Figure 3.21 and  Supplementary table 3.4).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: Enrichment of H3K4me3 modification in BGC CpG islands under selective pressure. 
Same notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Enrichment of H3K27ac modification in hypo-deaminated CpG islands under selective 
pressure. Same notation as Figure 3.1. 
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Figure 3.19: Enrichment of H3K27ac modification in BGC CpG islands under selective pressure. Same 
notation as Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: Enrichment of H3K36me3 modification in hypo-deaminated CpG islands under selective 
pressure. Same notation as Figure 3.1. 
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Figure 3.21: Enrichment of H3K36me3 modification in BGC CpG islands under selective pressure. 
Same notation as Figure 3.1. 
 
 
Discussion 
In this study, we investigated the hypothesis that CGIs under selective pressure are enriched with 
histone modifications that are associated with gene activation. To do this, we analyzed data from 
thirteen human cell lines for three well-known histone modifications (H3K4me3, H3K27ac and 
H3K36me3) to explore their relationship with both recent and ancient events of selective pressure. 
 
H3K4me3 and H3K27ac are epigenetic marks that are generally associated with gene activation 
(Kouzarides 2007; Wang et al. 2008) while H3K36me3 is associated with transcriptional elongation (Li 
et al. 2007). Moreover, H3K4me3 and H3K27ac are evolutionarily conserved among species (Woo and 
Li 2012)  and negatively correlated with DNA methylation (Okitsu and Hsieh 2007; Thomson et al. 
2010; Bell et al. 2011; Balasubramanian et al. 2012). Also H3K36me3 in exons is found to be conserved 
between human and mouse (Kolasinska-Zwierz et al. 2009). 
 
Using the entire set of human CGIs we found that the CGIs associated with signatures of selective 
pressure were significantly enriched with H3K4me3 and H3K27ac in almost all considered cell lines. 
H3K36me3, on the other hand, showed a significant enrichment in global CGIs only in CE regions: this 
could be due to a small sample size effect (Table S2). These findings support a previous study in which 
we found that CGIs located in regions under selective pressure are more protected from DNA 
methylation compared the CGIs in other genomic regions (Cocozza et al. 2011).    
    
When we divided CGIs according to their positions with respect to the genes, we found that the 
statistical differences between CGIs with and without signatures of selective pressure were clearest 
for CGIs located in the 5' regions for both H3K4me3 and H3K27ac. This result is intriguing in the light 
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of the well established evidence that CGIs at the 5' ends of genes are involved mainly in the control of 
gene expression (Ruthenburg et al. 2007). It is also possible that the small sample size led to a lack of 
statistical confidence in the results for CGIs in other positions. We noticed a different behavior for 
H3K36me3. H3K36me3 was the only mark to be enriched in 3' and intragenic CGIs in CE regions for 
majority of cell lines;  this finding is again intriguing considering that H3K36me3 is reported to be a 
gene body mark (Barski et al. 2007; Li et al. 2007).  
 
Two different evolutionary processes, namely hypo-deamination and BCG, are involved in the 
generation and maintenance of CGIs (Cohen et al. 2011). The majority of hypo-deaminated CGIs are 
usually unmethylated while most BGC CGIs are constitutively methylated and clustered in 
subtelomeric regions. We found H3K4me3, H3K27ac and H3K36me3 enrichment in CGIs in CE regions, 
independently of the evolutionary process involved in their generation. Since CGIs belonging to these 
two groups differ in their DNA methylation levels, our finding seems to suggest that the difference we 
found was quite independent of the DNA methylation status.  
 
The impact of natural selection on functional elements in human genome is also addressed in the last 
report from ENCODE project (Dunham et al. 2012). In that case the authors focused their attention 
mainly on the relationship between negative selection and a subset of functional elements but they 
did not specifically address histone modifications. Positive selection, on the other hand, was 
addressed in a recent work by Vernot et al. (Vernot et al. 2012) who studied the impact of this kind of 
selective pressure on DNase I peaks. 
 
It has been hypothesized that CGIs are fundamental regulatory structures that have evolved under 
selection in genomes where DNA methylation plays a regulatory role (Deaton and Bird 2011; Shulha et 
al. 2012). In particular, CGIs act as a platform where chromatin modifications and additional signaling 
help to define the functional output of the respective genes. The present study concerning H3K4me3, 
H3K27ac and H3K36me3 enrichment in  CGIs under selective pressure, supplements a previous study 
by  Cocozza et al (Cocozza et al. 2011).       
 
To our knowledge, the present study is the first report addressing the relationship between histone 
modifications and natural selection and the overall framework emerging from our analyses support 
the hypothesis that CGIs that have experienced selection could be characterized by distinct epigenetic 
signatures. 
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Materials and methods 
Histone modification data 
The histone modification (H3K4me3, H3K27ac and H3K36me3) data for thirteen human cell lines 
(HUVEC, Monocytes-CD14+-RO01746 (CD14+), HMEC, HSMM, HSMMtube, NH-A, NHDF-Ad, NHEK, 
NHLF, K562, HeLa-S3, HepG2 and Dnd41) were downloaded from the “Broad histone” track of the 
UCSC GB. This track contains genome-wide histone modification data of different cell lines, generated 
using ChIP-seq high-throughput sequencing as a part of the ENCODE project (Ernst et al. 2011). In this 
study, we used the “Peaks Signal” (PS), which identifies discrete intervals of ChIP-seq fragment 
enrichment. In particular, we considered the CGIs in our sample that contained at least one PS. 
 
CpG islands 
UCSC CGIs: CGIs coordinates were downloaded from the “CpgIslandExt” track of the UCSC GB 
(http://genome.ucsc.edu/). The CGIs in this track were predicted by searching the human genome 
assembly (GRCh37/hg19) sequence, scoring each dinucleotide and identifying maximally scoring 
segments. In this dataset, a CpG island was defined according to the following criteria: i) GC content of 
50% or greater, ii) length of at least 200 bp, and iii) observed CpG / expected CpG ratio greater than 
0.6. The CGI set that we obtained consisted of 27718 CGIs (this excluded  the CGIs in the data related 
to the alternative haplotype sequences). 
 
5', intragenic, 3', and intergenic CGIs: We used the classification system that was described previously 
by Medvedeva et al. (Medvedeva et al. 2010)  in which the CGIs were classified according to their 
locations. Thus, the CGIs were classified into four classes:  
1) 5' CGIs - located in the 5' flank region (3 kb upstream the TSS), the 5' UTR-exon, the 5' UTR- intron, 
the initial coding exon or the initial intron. 
2) Intragenic CGIs are located in the internal exons and introns. 
3) 3' CGIs are located in the final exon, the final introns, the 3' UTR-exon or in the 3' UTR-intron.  
4) Intergenic CGIs are located at least 3 kb upstream or downstream from any known gene.        
 
Hypo-deaminated and biased gene conversion (BGC) CGIs: Two sets of CGIs were described by Cohen 
et al. (Cohen et al. 2011) using a new parameter-rich evolutionary model in combination with high 
resolution DNA methylation data to study the origin of the CpG repertoire in primate genomes 
(marmoset, rhesus, orangutan, chimp and human). Following a clustering analysis, they observed that 
most CGIs were constitutively unmethylated and underwent slow C-to-T deamination. They denoted 
this group as hypo-deaminated CGIs. In contrast, another class of CGI was constitutively methylated 
with a rapid deamination rate and was termed as BGC CGIs. For our analysis, we considered the 9091 
hypo-deaminated and 4782 BGC CGIs from the UCSC CGIs sample.  
 
Integrated haplotype score (iHS) 
The iHS belongs to the Extended Haplotype Homozygosity statistic “family” (Sabeti et al. 2002) and is 
a marker of recent positive selection (Voight et al. 2006). The iHS measures the decay of identity, as a 
function of distance, of haplotypes that carry a specified ‘‘core’’ allele. We downloaded the iHS 
normalized values from the ‘‘HGDP iHS’’ track of the UCSC GB. The scores were calculated using SNPs 
genotyped in 1043 individual taken from 53 populations worldwide by the Human Genome Diversity 
Project in collaboration with the Centre d’Etude du Polymorphisme Humain (HGDP-CEPH). The 53 
populations were divided into seven continental groups: Africa (Bantu populations only), Middle East, 
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Europe, South Asia, East Asia, Oceania and the Americas. For each population group, the iHS was 
calculated and then normalized (Voight et al. 2006). Per-SNP iHSs were smoothed in windows of 31 
SNPs, centered on each SNP. The final score is -log10 of the proportion of smoothed scores higher 
than each SNP’s smoothed score. For our analysis, we used the Batch Coordinate Conversion (liftOver) 
utility (UCSC GB) to convert the genome coordinates from assembly NCBI36/hg18 to assembly 
GRCh37/hg19. We scanned the normalized iHSs across the whole genome and selected the genomic 
intervals where the iHS was ≥ 2. After these regions were identified, we extended their boundaries to 
the nearest loci where the iHS exactly vanished.  
 
Selective sweep scan (S): the 5% lowest S scores (5LSR) 
The S score is based on a comparison between Homo sapiens DNA and Neanderthal DNA (Green et al. 
2010). We downloaded the regions with S scores from the ‘‘5% Lowest S’’ track of the UCSC GB and 
denoted them as “5LSRs” (5% lowest S regions). Green et. al.  identified polymorphic sites among five 
modern human genomes and determined the ancestral or derived state of each SNP (Green et al. 
2010). The states of the human alleles were used to estimate the expected number of derived alleles 
in Neanderthal in a 100000-base window around each SNP. The S scores were used to compare the 
observed number of Neanderthal alleles to the expected number in each window. A positive S score 
indicates more derived alleles in Neanderthal than expected given the frequency of derived alleles in 
human; a negative S score, on the other hand, indicates fewer derived alleles in Neanderthal, which 
might suggest positive selection in the human lineage after divergence from Neanderthal and before 
divergence in human populations. The 5LSRs represent the regions in the 5% lower percentile of the S 
score.  
 
Conserved elements (CEs) 
CEs are sequences in the genome that are conserved across species (Pollard et al. 2010). Conserved 
regions have a reduced rate of evolution compared to the expected rate under neutral drift. The CEs 
used in this study were downloaded from the “Conservation (cons46way)” track of the UCSC GB. This 
track shows measurements of evolutionary conserved elements using two phylogenetic methods, 
phastCons and phyloP. The CEs used in this study were predicted using ten primates, Homo sapiens 
(reference species), Pan troglodytes, Gorilla gorilla, Pongo pygmaeus abelii, Macaca mulatta, Papio 
hamadryas, Callithrix jacchus, Tarsier syrichta, Microcebus murinus and Otolemur garnettii. 
 
Statistical analysis 
We used a hypergeometric-based approach to test the null hypothesis that the possible enrichment of 
H3K4me3, H3k27ac and H3K36me3 is independent of the presence of signals of natural selection. In 
particular we considered: k, the observed number of CGIs containing both PSs and signatures of 
selective pressure, as the number of success in the sample; n, the number of CGIs characterized by 
signatures of selective pressure only, as the sample size; M, the total number of CGIs with PS, as the 
number of successes in the population; and N, the total number of CGIs, as the population size (see  
supplementary table 3.2-3.4). For statistical significance we set the threshold for the Bonferroni 
corrected p-value at 10-3. All the statistical analyses were performed with R ver. 2.14.2 (R Foundation 
for Statistical Computing, Vienna, Austria; http://www.r-project.org/). 
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General conclusion  
Analyzing two different epigenetic marks such as DNA methylation and histone modifications 
(H3K4me3, H3K27ac and H3K36me3) of different human cell lines (including normal and cancer cell), 
we found that CGIs that experienced selective events are characterized by distinct epigenetic 
features. In particular, we found overall undermethylation of CGIs in the regions under selective 
pressure. On the  other hand, we found in the same regions, enrichment of three histone marks, 
associated with active gene. 
Further studies using other epigenetic marks could help to clarify the relation between epigenetic 
modifications and selective pressure in human genome. 
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Supplementary informations 
 
 
Supplementary table 2.1: Complete list of the cell used in this study, with their characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell ID Category Tissue Cell Type 
Hek293 cancer embryonic kidney various cell types  (mostly neuronal) 
MCF-7 cancer pleural effusion   luminal epithelial 
Hepg2 cancer Epithelial Cells endoderm 
Cmk cancer peripheral blood megakaryocytes 
NB4 cancer stromal fibroblasts promyelocytes 
NT2-D1 cancer testis Epithelial Cells 
Gm19239 EBV Blood B-Lymphocyte 
Gm19240 EBV Blood B-Lymphocyte 
Ag04449 normal Skin Fibroblast 
Ag04450 normal Lung Fibroblast 
Ag09309 normal Skin Fibroblast 
Ag09319 normal Gingival Fibroblast 
Ag10803 normal Skin Fibroblast 
Fibrobl normal Skin Fibroblast 
HAEpiC normal Epithelial Cells Endothelial Cells 
HCF normal heart Fibroblast 
HCM normal heart  Myocytes 
HEEpiC normal Epithelial Cells Epithelial Cells 
HIPEpiC normal Iris Pigment Cells Epithelial Cells 
HMEC normal Epithelial Cells Epithelial Cells 
HNPCEpiC normal basal membranes( NPCEC)  ciliary epithelium  
HRCEpiC normal  renal epithelial cells epithelial cells 
HSMMtube normal Skeletal Muscle myoblasts and myotubes 
NHBE normal Bronchial/Tracheal Epithelial cells epithelial cells 
Skmc normal Muscle Cells Muscle Cells 
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Supplementary table 2.2: Lists, for each cell type, the number of CpG analyzed, the number of CpGs 
inside CGIs, the number of CGIs for which we were able to estimate methylation, the number of CpG 
analyzed per CGI and the mean value of CGI methylation. 
 
 
Cell line 
Total no. 
of CpG 
analyzed 
No. of CpGs 
inside the 
CGIs 
No. of CGIs 
with 
estimated 
methylation 
No. of CpG 
analyzed/CGI 
Mean value 
of CGI 
methylation 
Hek293 556343 410965 16821 24.43 21.35 
MCF-7 691911 477299 18199 26.23 32.77 
Hepg2 632281 445920 18191 24.51 27.02 
Cmk 668036 469564 17843 26.32 32.93 
NB4 671651 482994 17845 27.07 31.47 
NT2-D1 546153 414540 16471 25.17 15.95 
Gm19239 520138 374026 16858 22.19 17.47 
Gm19240 683988 476468 18577 25.65 20.39 
Ag04449 601041 467048 17108 27.30 9.96 
Ag04450 630183 447284 18043 24.79 13.66 
Ag09309 691076 493539 18113 27.25 16.79 
Ag09319 545847 396283 17150 23.11 14.44 
Ag10803 774389 535976 19161 27.97 15.66 
Fibrobl 632283 451557 17608 25.64 17.17 
HAEpiC 681081 495882 18034 27.50 13.75 
HCF 512497 378981 16137 23.49 12.6 
HCM 760148 548934 18646 29.44 13.29 
HEEpiC 624594 449729 18644 24.12 13.06 
HIPEpiC 628948 459947 17722 25.95 13.22 
HMEC 635871 460372 17825 25.83 16 
HNPCEpiC 718881 530483 18431 28.78 12.8 
HRCEpiC 505006 374743 16807 22.30 11.72 
HSMMtube 704265 493549 14869 33.19 19.48 
NHBE 680749 491581 18156 27.08 14.18 
Skmc 674758 477801 16471 29.01 15.95 
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Supplementary table 2.3: Lists, for each HIR identified, the chromosome, the start position, the end 
position, the total length and the human population in which it has been detected. Genomic 
coordinates refer to assembly GRCh37/hg19.  
 
Chromosome Start End Length Population 
chr1 202566430 202843126 276696 Bantu 
chr1 113828836 114587765 758929 Bantu 
chr1 175113118 175336529 223411 Bantu 
chr1 160838638 161232771 394133 Bantu 
chr1 37023791 37307280 283489 Bantu 
chr1 79217345 79519426 302081 Bantu 
chr1 88983612 89384716 401104 Bantu 
chr1 35322503 36756490 1433987 Middle East 
chr1 229851411 230250181 398770 Middle East 
chr1 155059851 156078248 1018397 Middle East 
chr1 74560411 75027257 466846 Middle East 
chr1 154795389 156148164 1352775 East Asia 
chr1 65661665 66225796 564131 East Asia 
chr1 8320045 9000881 680836 East Asia 
chr1 172498216 173266577 768361 East Asia 
chr1 234701860 234906828 204968 East Asia 
chr1 30348925 30562065 213140 East Asia 
chr1 75098453 76399205 1300752 East Asia 
chr1 23184206 23834485 650279 East Asia 
chr1 64163143 64490892 327749 East Asia 
chr1 76463072 76729910 266838 East Asia 
chr1 81474889 81908616 433727 East Asia 
chr1 92464663 93523082 1058419 East Asia 
chr1 234637347 234853058 215711 South Asia 
chr1 186205867 186700958 495091 South Asia 
chr1 219644224 220082149 437925 South Asia 
chr1 236708968 236993127 284159 South Asia 
chr1 248004775 248344597 339822 Europe 
chr1 35321242 36833079 1511837 Europe 
chr1 161950451 162303458 353007 Europe 
chr1 186164899 186719569 554670 Europe 
chr1 30638016 30791524 153508 Europe 
chr1 184905261 185437237 531976 Europe 
chr1 220535456 220934076 398620 Europe 
chr1 11419868 11736599 316731 Europe 
chr1 89415576 90132068 716492 America 
chr1 161263380 162008078 744698 America 
chr2 155649338 156309902 660564 Bantu 
chr2 72353138 73170729 817591 Bantu 
chr2 212010493 212199993 189500 Bantu 
chr2 238592234 238789194 196960 Bantu 
chr2 209141066 209434192 293126 Bantu 
chr2 33174806 33338735 163929 Bantu 
  54 
chr2 46622873 46748065 125192 Bantu 
chr2 140962703 141212782 250079 Bantu 
chr2 200751772 201256573 504801 Bantu 
chr2 72239692 73220137 980445 Middle East 
chr2 1752229 2163075 410846 Middle East 
chr2 178148204 178579812 431608 Middle East 
chr2 195377437 195968049 590612 Middle East 
chr2 14756349 15076200 319851 Middle East 
chr2 74463566 75012326 548760 Middle East 
chr2 235709572 235971970 262398 Middle East 
chr2 21587225 22197491 610266 Middle East 
chr2 117838706 118274001 435295 Middle East 
chr2 157923137 158915734 992597 Middle East 
chr2 108546122 109825515 1279393 East Asia 
chr2 16798475 18056446 1257971 East Asia 
chr2 212788895 213695701 906806 East Asia 
chr2 84536960 85288571 751611 East Asia 
chr2 125232609 127372727 2140118 East Asia 
chr2 154510972 155053139 542167 East Asia 
chr2 8794240 9870630 1076390 East Asia 
chr2 177293076 179236047 1942971 East Asia 
chr2 223503370 223856275 352905 East Asia 
chr2 43638712 44129773 491061 East Asia 
chr2 177914806 178612845 698039 South Asia 
chr2 231638974 231869040 230066 South Asia 
chr2 195552753 197098637 1545884 South Asia 
chr2 223549297 224218792 669495 South Asia 
chr2 157993888 158922574 928686 South Asia 
chr2 82644948 83438063 793115 South Asia 
chr2 73590806 74119507 528701 South Asia 
chr2 178158043 178612269 454226 Europe 
chr2 167525345 168461160 935815 Europe 
chr2 197255486 198056040 800554 Europe 
chr2 195198744 196465135 1266391 Europe 
chr2 74461634 75008283 546649 Europe 
chr2 196622252 197143630 521378 Europe 
chr2 158095057 158890761 795704 Europe 
chr2 121152814 121332190 179376 Europe 
chr2 141536876 141803601 266725 Europe 
chr2 17432556 18185589 753033 America 
chr2 169610232 169870854 260622 America 
chr2 36045002 36399317 354315 America 
chr2 39776534 40283458 506924 America 
chr2 102288186 103208609 920423 America 
chr3 4445436 4593187 147751 Bantu 
chr3 29582412 29735362 152950 Bantu 
chr3 56467691 56858493 390802 Bantu 
  55 
chr3 61066987 61267415 200428 Bantu 
chr3 76685884 76869830 183946 Bantu 
chr3 30263217 30416461 153244 Bantu 
chr3 63029516 63168593 139077 Bantu 
chr3 105006914 105670159 663245 Bantu 
chr3 25495637 26448193 952556 Middle East 
chr3 5547942 5777221 229279 Middle East 
chr3 148640368 148947187 306819 Middle East 
chr3 175042776 175530096 487320 East Asia 
chr3 104618616 104903304 284688 East Asia 
chr3 44091635 45170504 1078869 East Asia 
chr3 195606770 196351214 744444 East Asia 
chr3 25666156 26450380 784224 East Asia 
chr3 26976847 27638499 661652 East Asia 
chr3 112911525 113233187 321662 East Asia 
chr3 166170696 167890717 1720021 East Asia 
chr3 25489318 26447274 957956 South Asia 
chr3 140485038 141050804 565766 South Asia 
chr3 129699722 130468624 768902 South Asia 
chr3 165267688 166012937 745249 South Asia 
chr3 12481375 12857492 376117 South Asia 
chr3 66744399 66996178 251779 South Asia 
chr3 101816344 102457117 640773 South Asia 
chr3 182957573 183177706 220133 South Asia 
chr3 72533768 72667610 133842 Europe 
chr3 129658706 130477565 818859 Europe 
chr3 190295730 190629384 333654 Europe 
chr3 156259485 156821807 562322 America 
chr3 100561439 100892053 330614 America 
chr3 20984501 21456169 471668 America 
chr3 63663692 64099568 435876 America 
chr4 118796265 119853637 1057372 Bantu 
chr4 41798793 42165798 367005 Bantu 
chr4 129779076 130144490 365414 Bantu 
chr4 33653757 35047016 1393259 Bantu 
chr4 65507693 65895584 387891 Bantu 
chr4 429720 871674 441954 Bantu 
chr4 86088554 86358620 270066 Bantu 
chr4 111540391 111765494 225103 Bantu 
chr4 33756410 34855431 1099021 Middle East 
chr4 169771612 170787253 1015641 Middle East 
chr4 148032003 148987971 955968 Middle East 
chr4 14442433 14861269 418836 Middle East 
chr4 29775276 30429541 654265 Middle East 
chr4 41322398 42206573 884175 Middle East 
chr4 172311051 172742576 431525 Middle East 
chr4 104890866 105457179 566313 East Asia 
  56 
chr4 143493213 144542212 1048999 East Asia 
chr4 152792791 153097095 304304 East Asia 
chr4 157656264 160680412 3024148 East Asia 
chr4 41322398 42244444 922046 East Asia 
chr4 169669891 170762016 1092125 East Asia 
chr4 41407668 42241035 833367 South Asia 
chr4 5171986 5426326 254340 South Asia 
chr4 173213263 173863771 650508 South Asia 
chr4 179935508 180172955 237447 South Asia 
chr4 32672332 34855431 2183099 Europe 
chr4 5218136 5425361 207225 Europe 
chr4 41333429 42227496 894067 Europe 
chr4 171743216 172783333 1040117 Europe 
chr4 148025559 148491479 465920 Europe 
chr4 14438997 14862872 423875 Europe 
chr4 123228113 124245085 1016972 Europe 
chr4 42331579 42627835 296256 America 
chr4 126738833 127236804 497971 America 
chr4 128495654 129509264 1013610 America 
chr5 108964907 109272681 307774 Bantu 
chr5 160174288 160380400 206112 Bantu 
chr5 66794632 67121200 326568 Bantu 
chr5 87125578 88021526 895948 Bantu 
chr5 169485227 169625918 140691 Bantu 
chr5 25495542 25691581 196039 Bantu 
chr5 142031751 142520585 488834 Middle East 
chr5 24497516 24847070 349554 Middle East 
chr5 11366401 11893756 527355 Middle East 
chr5 19493684 20429331 935647 Middle East 
chr5 109401940 110455898 1053958 Middle East 
chr5 30028447 30913502 885055 Middle East 
chr5 92219182 92675984 456802 Middle East 
chr5 90466296 90782146 315850 Middle East 
chr5 37913527 38135717 222190 East Asia 
chr5 97821452 98569708 748256 East Asia 
chr5 107994013 108579888 585875 East Asia 
chr5 113425033 113847911 422878 East Asia 
chr5 172845597 173103336 257739 East Asia 
chr5 92595749 93637332 1041583 East Asia 
chr5 54601452 55204186 602734 South Asia 
chr5 109636606 110500986 864380 South Asia 
chr5 37909151 38166348 257197 South Asia 
chr5 158944085 159230739 286654 South Asia 
chr5 120960853 121265924 305071 South Asia 
chr5 142031751 142238118 206367 South Asia 
chr5 165886820 166090938 204118 South Asia 
chr5 108031617 108581017 549400 South Asia 
  57 
chr5 109475723 110399880 924157 Europe 
chr5 21541191 22083472 542281 Europe 
chr5 37915147 38165207 250060 Europe 
chr5 24486805 24851079 364274 Europe 
chr5 142020380 142529959 509579 Europe 
chr5 80687791 81327041 639250 America 
chr5 140553664 141326961 773297 America 
chr5 164283543 164865385 581842 America 
chr5 59556461 60224913 668452 America 
chr5 153277759 153988723 710964 America 
chr6 74981125 75538209 557084 Bantu 
chr6 76857008 77299932 442924 Bantu 
chr6 130503306 130789540 286234 Bantu 
chr6 72662228 73018440 356212 Bantu 
chr6 168410476 168546851 136375 Bantu 
chr6 40420901 40616865 195964 Bantu 
chr6 70802259 70990469 188210 Bantu 
chr6 132919948 133067732 147784 Bantu 
chr6 97538657 98044631 505974 Bantu 
chr6 73650662 73866941 216279 Middle East 
chr6 107420270 108089687 669417 Middle East 
chr6 1045539 1149482 103943 Middle East 
chr6 4744063 4984230 240167 Middle East 
chr6 14688469 15016186 327717 Middle East 
chr6 16109163 16362387 253224 Middle East 
chr6 123902541 124158251 255710 Middle East 
chr6 25352637 27356924 2004287 East Asia 
chr6 105369510 106017975 648465 East Asia 
chr6 37278933 37585912 306979 East Asia 
chr6 73650662 74064395 413733 South Asia 
chr6 105105089 105977159 872070 South Asia 
chr6 213983 412740 198757 South Asia 
chr6 104765922 106006229 1240307 Europe 
chr6 73652443 73893196 240753 Europe 
chr6 167169223 167521623 352400 Europe 
chr6 121812866 123188087 1375221 America 
chr6 46859043 47196209 337166 America 
chr6 46283922 46745998 462076 America 
chr6 152774033 153103098 329065 America 
chr6 158382074 158865656 483582 America 
chr6 33889404 36757265 2867861 America 
chr6 49902734 50629153 726419 America 
chr6 72806978 73161392 354414 America 
chr6 150748277 150945214 196937 America 
chr7 40485949 40946512 460563 Bantu 
chr7 2739017 2966137 227120 Bantu 
chr7 141214012 141710898 496886 Bantu 
  58 
chr7 28753387 28926167 172780 Bantu 
chr7 91998495 92480883 482388 Bantu 
chr7 17912336 18094286 181950 Bantu 
chr7 115654075 115851980 197905 Bantu 
chr7 123656664 124152389 495725 Bantu 
chr7 156416220 156754980 338760 Bantu 
chr7 118610284 120731948 2121664 Middle East 
chr7 124182414 124827235 644821 Middle East 
chr7 33555119 33839113 283994 Middle East 
chr7 97626161 98123879 497718 Middle East 
chr7 98772131 99447045 674914 Middle East 
chr7 3726122 4333609 607487 East Asia 
chr7 49640912 50313351 672439 East Asia 
chr7 28693593 28934502 240909 East Asia 
chr7 29833587 30217699 384112 East Asia 
chr7 64807261 66384314 1577053 East Asia 
chr7 111811004 112304166 493162 East Asia 
chr7 126457779 127852064 1394285 East Asia 
chr7 138518783 138794878 276095 East Asia 
chr7 117496319 120683750 3187431 South Asia 
chr7 36969211 37341476 372265 South Asia 
chr7 148636850 149017787 380937 South Asia 
chr7 36818523 37260711 442188 Europe 
chr7 98759117 99525240 766123 Europe 
chr7 119301786 120683750 1381964 Europe 
chr7 102486254 103231289 745035 Europe 
chr7 107948721 108262713 313992 America 
chr7 99300758 100968362 1667604 America 
chr7 122627567 123037886 410319 America 
chr7 92623141 93013573 390432 America 
chr8 21164751 21311469 146718 Bantu 
chr8 113645627 114021483 375856 Bantu 
chr8 9410495 9681256 270761 Bantu 
chr8 68653516 68838275 184759 Bantu 
chr8 99766557 100855842 1089285 Bantu 
chr8 5225481 5409370 183889 Bantu 
chr8 9087278 9243427 156149 Bantu 
chr8 139901178 140127522 226344 Middle East 
chr8 18514100 18673191 159091 Middle East 
chr8 59793692 59962803 169111 Middle East 
chr8 36629798 37046811 417013 Middle East 
chr8 129503361 130268559 765198 East Asia 
chr8 134804170 135328581 524411 East Asia 
chr8 21616454 21988514 372060 South Asia 
chr8 57826145 58251654 425509 South Asia 
chr8 66555818 67019987 464169 South Asia 
chr8 42045655 43215239 1169584 South Asia 
  59 
chr8 139926589 140131393 204804 Europe 
chr8 29692897 30218244 525347 Europe 
chr8 18511097 18673191 162094 Europe 
chr8 32507149 33806909 1299760 America 
chr8 99383408 100997713 1614305 America 
chr8 95303456 95847149 543693 America 
chr8 707884 1099985 392101 America 
chr9 23785967 24654574 868607 Bantu 
chr9 115404746 115678032 273286 Bantu 
chr9 114868003 115347087 479084 Bantu 
chr9 100507159 100871716 364557 Bantu 
chr9 3862693 3961491 98798 Bantu 
chr9 95374368 95855099 480731 Bantu 
chr9 96447721 96681387 233666 Bantu 
chr9 111693132 111961388 268256 Bantu 
chr9 76765949 77038958 273009 Bantu 
chr9 139647074 140376667 729593 Bantu 
chr9 8787733 8868683 80950 Bantu 
chr9 1707518 2165757 458239 Middle East 
chr9 107870014 108376435 506421 Middle East 
chr9 126154354 126768047 613693 Middle East 
chr9 12935290 13426560 491270 Middle East 
chr9 111537522 111961388 423866 Middle East 
chr9 136658987 136807769 148782 Middle East 
chr9 22986049 23425709 439660 East Asia 
chr9 126153636 126783846 630210 East Asia 
chr9 26506859 27148474 641615 East Asia 
chr9 106554028 106960541 406513 East Asia 
chr9 13780058 14014967 234909 East Asia 
chr9 111114252 111973019 858767 East Asia 
chr9 130755693 131580743 825050 South Asia 
chr9 1784090 2160104 376014 South Asia 
chr9 126154354 126769290 614936 South Asia 
chr9 107878896 108244575 365679 South Asia 
chr9 107869514 108315068 445554 Europe 
chr9 3161347 3579890 418543 Europe 
chr9 93928416 94448776 520360 Europe 
chr9 126154354 126749630 595276 Europe 
chr9 130908044 131595406 687362 Europe 
chr9 111639682 111957172 317490 Europe 
chr9 9729134 9893070 163936 Europe 
chr9 16046983 16252409 205426 Europe 
chr9 18944389 19144190 199801 Europe 
chr9 12925921 13755191 829270 Europe 
chr9 93946379 94498549 552170 America 
chr9 113300206 113527564 227358 America 
chr10 85960149 86356554 396405 Bantu 
  60 
chr10 90042154 90436200 394046 Bantu 
chr10 69021184 69430997 409813 Bantu 
chr10 100339741 101069351 729610 Bantu 
chr10 83577099 84424077 846978 Middle East 
chr10 118047298 118351904 304606 Middle East 
chr10 131166636 131498390 331754 Middle East 
chr10 21783634 22926992 1143358 Middle East 
chr10 53139938 53415187 275249 East Asia 
chr10 3877968 4469291 591323 East Asia 
chr10 107027076 107533730 506654 East Asia 
chr10 109428376 110348375 919999 East Asia 
chr10 73656982 74450318 793336 East Asia 
chr10 93348014 95233855 1885841 East Asia 
chr10 83583540 84386092 802552 South Asia 
chr10 59386322 60255968 869646 South Asia 
chr10 131160866 131494256 333390 South Asia 
chr10 100225657 101185829 960172 South Asia 
chr10 114912534 115198442 285908 Europe 
chr10 118052051 118381944 329893 Europe 
chr10 83835639 84386972 551333 Europe 
chr10 6768836 6930654 161818 Europe 
chr10 112570243 112918572 348329 Europe 
chr10 109950470 110410029 459559 America 
chr10 116565387 117735418 1170031 America 
chr11 110336182 110796084 459902 Bantu 
chr11 112727378 113103995 376617 Bantu 
chr11 9791579 10432369 640790 Bantu 
chr11 6043277 6301176 257899 Bantu 
chr11 129392269 129568491 176222 Bantu 
chr11 83638942 84024745 385803 Middle East 
chr11 129832270 130264277 432007 Middle East 
chr11 20702034 20979130 277096 Middle East 
chr11 12157657 12285089 127432 Middle East 
chr11 37977241 38407175 429934 Middle East 
chr11 24839058 25755820 916762 East Asia 
chr11 66688100 67438194 750094 East Asia 
chr11 80930312 81515166 584854 East Asia 
chr11 112812563 113056322 243759 East Asia 
chr11 87342854 87674034 331180 South Asia 
chr11 39439328 40043059 603731 South Asia 
chr11 129832270 130264277 432007 South Asia 
chr11 92108243 92623348 515105 South Asia 
chr11 105719522 106288553 569031 South Asia 
chr11 66240882 68468669 2227787 South Asia 
chr11 87187306 87678365 491059 Europe 
chr11 66687863 67414491 726628 Europe 
chr11 86403375 86586679 183304 Europe 
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chr11 69231796 69579069 347273 America 
chr11 6577577 6885406 307829 America 
chr11 70966997 72935824 1968827 America 
chr11 42864284 43656534 792250 America 
chr12 28118847 28290777 171930 Bantu 
chr12 5374517 5555039 180522 Bantu 
chr12 81966423 82312036 345613 Bantu 
chr12 113458677 113935480 476803 Bantu 
chr12 126017498 126322479 304981 Middle East 
chr12 99265706 99870626 604920 Middle East 
chr12 10069302 10492981 423679 Middle East 
chr12 127043455 127329166 285711 Middle East 
chr12 121196891 121669181 472290 Middle East 
chr12 888428 1644884 756456 East Asia 
chr12 100097346 100868682 771336 East Asia 
chr12 24451627 24925238 473611 East Asia 
chr12 80462262 81032937 570675 South Asia 
chr12 99332599 99870626 538027 South Asia 
chr12 850613 1510504 659891 South Asia 
chr12 95184157 95735182 551025 South Asia 
chr12 59128693 59494105 365412 South Asia 
chr12 65827996 66140732 312736 South Asia 
chr12 2609562 2919700 310138 Europe 
chr12 11460063 11714653 254590 Europe 
chr12 10046052 10424626 378574 Europe 
chr12 126039433 126290696 251263 Europe 
chr12 99638276 99866158 227882 Europe 
chr12 102389496 102838514 449018 Europe 
chr12 47618366 48257765 639399 America 
chr12 3723673 4042533 318860 America 
chr13 30462712 30621645 158933 Bantu 
chr13 46755852 47132369 376517 Bantu 
chr13 104067224 104357021 289797 Middle East 
chr13 33191371 33553782 362411 Middle East 
chr13 74840712 75105119 264407 Middle East 
chr13 104989752 105265994 276242 East Asia 
chr13 34783249 35085471 302222 East Asia 
chr13 103992269 104361190 368921 South Asia 
chr13 67731496 68459217 727721 South Asia 
chr13 92250545 92847826 597281 South Asia 
chr13 45401128 45900266 499138 South Asia 
chr13 103989946 104354010 364064 Europe 
chr13 88900080 89934018 1033938 America 
chr13 38429073 38803973 374900 America 
chr14 60185336 61572948 1387612 Bantu 
chr14 98497054 98776337 279283 Bantu 
chr14 32007373 32391208 383835 Bantu 
  62 
chr14 43480483 44259508 779025 Bantu 
chr14 48570466 49066430 495964 Bantu 
chr14 33942839 34054942 112103 Bantu 
chr14 36524098 36809925 285827 Bantu 
chr14 72658681 72892393 233712 Bantu 
chr14 61662167 62159911 497744 Middle East 
chr14 100852820 101247031 394211 Middle East 
chr14 55218435 55888532 670097 Middle East 
chr14 87470029 87984703 514674 East Asia 
chr14 64873599 65660501 786902 South Asia 
chr14 62536948 64673866 2136918 South Asia 
chr14 102238630 102900767 662137 South Asia 
chr14 24406306 24903963 497657 Europe 
chr14 100852820 101240529 387709 Europe 
chr14 100781877 101200644 418767 America 
chr15 61994586 62397233 402647 Bantu 
chr15 50944589 51394410 449821 Bantu 
chr15 56337527 56659827 322300 Bantu 
chr15 95284161 95544856 260695 Bantu 
chr15 67049507 67234339 184832 Middle East 
chr15 69178312 69991416 813104 Middle East 
chr15 48132379 49038469 906090 Middle East 
chr15 93984201 94225522 241321 Middle East 
chr15 93293836 93648497 354661 East Asia 
chr15 67029307 67227210 197903 South Asia 
chr15 69424143 69991613 567470 South Asia 
chr15 91716130 91864817 148687 South Asia 
chr15 48224971 48812019 587048 Europe 
chr15 42744094 43796907 1052813 Europe 
chr15 72060049 73086730 1026681 Europe 
chr15 58210398 58601803 391405 America 
chr15 59655578 60363167 707589 America 
chr15 72299481 73109628 810147 America 
chr15 24267426 24999290 731864 America 
chr16 81365974 81595185 229211 Bantu 
chr16 22915924 23274063 358139 Bantu 
chr16 12655483 12704564 49081 Bantu 
chr16 25932733 26101005 168272 Bantu 
chr16 82987188 83162677 175489 Middle East 
chr16 1522670 2010137 487467 Middle East 
chr16 24609208 24888453 279245 Middle East 
chr16 65519567 65914253 394686 East Asia 
chr16 79679369 79981629 302260 East Asia 
chr16 17131750 17761858 630108 East Asia 
chr16 75492242 76018395 526153 East Asia 
chr16 79741569 79991174 249605 Europe 
chr16 82228076 82456634 228558 Europe 
  63 
chr16 10928112 11693535 765423 America 
chr16 13594921 13853466 258545 America 
chr16 82120192 82296370 176178 America 
chr16 11919959 12314450 394491 America 
chr16 70723925 73016767 2292842 America 
chr17 3423578 3769406 345828 Bantu 
chr17 45278790 45908404 629614 Bantu 
chr17 49929451 50258110 328659 Bantu 
chr17 19613601 20699544 1085943 Bantu 
chr17 57637803 59345378 1707575 Middle East 
chr17 55274630 55522449 247819 Middle East 
chr17 63123532 63541496 417964 Middle East 
chr17 74574103 74916503 342400 Middle East 
chr17 53573902 54158281 584379 Middle East 
chr17 76890864 77110043 219179 Middle East 
chr17 48367272 48860431 493159 East Asia 
chr17 27322441 29161357 1838916 East Asia 
chr17 57832391 59423419 1591028 East Asia 
chr17 63155764 63505321 349557 South Asia 
chr17 53563973 54094316 530343 South Asia 
chr17 63109056 63515782 406726 Europe 
chr17 53519844 54106536 586692 Europe 
chr17 74563175 74938080 374905 Europe 
chr17 9390389 9708955 318566 Europe 
chr17 76885117 77104322 219205 Europe 
chr17 38775805 39650803 874998 America 
chr17 35020291 35826181 805890 America 
chr18 42619149 42883958 264809 Bantu 
chr18 43959703 44146835 187132 Bantu 
chr18 37544937 37836985 292048 Bantu 
chr18 7384596 7706346 321750 Middle East 
chr18 66570423 66881411 310988 Middle East 
chr18 31042855 31383570 340715 East Asia 
chr18 66587607 66871598 283991 South Asia 
chr18 32009672 32375776 366104 South Asia 
chr18 57598173 57767634 169461 South Asia 
chr18 46076096 46240710 164614 South Asia 
chr18 7147079 7732916 585837 Europe 
chr18 66574279 66887310 313031 Europe 
chr19 51907788 52127052 219264 Bantu 
chr19 38602214 39002139 399925 Bantu 
chr19 42207625 43192390 984765 Bantu 
chr19 10621108 11163561 542453 Bantu 
chr19 31369317 31796288 426971 Bantu 
chr19 32083035 32471522 388487 Bantu 
chr19 36876843 37367131 490288 Bantu 
chr19 37412887 38475085 1062198 Bantu 
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chr19 22635052 23430435 795383 Middle East 
chr19 22692592 23430435 737843 South Asia 
chr19 22709636 23461423 751787 Europe 
chr20 47177768 47591081 413313 Bantu 
chr20 37080007 37933672 853665 Bantu 
chr20 15017240 15178252 161012 Bantu 
chr20 52884386 53287736 403350 Middle East 
chr20 22282991 22703676 420685 Middle East 
chr20 15571727 15817105 245378 Middle East 
chr20 20993838 21906779 912941 Middle East 
chr20 49063166 49649709 586543 Middle East 
chr20 33737661 34875144 1137483 East Asia 
chr20 30437522 31712589 1275067 East Asia 
chr20 52804492 53288594 484102 South Asia 
chr20 22194770 22708358 513588 South Asia 
chr20 49097525 49653969 556444 South Asia 
chr20 53581724 53816637 234913 South Asia 
chr20 6893128 7164724 271596 Europe 
chr20 22185332 22506049 320717 Europe 
chr20 33844938 34442671 597733 Europe 
chr20 8566792 8889612 322820 America 
chr20 16513316 16683777 170461 America 
chr21 30031030 30864811 833781 Bantu 
chr21 44172913 44422295 249382 Bantu 
chr21 46032094 46158737 126643 Bantu 
chr21 46982335 47322335 340000 Middle East 
chr21 17817942 18114357 296415 East Asia 
chr21 29966286 31178625 1212339 South Asia 
chr21 40326522 41030756 704234 America 
chr21 41049045 41278301 229256 America 
chr21 15861455 15984177 122722 America 
chr22 31530730 32289918 759188 Bantu 
chr22 46447097 46863377 416280 Middle East 
chr22 18526789 18918824 392035 Middle East 
chr22 35518987 35797832 278845 Middle East 
chr22 32275353 32699672 424319 East Asia 
chr22 36478027 36935795 457768 East Asia 
chr22 46447097 46863377 416280 South Asia 
chr22 28244191 29198150 953959 South Asia 
chr22 25619339 25950749 331410 South Asia 
chr22 35519850 35795412 275562 Europe 
chr22 49912406 50491712 579306 Europe 
chr22 30654464 30921370 266906 Europe 
chr22 49855674 50278567 422893 America 
chrX 121993027 122366636 373609 Bantu 
chrX 126640531 127637654 997123 Bantu 
chrX 109096770 110400647 1303877 Bantu 
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chrX 34986964 35753528 766564 Bantu 
chrX 65922033 67286067 1364034 Bantu 
chrX 137952577 138233542 280965 Bantu 
chrX 34225721 36560061 2334340 Middle East 
chrX 109689152 111504315 1815163 Middle East 
chrX 98117578 99486285 1368707 Middle East 
chrX 97004924 97760765 755841 Middle East 
chrX 30026227 30597320 571093 Middle East 
chrX 18859525 20417949 1558424 Middle East 
chrX 5728176 6134767 406591 Middle East 
chrX 153189819 153627145 437326 Middle East 
chrX 67177760 68076640 898880 East Asia 
chrX 97108437 97837882 729445 East Asia 
chrX 14035798 15163507 1127709 East Asia 
chrX 150438543 150901389 462846 East Asia 
chrX 64405169 68053507 3648338 South Asia 
chrX 20522619 21802998 1280379 South Asia 
chrX 108966425 111694354 2727929 South Asia 
chrX 30272489 30546430 273941 South Asia 
chrX 121222635 121942321 719686 South Asia 
chrX 125843757 127823996 1980239 Europe 
chrX 95072450 95872001 799551 Europe 
chrX 98224405 99486285 1261880 Europe 
chrX 65435257 67923735 2488478 Europe 
chrX 106736820 111555208 4818388 America 
chrX 5650083 6135610 485527 America 
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Supplementary table 2.4: Lists, for each cell type, the mean methylation of CGIs inside HIRs (with its standard error), the mean methylation of CGIs localized outside    
these regions (with its standard error), the number of CGIs inside HIRs, the number of CGIs localized outside HIRs and the Bootstrap p-values. 
 
Cell ID Cell type HIR CGIs mean HIR SE Other CGIs mean Other SE No. of HIR CGIs No. of other CGIs Bootstrap p-value 
Hek293 cancer 18.07209546 0.74963397 21.71357874 0.27182048 1662 15159 < 1.0E-04 
MCF-7 cancer 28.3134172 0.90845651 33.25740612 0.31383639 1784 16415 < 1.0E-04 
Hepg2 cancer 23.58733521 0.81826007 27.39282804 0.28077965 1764 16427 1.0E-04 
Cmk cancer 26.3994764 0.89198779 33.63190574 0.31407055 1741 16102 < 1.0E-04 
NB4 cancer 27.10041988 0.86443758 31.93859768 0.29668278 1745 16100 < 1.0E-04 
NT2-D1 cancer 12.67613946 0.70799264 16.301809 0.26401909 1616 14855 < 1.0E-04 
Gm19239 EBV 13.61689916 0.64389488 17.88822672 0.24354854 1635 15223 < 1.0E-04 
Gm19240 EBV 17.0858443 0.67483608 20.74296261 0.24533451 1811 16766 < 1.0E-04 
Ag04449 normal 8.291692217 0.42508266 10.14338957 0.16246635 1696 15412 1.0E-04 
Ag04450 normal 11.03531603 0.56654663 13.94272058 0.21097382 1758 16285 < 1.0E-04 
Ag09309 normal 13.68236452 0.59444949 17.1290823 0.22176914 1758 16355 < 1.0E-04 
Ag09319 normal 11.61979758 0.59526593 14.74437777 0.22517808 1691 15459 < 1.0E-04 
Ag10803 normal 12.37297695 0.58687882 16.00796514 0.22029061 1855 17306 < 1.0E-04 
Fibrobl normal 14.11595976 0.630049 17.49915036 0.23169448 1701 15907 < 1.0E-04 
HAEpiC normal 10.42137587 0.56003811 14.11197435 0.21809566 1764 16270 < 1.0E-04 
HCF normal 9.07611084 0.55552218 12.9804742 0.22368603 1591 14546 < 1.0E-04 
HCM normal 10.40447994 0.56516963 13.60023807 0.21422817 1817 16829 < 1.0E-04 
HEEpiC normal 10.04693673 0.54926804 13.38862614 0.21297418 1729 15915 < 1.0E-04 
HIPEpiC normal 10.41191083 0.5493907 13.52147836 0.21222731 1742 15980 < 1.0E-04 
HMEC normal 12.72713219 0.61298982 16.35859901 0.23280776 1736 16089 < 1.0E-04 
HNPCEpiC normal 10.14362759 0.54589589 13.08930351 0.20736638 1801 16630 < 1.0E-04 
HRCEpiC normal 9.108447913 0.56073348 12.00655231 0.21357911 1646 15161 < 1.0E-04 
HSMMtube normal 18.00726159 0.66202673 21.25326949 0.2386281 1789 16680 < 1.0E-04 
NHBE normal 11.02629679 0.57314939 14.52355975 0.22030469 1767 16389 < 1.0E-04 
Skmc normal 10.79080888 0.59161788 14.86922907 0.22582651 1741 16221 < 1.0E-04 
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Supplementary table 2.5: Lists, for each 5SLR identified, the chromosome, the start position, the end 
position and the total length. Genomic coordinates refer to assembly GRCh37/hg19. 
 
 
Regions Start End Length 
chr1 29250635 29582124 331489 
chr1 46026531 46214183 187652 
chr1 63862069 64092146 230077 
chr1 114057822 114381300 323478 
chr1 115116433 115378793 262360 
chr1 46554517 46718374 163857 
chr1 51008171 51235816 227645 
chr1 78052717 78289590 236873 
chr1 94639336 94839130 199794 
chr1 97229888 97509581 279693 
chr1 98053562 98445381 391819 
chr1 151286575 151611883 325308 
chr1 199900613 200030369 129756 
chr1 210136341 210369242 232901 
chr1 243662053 243895373 233320 
chr1 85066633 85177704 111071 
chr2 63927885 64188651 260766 
chr2 74448828 74715238 266410 
chr2 99573995 99832771 258776 
chr2 103756037 103972017 215980 
chr2 144697382 145176389 479007 
chr2 145592590 145791678 199088 
chr2 148547241 149002548 455307 
chr2 176927165 177270516 343351 
chr2 205421745 205651824 230079 
chr2 15412979 15586646 173667 
chr2 22662161 22828842 166681 
chr2 31733656 31971218 237562 
chr2 32718848 32917771 198923 
chr2 37095793 37258412 162619 
chr2 43411503 43747885 336382 
chr2 57948185 58116477 168292 
chr2 61424903 61742537 317634 
chr2 62981797 63289808 308011 
chr2 72690520 72852907 162387 
chr2 73549924 73794209 244285 
chr2 99185422 99478291 292869 
chr2 123575222 123715501 140279 
chr2 135845130 136125165 280035 
chr2 142960140 143128724 168584 
chr2 146134867 146337410 202543 
chr2 152247420 152435284 187864 
chr2 155700922 155938213 237291 
chr2 187897747 188105218 207471 
chr2 232835431 233180541 345110 
chr3 49097085 49399863 302778 
chr3 94365581 94623235 257654 
chr3 95238967 95423773 184806 
chr3 99494533 99834482 339949 
chr3 136208787 136429395 220608 
  68 
chr3 13969054 14217300 248246 
chr3 25797576 25976557 178981 
chr3 44325263 44663213 337950 
chr3 48613019 48895220 282201 
chr3 58841784 59137547 295763 
chr3 71400071 71615018 214947 
chr3 79204857 79537773 332916 
chr3 110619507 110904347 284840 
chr3 114684268 114906146 221878 
chr3 119975093 120114914 139821 
chr3 130635092 130860757 225665 
chr3 155761633 156114898 353265 
chr3 156493013 156744033 251020 
chr3 159979892 160278818 298926 
chr3 176706064 176840396 134332 
chr3 180964991 181123818 158827 
chr3 181695505 181910529 215024 
chr4 128619572 128993304 373732 
chr4 34010143 34247945 237802 
chr4 46173112 46557143 384031 
chr4 67417795 67622971 205176 
chr4 74983811 75148509 164698 
chr4 81177928 81697216 519288 
chr4 98214952 98529524 314572 
chr4 123960051 124100556 140505 
chr4 172431101 172637662 206561 
chr5 109035495 109234306 198811 
chr5 19608621 19981207 372586 
chr5 43889881 44105084 215203 
chr5 45050586 45393754 343168 
chr5 61682074 61960620 278546 
chr5 93050452 93551028 500576 
chr5 114116640 114350704 234064 
chr5 131013414 131263355 249941 
chr5 17921280 18056522 135242 
chr5 27016109 27151405 135296 
chr5 37380577 37649448 268871 
chr5 71456746 71647477 190731 
chr5 81284883 81637960 353077 
chr5 86549391 86844673 295282 
chr5 126999041 127242725 243684 
chr5 160787118 161026677 239559 
chr6 79526516 79820785 294269 
chr6 126668173 126989092 320919 
chr6 132102752 132196457 93705 
chr6 140338210 140976317 638107 
chr6 45332304 45597525 265221 
chr6 49788953 50101371 312418 
chr6 84298676 84482187 183511 
chr6 90706068 90847204 141136 
chr6 98985278 99143313 158035 
chr6 128110771 128305888 195117 
chr7 69025009 69636926 611917 
chr7 98521518 98713281 191763 
chr7 132988393 133189530 201137 
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chr7 18379007 18586307 207300 
chr7 40050109 40192009 141900 
chr7 41571216 41871572 300356 
chr7 43605654 43888375 282721 
chr7 48654708 48827838 173130 
chr7 93759190 93985638 226448 
chr7 107010512 107177005 166493 
chr7 114411347 114629622 218275 
chr7 121976180 122495427 519247 
chr7 127178538 127662335 483797 
chr8 34598254 34831202 232948 
chr8 49252900 49477598 224698 
chr8 53439456 53638576 199120 
chr8 64868710 65123925 255215 
chr8 116359583 116569557 209974 
chr8 19385418 19497670 112252 
chr8 28773614 29154132 380518 
chr8 35772643 36067503 294860 
chr8 47708415 48104073 395658 
chr8 49594702 49828725 234023 
chr8 58427937 58603646 175709 
chr8 63732189 63873882 141693 
chr8 66307235 66408755 101520 
chr8 71004379 71195443 191064 
chr8 92653592 92906609 253017 
chr8 99633644 100014611 380967 
chr8 100117902 100308266 190364 
chr8 127090898 127173121 82223 
chr9 125718241 126026082 307841 
chr9 84794785 85035221 240436 
chr9 37785698 37927533 141835 
chr9 102334727 102629879 295152 
chr10 62673306 62985661 312355 
chr10 74413470 74667147 253677 
chr10 103706040 104007262 301222 
chr10 9610081 9746948 136867 
chr10 32879965 33141717 261752 
chr10 50674530 50815585 141055 
chr10 60345768 60592816 247048 
chr10 75275890 75476096 200206 
chr10 83346626 83724563 377937 
chr10 106713807 106848420 134613 
chr10 24907707 25031090 123383 
chr11 31061804 31670889 609085 
chr11 27485795 27721022 235227 
chr11 30644423 31036216 391793 
chr11 41655528 41784303 128775 
chr11 45325027 45512886 187859 
chr11 45746288 45911305 165017 
chr11 55023837 55441682 417845 
chr11 55647914 55896015 248101 
chr11 56627239 56896648 269409 
chr11 57008535 57100848 92313 
chr11 59857388 60041190 183802 
chr11 71895114 72237309 342195 
  70 
chr11 72517367 72762960 245593 
chr11 95893439 96227949 334510 
chr11 108543742 108800455 256713 
chr12 89009747 89366763 357016 
chr12 15405896 15572168 166272 
chr12 16884746 17099885 215139 
chr12 65795003 65925191 130188 
chr12 87278562 87505777 227215 
chr12 90247389 90498984 251595 
chr13 20534301 20657647 123346 
chr13 51944276 52082437 138161 
chr13 60540445 60789907 249462 
chr13 68623480 68924857 301377 
chr13 84132000 84421285 289285 
chr14 75426604 75646308 219704 
chr14 59676151 59822731 146580 
chr14 49861650 50025588 163938 
chr14 68276249 68463491 187242 
chr14 71750112 72211600 461488 
chr14 83608854 83776600 167746 
chr14 101178423 101347971 169548 
chr14 105636111 105757770 121659 
chr15 72142918 72396120 253202 
chr15 49675957 49862449 186492 
chr15 64593136 64952886 359750 
chr15 84016770 84224384 207614 
chr15 84319667 84496111 176444 
chr16 34269791 34737702 467911 
chr16 61845083 62098061 252978 
chr16 63811605 64117746 306141 
chr16 34917709 35149023 231314 
chr16 46805547 47144825 339278 
chr17 28223981 28512879 288898 
chr17 27410713 27594951 184238 
chr17 30947344 31213911 266567 
chr17 33121487 33398915 277428 
chr17 58271331 58508582 237251 
chr17 62469023 62706874 237851 
chr17 67929661 68017584 87923 
chr18 34395780 34824354 428574 
chr18 31557831 31867235 309404 
chr18 41300552 41565496 264944 
chr19 10931683 11147333 215650 
chr20 33474216 33644358 170142 
chr20 11423194 11555408 132214 
chr20 13388946 13660066 271120 
chr20 30247858 30480632 232774 
chr20 34425967 34610890 184923 
chr20 32988114 33235384 247270 
chr21 38658252 38867218 208966 
chr22 28575508 28914746 339238 
chrX 63515628 63803599 287971 
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Supplementary table 2.6: Lists, for each cell type, the mean methylation of CGIs inside 5SLRs (with its standard error), the mean methylation of CGIs localized 
outside these regions (with its standard error), the number of CGIs inside 5SLRs, the number of CGIs localized outside 5SLRs and the Bootstrap p-values. 
 
Cell ID Cell type 5SLR CGIs mean 5SLR SE Other CGIs mean Other SE No. of  5SLR CGIs No. of other CGIs Bootstrap p-value 
Hek293 cancer 14.13274539 1.8511369 21.45874374 0.25828709 241 16580 1.0E-04 
MCF-7 cancer 27.71896703 2.41106012 32.84600737 0.29918481 260 17939 0.0177 
Hepg2 cancer 22.04356073 2.04318492 27.0943291 0.26797811 254 17937 0.0115 
Cmk cancer 25.47229476 2.31296117 33.0334249 0.29927342 253 17590 0.0014 
NB4 cancer 25.0108622 2.26837969 31.55868889 0.28301359 254 17591 0.0022 
NT2-D1 cancer 11.17169623 1.67069663 16.01758022 0.25061011 243 16228 0.0069 
Gm19239 EBV 10.98331376 1.41763614 17.56968601 0.2311772 245 16613 1.0E-04 
Gm19240 EBV 11.81273641 1.36922079 20.50909299 0.23348113 262 18315 <1.0E-04 
Ag04449 normal 7.649343629 0.98891071 9.995338002 0.15394158 259 16849 0.0256 
Ag04450 normal 7.43814311 1.07195526 13.75182071 0.20059277 264 17779 <1.0E-04 
Ag09309 normal 12.56376747 1.470223 16.85736998 0.21045972 265 17848 0.0043 
Ag09319 normal 8.559445713 1.25525234 14.52322794 0.21365955 250 16900 1.0E-04 
Ag10803 normal 9.817678077 1.30871342 15.74044319 0.20913789 273 18888 2.0E-04 
Fibrobl normal 11.861235 1.46617254 17.24912499 0.22019253 251 17357 0.0013 
HAEpiC normal 7.342581647 1.13871897 13.84691597 0.20668094 266 17768 1.0E-04 
HCF normal 7.011662842 1.220579 12.67769232 0.21138466 234 15903 3.0E-04 
HCM normal 6.637513291 1.11430818 13.38838552 0.20339969 275 18371 <1.0E-04 
HEEpiC normal 8.023852996 1.22452669 13.13591306 0.20173261 258 17386 3.0E-04 
HIPEpiC normal 7.311095836 1.14318102 13.3044253 0.20114004 262 17460 <1.0E-04 
HMEC normal 9.655115391 1.28904814 16.09928353 0.22093885 261 17564 <1.0E-04 
HNPCEpiC normal 6.66867062 1.03489542 12.89298353 0.19688426 271 18160 <1.0E-04 
HRCEpiC normal 6.161202927 1.0698717 11.80499639 0.20272315 245 16562 <1.0E-04 
HSMMtube normal 13.95838672 1.38350565 21.03812762 0.22722535 259 18210 <1.0E-04 
NHBE normal 8.672499068 1.25910838 14.26513149 0.20885555 266 17890 2.0E-04 
Skmc normal 7.906367112 1.17897318 14.57038231 0.21436746 260 17702 <1.0E-04 
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Supplementary table 2.7: Lists, for each cell type, the mean methylation of CGIs containing CEs (with its standard error), the mean methylation of CGIs that not 
contain CEs (with its standard error), the number of CE CGIs, the number of non-CE CGIs and the Bootstrap pvalues. 
 
Cell ID Cell type CE CGIs mean CE SE Other CGIs mean Other SE No. of CE CGIs No. of  other CGIs Bootstrap p-value 
Hek293 cancer 18.06194902 0.30389391 26.63876414 0.4472349 10365 6456 <1.0E-04 
MCF-7 cancer 29.31174071 0.3666015 38.08065182 0.4934211 11016 7183 <1.0E-04 
Hepg2 cancer 24.10220364 0.32920185 31.47347397 0.44026143 10981 7210 <1.0E-04 
Cmk cancer 30.52155783 0.37046424 36.63095243 0.49000397 10820 7023 <1.0E-04 
NB4 cancer 28.67202877 0.3463578 35.77711741 0.46939085 10829 7016 <1.0E-04 
NT2-D1 cancer 12.66381809 0.28249896 21.215268 0.45310448 10149 6322 <1.0E-04 
Gm19239 EBV 14.64260305 0.2693243 21.94428629 0.40303282 10321 6537 <1.0E-04 
Gm19240 EBV 17.38779645 0.27665389 24.94318509 0.39712404 11204 7373 <1.0E-04 
Ag04449 normal 8.162944221 0.17489162 12.76902457 0.27540567 10434 6674 <1.0E-04 
Ag04450 normal 11.42000275 0.23610187 17.08627404 0.34446075 10912 7131 <1.0E-04 
Ag09309 normal 14.45463991 0.25464626 20.3435999 0.35121572 10916 7197 <1.0E-04 
Ag09319 normal 11.9928598 0.24871994 18.27074267 0.37295181 10475 6675 <1.0E-04 
Ag10803 normal 13.05760133 0.25026711 19.48613818 0.35094952 11416 7745 <1.0E-04 
Fibrobl normal 14.65374098 0.26273602 21.06414299 0.37384171 10690 6918 <1.0E-04 
HAEpiC normal 11.11014802 0.23744364 17.78682268 0.36280708 10901 7133 <1.0E-04 
HCF normal 10.25670137 0.24188447 16.36772469 0.3777372 9961 6176 <1.0E-04 
HCM normal 11.02712334 0.2386924 16.71753014 0.35013204 11235 7411 <1.0E-04 
HEEpiC normal 10.74731068 0.23342271 16.64781495 0.35385824 10725 6919 <1.0E-04 
HIPEpiC normal 10.83446026 0.2315216 16.90413784 0.35407515 10769 6953 <1.0E-04 
HMEC normal 13.37336375 0.25791805 20.05535694 0.38294662 10805 7020 <1.0E-04 
HNPCEpiC normal 10.51655713 0.22922112 16.27207527 0.34130963 11114 7317 <1.0E-04 
HRCEpiC normal 9.776230222 0.23552555 14.82870027 0.35643076 10332 6475 <1.0E-04 
HSMMtube normal 17.72691312 0.26767559 25.78575942 0.38746289 11108 7361 <1.0E-04 
NHBE normal 11.61694328 0.24213548 18.12160123 0.36439618 10993 7163 <1.0E-04 
Skmc normal 11.82268113 0.25106864 18.53088857 0.36932762 10863 7099 <1.0E-04 
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Supplementary table 2.8: Lists, for each cell type, the mean methylation of HIR+CE CGIs (with its standard error), the mean methylation of CE CGIs (with its standard 
error), the number of HIR+CE CGIs, the number of CE CGIs and the Bootstrap p-values. 
 
Cell ID Cell type HIR+CE CGIs mean HIR+CE SE CE CGIs mean CE SE No. of HIR+CE CGIs No. of CE CGIs Bootstrap p-value 
Hek293 cancer 15.83623485 0.89925163 18.30541256 0.32238172 1022 9343 0.0069 
MCF-7 cancer 24.78486437 1.10807098 29.80379249 0.38789151 1080 9936 < 1.E-04 
Hepg2 cancer 20.94443157 1.00181754 24.44453201 0.34819505 1074 9907 0.0011 
Cmk cancer 24.43245785 1.10632827 31.18149102 0.39215476 1058 9762 < 1.E-04 
NB4 cancer 24.48509553 1.05010054 29.12728863 0.36637262 1062 9767 < 1.E-04 
NT2-D1 cancer 9.818266859 0.78875638 12.97139486 0.30103731 990 9159 7.E-04 
Gm19239 EBV 11.78969143 0.764194 14.9486766 0.28655855 1000 9321 1.E-04 
Gm19240 EBV 14.98866755 0.80971263 17.64898427 0.29372972 1100 10104 1.E-03 
Ag04449 normal 7.017109602 0.48293697 8.28858024 0.18666602 1031 9403 0.013 
Ag04450 normal 9.514735893 0.68227508 11.62520914 0.25091804 1061 9851 0.0025 
Ag09309 normal 12.12900686 0.73520006 14.70528151 0.27062392 1062 9854 9.E-04 
Ag09319 normal 9.680989007 0.69333385 12.24551792 0.26517444 1032 9443 7.E-04 
Ag10803 normal 10.67151203 0.70994591 13.31510631 0.26636641 1112 10304 7.E-04 
Fibrobl normal 12.49566357 0.76714702 14.88582598 0.27896015 1038 9652 0.0039 
HAEpiC normal 8.676708592 0.65495135 11.37417892 0.25329867 1067 9834 2.E-04 
HCF normal 7.853319139 0.6583744 10.51984736 0.25836529 983 8978 < 1.E-04 
HCM normal 8.903958885 0.6712296 11.25663199 0.25425245 1096 10139 0.0017 
HEEpiC normal 8.343485959 0.64060805 11.00764015 0.24909169 1048 9677 2.E-04 
HIPEpiC normal 8.803586043 0.63911698 11.05664923 0.24705585 1062 9707 0.0015 
HMEC normal 10.33919878 0.70639778 13.69995249 0.27518135 1050 9755 < 1.E-04 
HNPCEpiC normal 8.630212897 0.64394071 10.72105062 0.24421423 1087 10027 0.0028 
HRCEpiC normal 7.883028293 0.66014666 9.982026289 0.25099236 1013 9319 0.0027 
HSMMtube normal 15.67666393 0.7918037 17.94726892 0.28389121 1078 10030 0.0042 
NHBE normal 9.133926979 0.67076771 11.88441048 0.25816884 1069 9924 2.E-04 
Skmc normal 9.147031134 0.69973955 12.11139481 0.26756361 1058 9805 < 1.E-04 
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Supplementary table 2.9: Lists, for each cell type, the mean methylation of 5SLR+CE CGIs (with its standard error), the mean methylation of CE CGIs (with its 
standard error), the number of 5SLR+CE CGIs, the number of CE CGIs and the Bootstrap p-values. 
 
Cell ID Cell type 5LSR+CE CGIs mean 5LSR +CE SE CE CGIs mean CE SE No. of 5LSR +CE CGIs No. of CE CGIs Bootstrap p-value 
Hek293 cancer 10.37628825 1.90918117 18.17939079 0.30701808 156 10209 1.0E-04 
MCF-7 cancer 22.93389404 2.80151076 29.40812542 0.36966261 164 10852 0.0154 
Hepg2 cancer 18.90791051 2.32056151 24.1799812 0.3322738 162 10819 0.0242 
Cmk cancer 23.01581493 2.73381193 30.63492912 0.37369178 161 10659 0.0057 
NB4 cancer 22.02005809 2.66749511 28.77368555 0.34920252 163 10666 0.0066 
NT2-D1 cancer 5.441370892 1.1917729 12.77730129 0.28618458 157 9992 1.0E-04 
Gm19239 EBV 7.712200781 1.33052292 14.74827021 0.27254793 155 10166 2.0E-04 
Gm19240 EBV 8.662255749 1.29448932 17.51982193 0.27997111 167 11037 <1.0E-04 
Ag04449 normal 5.637730061 0.92448072 8.20301918 0.17703586 163 10271 0.0263 
Ag04450 normal 4.613737254 0.83680997 11.52707329 0.23931281 169 10743 <1.0E-04 
Ag09309 normal 8.804471169 1.51644723 14.54188903 0.25743204 166 10750 0.0013 
Ag09319 normal 4.964918459 0.99712684 12.09979784 0.25190454 157 10318 <1.0E-04 
Ag10803 normal 7.41177632 1.36409965 13.14396579 0.25315534 172 11244 0.0017 
Fibrobl normal 9.453901503 1.66012629 14.73224962 0.26545585 159 10531 0.0053 
HAEpiC normal 5.190239125 1.12907275 11.20281034 0.24040786 168 10733 3.0E-04 
HCF normal 4.781792145 1.15844024 10.34154041 0.24488216 152 9809 3.0E-04 
HCM normal 4.342251171 1.08079501 11.13289663 0.24173463 175 11060 <1.0E-04 
HEEpiC normal 5.087948543 1.14169091 10.83410578 0.23625912 162 10563 1.0E-04 
HIPEpiC normal 4.471057319 1.01658838 10.93408535 0.23448096 166 10603 <1.0E-04 
HMEC normal 5.524053762 0.86312715 13.49433798 0.26138397 164 10641 <1.0E-04 
HNPCEpiC normal 3.873851058 0.81003083 10.62159215 0.23235585 173 10941 <1.0E-04 
HRCEpiC normal 3.569559848 0.84418476 9.872618458 0.23870101 158 10174 1.0E-04 
HSMMtube normal 10.82291589 1.39448125 17.8297319 0.27075048 163 10945 2.0E-04 
NHBE normal 5.488231834 1.1643759 11.71263362 0.24513501 169 10824 2.0E-04 
Skmc normal 5.756426782 1.16640023 11.91624366 0.25420349 165 10698 2.0E-04 
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Supplementary table 2.10: Lists, for each cell type, the number, the mean methylation and the 
standard error of 59 CGIs, intragenic CGIs, 39 CGIs and intergenic CGIs.  
 
    5’ CGIs Intragenic CGIs 3’ CGIs Intergenic CGIs 
Cell ID Cell type number mean SE number mean SE number mean SE number mean SE 
Hek293 cancer 10947 12.55 0.24 995 64.95 1.2 746 55.61 1.46 3187 31.54 0.64 
MCF-7 cancer 11431 21.50 0.32 1238 74.17 1 888 65.73 1.31 3580 47.31 0.69 
Hepg2 cancer 11310 17.76 0.28 1291 64.87 1 966 60.73 1.26 3592 34.67 0.60 
Cmk cancer 11386 23.22 0.33 1165 70.83 1.1 843 61.89 1.38 3430 46.84 0.69 
NB4 cancer 11343 21.75 0.31 1145 70.30 1 856 60.96 1.33 3473 44.21 0.65 
NT2-D1 cancer 10744 8.73 0.22 926 57.94 1.4 723 44.37 1.63 3112 22.58 0.65 
Gm19239 EBV 10683 9.92 0.21 1110 57.05 1.2 821 45.17 1.38 3271 22.63 0.54 
Gm19240 EBV 11578 12.22 0.22 1314 60.63 1.1 945 48.41 1.31 3683 25.71 0.54 
Ag04449 normal 11105 5.92 0.13 880 35.20 1.2 735 26.95 1.16 3377 13.33 0.37 
Ag04450 normal 11411 7.75 0.18 1164 47.92 1.1 865 35.21 1.27 3554 17.01 0.47 
Ag09309 normal 11365 10.04 0.2 1219 53.42 1.1 874 41.84 1.28 3613 20.44 0.46 
Ag09319 normal 10969 8.16 0.19 1043 49.83 1.2 800 37.98 1.35 3348 19.19 0.51 
Ag10803 normal 11886 8.66 0.19 1333 52.14 1 969 40.00 1.24 3868 19.41 0.47 
Fibrobl normal 11036 9.88 0.2 1218 55.32 1.1 888 43.14 1.28 3454 21.27 0.50 
HAEpiC normal 11356 7.39 0.18 1174 48.80 1.2 872 35.81 1.31 3592 17.81 0.49 
HCF normal 10325 6.61 0.18 974 47.72 1.3 774 35.08 1.36 3140 16.39 0.51 
HCM normal 11704 7.09 0.18 1218 48.23 1.2 918 35.37 1.27 3736 16.73 0.48 
HEEpiC normal 11181 7.12 0.18 1143 47.11 1.2 840 33.88 1.28 3462 16.74 0.49 
HIPEpiC normal 11280 7.46 0.18 1105 47.52 1.2 840 34.57 1.3 3480 16.71 0.48 
HMEC normal 11259 9.10 0.2 1156 52.98 1.2 867 40.72 1.34 3514 20.88 0.52 
HNPCEpiC normal 11625 6.95 0.17 1174 46.57 1.2 878 33.32 1.28 3676 16.12 0.46 
HRCEpiC normal 10767 6.27 0.18 1026 45.96 1.3 780 33.33 1.36 3260 14.78 0.48 
HSMMtube normal 11506 12.90 0.21 1307 58.57 1 938 47.63 1.23 3658 26.84 0.53 
NHBE normal 11450 7.68 0.19 1182 49.57 1.2 890 37.16 1.28 3587 18.47 0.50 
Skmc normal 11216 7.44 0.19 1238 51.56 1.1 915 39.05 1.26 3572 18.44 0.50 
 
For each cell line, Kruskal Wallis Test, p-value ≤ 2.2 10-16 
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Supplementary table 2.11: Lists, for each cell type and for each CGIs class (59 CGIs, intragenic CGIs, 39 CGIs and intergenic CGIs) the number and the mean 
methylation of CGIs containing CEs (with its standard error), the number and the mean methylation of CGIs that do not contain CEs (with its standard error), and the 
Bootstrap p-values. 
 
5 ' CGIs Intragenic CGIs 3' CGIs Intergenic CGIs 
CE CGIs Other CGIs   CE CGIs Other CGIs   CE CGIs Other CGIs   CE CGIs Other CGIs   
  
  
Cell ID 
  
  
Cell 
type n. mean SE n. mean SE p-value n. mean SE n. mean SE p-value n. mean SE n. mean SE p-value n. mean SE n. mean SE p-value 
Hek293 cancer 7117 11.31 0.28 3831 14.85 0.45 < 10-4 526 64.80 1.65 469 65.11 1.72 0.4456 445 57.70 1.87 301 52.53 2.34 0.9589 1228 23.56 0.94 1960 36.52 0.84 < 10-4 
MCF-7 cancer 7376 20.58 0.38 4056 23.18 0.56 < 10-4 646 74.77 1.36 592 73.52 1.44 0.7359 518 67.43 1.70 370 63.34 2.05 0.9417 1306 40.35 1.11 2275 51.30 0.87 < 10-4 
Hepg2 cancer 7302 16.61 0.34 4009 19.84 0.52 < 10-4 680 66.66 1.40 611 62.89 1.50 0.9700 559 62.73 1.64 407 57.98 1.97 0.9692 1300 27.76 0.94 2293 38.57 0.75 < 10-4 
Cmk cancer 7338 22.94 0.40 4049 23.71 0.57 0.1354 617 73.28 1.41 548 68.08 1.58 0.9924 488 64.18 1.77 355 58.73 2.17 0.974 1261 41.65 1.11 2170 49.84 0.88 < 10-4 
NB4 cancer 7325 21.23 0.37 4019 22.70 0.53 0.0100 605 70.85 1.40 540 69.68 1.51 0.7146 496 63.82 1.67 360 57.01 2.15 0.9952 1274 37.67 1.01 2200 47.99 0.83 < 10-4 
NT2-D1 cancer 6995 7.71 0.26 3750 10.61 0.42 < 10-4 484 55.41 1.99 442 60.71 2.02 0.0332 425 45.31 2.12 298 43.04 2.54 0.7574 1198 13.15 0.83 1915 28.47 0.90 < 10-4 
Gm19239 EBV 6964 8.99 0.24 3720 11.65 0.40 < 10-4 587 56.50 1.61 523 57.67 1.66 0.3053 484 45.70 1.80 337 44.41 2.17 0.6844 1225 14.73 0.72 2047 27.35 0.73 < 10-4 
Gm19240 EBV 7469 11.11 0.26 4110 14.23 0.41 < 10-4 698 60.39 1.47 616 60.90 1.51 0.4053 547 49.79 1.73 398 46.52 2.00 0.8881 1334 17.31 0.74 2350 30.46 0.71 < 10-4 
Ag04449 normal 7193 5.37 0.15 3913 6.93 0.25 < 10-4 448 32.50 1.63 432 38.00 1.64 0.0103 425 28.03 1.56 310 25.48 1.74 0.8632 1274 8.83 0.49 2104 16.04 0.51 < 10-4 
Ag04450 normal 7359 6.97 0.21 4053 9.16 0.34 < 10-4 617 46.96 1.61 547 49.01 1.63 0.1848 499 37.09 1.71 366 32.66 1.91 0.9513 1304 11.11 0.63 2251 20.43 0.63 < 10-4 
Ag09309 normal 7339 9.29 0.24 4027 11.40 0.35 < 10-4 623 52.57 1.56 596 54.31 1.51 0.2084 511 43.15 1.69 363 39.98 1.96 0.8907 1303 14.51 0.68 2311 23.78 0.60 < 10-4 
Ag09319 normal 7117 7.27 0.22 3853 9.81 0.36 < 10-4 553 48.76 1.74 490 51.05 1.79 0.1807 463 39.38 1.80 337 36.06 2.05 0.8828 1258 12.46 0.68 2091 23.24 0.69 < 10-4 
Ag10803 normal 7604 7.77 0.23 4283 10.24 0.35 < 10-4 693 51.19 1.49 640 53.17 1.46 0.1695 553 41.69 1.65 416 37.75 1.86 0.9441 1367 12.30 0.66 2502 23.30 0.62 < 10-4 
Fibrobl normal 7156 9.05 0.24 3881 11.39 0.37 < 10-4 639 54.80 1.53 579 55.89 1.53 0.3147 517 44.02 1.69 371 41.90 1.96 0.797 1267 14.43 0.70 2188 25.22 0.66 < 10-4 
HAEpiC normal 7331 6.62 0.21 4026 8.78 0.34 < 10-4 615 47.10 1.65 559 50.66 1.68 0.0676 510 36.50 1.72 362 34.85 2.02 0.7205 1298 10.05 0.62 2295 22.19 0.67 < 10-4 
HCF normal 6773 5.98 0.21 3553 7.81 0.34 < 10-4 522 47.48 1.80 452 48.00 1.85 0.4240 450 34.95 1.77 324 35.26 2.13 0.4675 1196 9.52 0.64 1945 20.60 0.71 < 10-4 
HCM normal 7522 6.37 0.21 4183 8.37 0.33 < 10-4 648 47.29 1.61 570 49.31 1.66 0.1872 529 36.96 1.69 389 33.20 1.92 0.9281 1348 9.84 0.63 2389 20.62 0.65 < 10-4 
HEEpiC normal 7232 6.43 0.21 3950 8.39 0.33 < 10-4 608 45.70 1.63 535 48.71 1.70 0.0922 488 34.05 1.69 352 33.65 1.96 0.562 1288 10.49 0.64 2175 20.43 0.66 < 10-4 
HIPEpiC normal 7282 6.54 0.20 3999 9.13 0.34 < 10-4 581 45.88 1.68 524 49.33 1.72 0.0755 484 35.32 1.73 356 33.55 1.95 0.7564 1296 10.26 0.61 2185 20.53 0.65 < 10-4 
HMEC normal 7276 8.23 0.24 3984 10.70 0.38 < 10-4 615 52.15 1.61 541 53.92 1.71 0.2315 503 41.27 1.75 364 39.97 2.07 0.6856 1296 13.84 0.71 2219 24.98 0.70 < 10-4 
HNPCEpiC normal 7485 6.33 0.20 4141 8.07 0.32 < 10-4 618 46.01 1.63 556 47.19 1.67 0.3054 505 34.63 1.71 373 31.55 1.91 0.8868 1337 9.32 0.59 2340 20.00 0.63 < 10-4 
HRCEpiC normal 7009 5.59 0.21 3759 7.53 0.34 < 10-4 549 45.54 1.74 477 46.45 1.83 0.3611 456 34.75 1.81 324 31.33 2.07 0.891 1243 8.68 0.60 2018 18.53 0.67 < 10-4 
HSMMtube normal 7388 11.56 0.25 4119 15.29 0.40 < 10-4 689 57.60 1.45 618 59.65 1.48 0.1625 540 49.25 1.61 398 45.43 1.88 0.9369 1319 18.12 0.73 2340 31.75 0.71 < 10-4 
NHBE normal 7392 6.93 0.22 4059 9.04 0.34 < 10-4 628 48.36 1.62 554 50.94 1.68 0.1309 513 37.23 1.70 377 37.07 1.96 0.5316 1312 11.29 0.66 2276 22.60 0.68 < 10-4 
Skmc normal 7259 6.72 0.23 3958 8.74 0.35 < 10-4 648 50.51 1.57 590 52.71 1.56 0.1601 525 39.89 1.67 390 37.92 1.93 0.784 1300 10.80 0.66 2273 22.81 0.68 < 10-4 
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             Supplementary  table 3.1: Characteristics of cell lines used in this study 
 
 
 
 
 
 
Cell line Karyotype  Lineage Tissue Karyotype  Sex 
HUVEC  normal mesoderm blood vessel normal U 
Monocytes-CD14+-
RO01746 (CD14+) 
normal mesoderm monocytes normal F 
HMEC normal ectoderm breast normal U 
HSMM normal mesoderm muscle normal U 
HSMMtube normal mesoderm muscle normal U 
NH-A normal ectoderm brain normal U 
NHDF-Ad normal mesoderm skin normal F 
NHEK normal ectoderm skin normal U 
NHLF normal endoderm lung normal U 
K562 cancer mesoderm blood cancer F 
HeLa-S3 cancer ectoderm cervix cancer F 
HepG2 cancer endoderm liver cancer M 
Dnd41 cancer mesoderm blood cancer M 
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Supplementary  table 3.2: Raw data used to calculate CGIs enriched with H3K4me3, H3K27ac and 
H3K36me3 in different cell lines. 
 
Histone 
mark 
Signature 
of selective 
pressure Cell lines Category 
No.of CGIs with 
peaks under 
selective 
pressure (k) 
No.of CGIs 
under 
selective 
pressure (n) 
No. of CGIs 
with peaks 
(M) 
Total no. 
of CGIs (N) 
Hypergeo-
metric  
P-value 
bonferroni 
P-value 
H3K4me3 HIR HUVEC normal 1652 2545 15934 27718 4.45E-16 6.7E-15 
  CD14+ normal 1652 2545 16121 27718 1.19E-13 1.8E-12 
  HMEC normal 1666 2545 16108 27718 7.47E-16 1.1E-14 
  HSMM normal 1766 2545 17071 27718 3.03E-18 4.5E-17 
  HSMMtube normal 1657 2545 16263 27718 1.31E-12 2.0E-11 
  NH-A normal 1677 2545 16418 27718 1.89E-13 2.8E-12 
  NHDF-Ad normal 1660 2545 15914 27718 1.32E-17 2.0E-16 
  NHEK normal 1715 2545 16659 27718 7.05E-16 1.1E-14 
  NHLF normal 1657 2545 15852 27718 5.22E-18 7.8E-17 
  K562 cancer 1422 2545 13719 27718 5.97E-12 9.0E-11 
  HeLa-S3 cancer 1418 2545 13799 27718 1.41E-10 2.1E-09 
  HepG2 cancer 1616 2545 15715 27718 1.08E-13 1.6E-12 
  Dnd41 cancer 1247 2545 11643 27718 3.66E-14 5.5E-13 
 5LSR HUVEC normal 256 348 15934 27718 1.27E-10 1.9E-09 
  CD14+ normal 247 348 16121 27718 2.42E-07 3.6E-06 
  HMEC normal 243 348 16108 27718 2.19E-06 3.3E-05 
  HSMM normal 270 348 17071 27718 4.94E-11 7.4E-10 
  HSMMtube normal 261 348 16263 27718 4.85E-11 7.3E-10 
  NH-A normal 262 348 16418 27718 8.69E-11 1.3E-09 
  NHDF-Ad normal 260 348 15914 27718 4.60E-12 6.9E-11 
  NHEK normal 253 348 16659 27718 2.83E-07 4.3E-06 
  NHLF normal 242 348 15852 27718 7.07E-07 1.1E-05 
  K562 cancer 207 348 13719 27718 6.84E-05 1.0E-03 
  HeLa-S3 cancer 195 348 13799 27718 0.008125 0.1218699 
  HepG2 cancer 234 348 15715 27718 2.04E-05 3.1E-04 
  Dnd41 cancer 174 348 11643 27718 0.001043 0.0156501 
 CE HUVEC normal 9032 13288 15934 27718 1.57E-254 2.4E-253 
  CD14+ normal 8941 13288 16121 27718 7.02E-194 1.1E-192 
  HMEC normal 9173 13288 16108 27718 3.47E-277 5.2E-276 
  HSMM normal 9604 13288 17071 27718 8.88E-274 1.3E-272 
  HSMMtube normal 9270 13288 16263 27718 4.04E-287 6.1E-286 
  NH-A normal 9330 13288 16418 27718 8.18E-283 1.2E-281 
  NHDF-Ad normal 8975 13288 15914 27718 2.02E-237 3.0E-236 
  NHEK normal 9439 13288 16659 27718 2.21E-282 3.3E-281 
  NHLF normal 8992 13288 15852 27718 8.48E-254 1.3E-252 
  K562 cancer 7700 13288 13719 27718 8.67E-162 1.3E-160 
  HeLa-S3 cancer 7874 13288 13799 27718 7.91E-203 1.2E-201 
  HepG2 cancer 8877 13288 15715 27718 1.81E-235 2.7E-234 
  Dnd41 cancer 6669 13288 11643 27718 1.54E-155 2.3E-154 
H3K27ac HIR HUVEC normal 1290 2545 12091 27718 2.45E-14 3.7E-13 
  CD14+ normal 1253 2545 12082 27718 8.35E-10 1.3E-08 
  HMEC normal 1226 2545 11595 27718 5.53E-12 8.3E-11 
  HSMM normal 1212 2545 11658 27718 1.25E-09 1.9E-08 
  HSMMtube normal 1178 2545 11452 27718 4.61E-08 6.9E-07 
  NH-A normal 1267 2545 11935 27718 3.47E-13 5.2E-12 
  NHDF-Ad normal 1328 2545 12985 27718 7.02E-09 1.1E-07 
  NHEK normal 1234 2545 11873 27718 7.50E-10 1.1E-08 
  NHLF normal 1308 2545 12452 27718 2.80E-12 4.2E-11 
  K562 cancer 1271 2545 11652 27718 1.47E-17 2.2E-16 
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  HeLa-S3 cancer 1278 2545 11893 27718 3.03E-15 4.6E-14 
  HepG2 cancer 1139 2545 10681 27718 8.13E-12 1.2E-10 
  Dnd41 cancer 1299 2545 12392 27718 7.60E-12 1.1E-10 
 5LSR HUVEC normal 202 348 12091 27718 2.05E-08 3.1E-07 
  CD14+ normal 194 348 12082 27718 1.80E-06 2.7E-05 
  HMEC normal 185 348 11595 27718 7.36E-06 1.1E-04 
  HSMM normal 191 348 11658 27718 4.94E-07 7.4E-06 
  HSMMtube normal 185 348 11452 27718 2.93E-06 4.4E-05 
  NH-A normal 198 348 11935 27718 6.89E-08 1.0E-06 
  NHDF-Ad normal 221 348 12985 27718 1.18E-10 1.8E-09 
  NHEK normal 186 348 11873 27718 2.49E-05 3.7E-04 
  NHLF normal 193 348 12452 27718 2.94E-05 4.4E-04 
  K562 cancer 176 348 11652 27718 0.000517 7.7E-03 
  HeLa-S3 cancer 178 348 11893 27718 0.000776 0.01 
  HepG2 cancer 174 348 10681 27718 4.91E-06 7.36E-05 
  Dnd41 cancer 182 348 12392 27718 0.001797 0.03 
 CE HUVEC normal 7015 13288 12091 27718 4.02E-193 6.0E-192 
  CD14+ normal 6758 13288 12082 27718 5.05E-122 7.6E-121 
  HMEC normal 6793 13288 11595 27718 3.39E-200 5.1E-199 
  HSMM normal 6852 13288 11658 27718 2.85E-209 4.3E-208 
  HSMMtube normal 6751 13288 11452 27718 1.39E-209 2.1E-208 
  NH-A normal 7007 13288 11935 27718 2.34E-215 3.5E-214 
  NHDF-Ad normal 7436 13288 12985 27718 1.77E-188 2.7E-187 
  NHEK normal 6883 13288 11873 27718 2.33E-185 3.5E-184 
  NHLF normal 7177 13288 12452 27718 1.51E-188 2.3E-187 
  K562 cancer 6654 13288 11652 27718 4.28E-150 6.4E-149 
  HeLa-S3 cancer 6971 13288 11893 27718 2.77E-210 4.2E-209 
  HepG2 cancer 6289 13288 10681 27718 2.03E-184 3.1E-183 
  Dnd41 cancer 6918 13288 12392 27718 3.12E-124 4.7E-123 
H3K36me3 HIR HUVEC normal 952 2545 9878 27718 0.024276 0.36 
  CD14+ normal 750 2545 7791 27718 0.0524 0.79 
  HMEC normal 944 2545 9943 27718 0.085784 1 
  HSMM normal 1195 2545 12139 27718 0.000354 5.3E-03 
  HSMMtube normal 991 2545 10456 27718 0.088709 1 
  NH-A normal 858 2545 8652 27718 0.002109 0.03 
  NHDF-Ad normal 1033 2545 10426 27718 0.000558 8.4E-03 
  NHEK normal 1069 2545 11179 27718 0.034092 0.51 
  NHLF normal 1077 2545 11387 27718 0.088354 1 
  K562 cancer 1059 2545 10009 27718 8.07E-10 1.2E-08 
  HeLa-S3 cancer 1016 2545 9759 27718 9.75E-08 1.5E-06 
  HepG2 cancer 946 2545 9488 27718 0.00051 7.6E-03 
  Dnd41 cancer 1129 2545 11261 27718 2.77E-05 4.2E-04 
 5LSR HUVEC normal 142 348 9878 27718 0.019402 0.29 
  CD14+ normal 108 348 7791 27718 0.100787 1 
  HMEC normal 131 348 9943 27718 0.226059 1 
  HSMM normal 175 348 12139 27718 0.006163 0.09 
  HSMMtube normal 127 348 10456 27718 0.661453 1 
  NH-A normal 125 348 8652 27718 0.025817 0.39 
  NHDF-Ad normal 156 348 10426 27718 0.002367 0.04 
  NHEK normal 153 348 11179 27718 0.074589 1 
  NHLF normal 153 348 11387 27718 0.124186 1 
  K562 cancer 158 348 10009 27718 0.000138 2.1E-03 
  HeLa-S3 cancer 170 348 9759 27718 5.59E-08 8.4E-07 
  HepG2 cancer 144 348 9488 27718 0.002193 0.03 
  Dnd41 cancer 156 348 11261 27718 0.048921 0.73 
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 CE HUVEC normal 5709 13288 9878 27718 1.16E-132 1.7E-131 
  CD14+ normal 4309 13288 7791 27718 1.34E-53 2.0E-52 
  HMEC normal 5725 13288 9943 27718 2.97E-128 4.5E-127 
  HSMM normal 6907 13288 12139 27718 4.92E-154 7.4E-153 
  HSMMtube normal 5894 13288 10456 27718 1.43E-106 2.1E-105 
  NH-A normal 5064 13288 8652 27718 1.13E-125 1.7E-124 
  NHDF-Ad normal 6111 13288 10426 27718 6.13E-169 9.2E-168 
  NHEK normal 6432 13288 11179 27718 2.83E-153 4.2E-152 
  NHLF normal 6540 13288 11387 27718 9.63E-155 1.4E-153 
  K562 cancer 5778 13288 10009 27718 1.44E-133 2.2E-132 
  HeLa-S3 cancer 5714 13288 9759 27718 1.09E-150 1.6E-149 
  HepG2 cancer 5378 13288 9488 27718 1.22E-98 1.8E-97 
  Dnd41 cancer 6373 13288 11261 27718 1.65E-126 2.5E-125 
  81 
Supplementary  table 3.3: Raw data used to calculate CGIs enriched with H3K4me3, H3K27ac and H3K36me3 at 5', intragenic, 3' and intergenic locations in different 
cell lines. 
 
Histone 
mark 
Signature 
of 
selective 
pressure 
CGIs in different 
gene region Cell lines Category 
No.of CGIs with 
peaks under 
selective  
pressure (k) 
No.of CGIs 
under 
selective 
pressure (n) 
No. of CGIs 
with peaks 
(M) 
Total no. 
of CGIs 
(N) 
Hypergeometric 
P-value 
bonferroni 
P-value 
H3K34me3 HIR 5'CGIs HUVEC normal 1233 1535 11399 15680 1.35E-13 1.76E-12 
   CD14+ normal 1222 1535 11296 15680 3.31E-13 4.31E-12 
   HMEC normal 1237 1535 11565 15680 1.82E-11 2.36E-10 
   HSMM normal 1292 1535 11939 15680 2.26E-16 2.94E-15 
   HSMMtube normal 1236 1535 11545 15680 1.29E-11 1.68E-10 
   NH-A normal 1244 1535 11638 15680 1.43E-11 1.86E-10 
   NHDF-Ad normal 1239 1535 11380 15680 3.02E-15 3.92E-14 
   NHEK normal 1261 1535 11718 15680 1.32E-13 1.71E-12 
   NHLF normal 1251 1535 11406 15680 1.65E-17 2.14E-16 
   K562 cancer 1082 1535 9977 15680 1.04E-09 1.35E-08 
   HeLa-S3 cancer 1094 1535 10081 15680 4.52E-10 5.88E-09 
   HepG2 cancer 1197 1535 11193 15680 2.99E-10 3.89E-09 
   Dnd41 cancer 974 1535 8921 15680 1.63E-08 2.11E-07 
  Intragenic CGIs HUVEC normal 29 235 441 3094 0.778663427 1 
   CD14+ normal 33 235 533 3094 0.897225807 1 
   HMEC normal 35 235 421 3094 0.239519947 1 
   HSMM normal 42 235 536 3094 0.368616379 1 
   HSMMtube normal 38 235 529 3094 0.613033528 1 
   NH-A normal 29 235 489 3094 0.925426067 1 
   NHDF-Ad normal 37 235 449 3094 0.252882188 1 
   NHEK normal 37 235 494 3094 0.49441344 1 
   NHLF normal 30 235 432 3094 0.668744467 1 
   K562 cancer 27 235 388 3094 0.649922962 1 
   HeLa-S3 cancer 31 235 456 3094 0.721606582 1 
   HepG2 cancer 44 235 461 3094 0.038337988 0.49839385 
   Dnd41 cancer 14 235 230 3094 0.774964619 1 
  3' CGIs HUVEC normal 44 143 473 1806 0.082899126 1 
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   CD14+ normal 47 143 533 1806 0.155772347 1 
   HMEC normal 46 143 437 1806 0.009110405 0.11843527 
   HSMM normal 47 143 521 1806 0.115614874 1 
   HSMMtube normal 43 143 464 1806 0.09035608 1 
   NH-A normal 44 143 467 1806 0.069095492 0.89824139 
   NHDF-Ad normal 45 143 471 1806 0.053754852 0.69881307 
   NHEK normal 54 143 522 1806 0.006561029 0.08529338 
   NHLF normal 45 143 453 1806 0.028522938 0.37079819 
   K562 cancer 35 143 401 1806 0.214107716 1 
   HeLa-S3 cancer 39 143 407 1806 0.066958041 0.87045453 
   HepG2 cancer 41 143 435 1806 0.077186295 1 
   Dnd41 cancer 28 143 252 1806 0.019055049 0.24771564 
  Intergenic CGIs HUVEC normal 250 509 2626 6835 1.34E-07 1.75E-06 
   CD14+ normal 252 509 2738 6835 2.94E-06 3.82E-05 
   HMEC normal 255 509 2681 6835 9.24E-08 1.20E-06 
   HSMM normal 283 509 3001 6835 1.45E-08 1.89E-07 
   HSMMtube normal 240 509 2670 6835 4.79E-05 0.00062262 
   NH-A normal 262 509 2813 6835 4.21E-07 5.48E-06 
   NHDF-Ad normal 243 509 2616 6835 2.49E-06 3.24E-05 
   NHEK normal 268 509 2876 6835 2.37E-07 3.09E-06 
   NHLF normal 236 509 2559 6835 7.67E-06 9.97E-05 
   K562 cancer 193 509 2086 6835 8.73E-05 0.00113484 
   HeLa-S3 cancer 169 509 2026 6835 0.031064262 0.4038354 
   HepG2 cancer 240 509 2648 6835 2.48E-05 0.00032186 
   Dnd41 cancer 147 509 1478 6835 2.43E-05 0.00031589 
 5LSR 5' CGIs HUVEC normal 199 233 11399 15680 1.06E-06 1.37E-05 
   CD14+ normal 193 233 11296 15680 3.89E-05 0.00050621 
   HMEC normal 195 233 11565 15680 0.000100394 1.31E-03 
   HSMM normal 208 233 11939 15680 8.45E-08 1.10E-06 
   HSMMtube normal 207 233 11545 15680 2.31E-09 3.00E-08 
   NH-A normal 204 233 11638 15680 1.50E-07 1.94E-06 
   NHDF-Ad normal 203 233 11380 15680 2.17E-08 2.82E-07 
   NHEK normal 199 233 11718 15680 2.31E-05 0.00029973 
   NHLF normal 197 233 11406 15680 5.72E-06 7.44E-05 
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   K562 cancer 170 233 9977 15680 0.000918968 0.01194659 
   HeLa-S3 cancer 170 233 10081 15680 0.001822082 0.02368706 
   HepG2 cancer 193 233 11193 15680 1.56E-05 0.00020322 
   Dnd41 cancer 154 233 8921 15680 0.00156345 0.02032485 
  Intragenic CGIs HUVEC normal 3 19 441 3094 0.281755207 1 
   CD14+ normal 2 19 533 3094 0.660375345 1 
   HMEC normal 2 19 421 3094 0.489015704 1 
   HSMM normal 2 19 536 3094 0.664427789 1 
   HSMMtube normal 6 19 529 3094 0.031464488 0.40903835 
   NH-A normal 3 19 489 3094 0.352808918 1 
   NHDF-Ad normal 6 19 449 3094 0.01343878 0.17470413 
   NHEK normal 3 19 494 3094 0.360328784 1 
   NHLF normal 2 19 432 3094 0.507362718 1 
   K562 cancer 1 19 388 3094 0.708891767 1 
   HeLa-S3 cancer 1 19 456 3094 0.793780457 1 
   HepG2 cancer 2 19 461 3094 0.554340034 1 
   Dnd41 cancer 1 19 230 3094 0.41826206 1 
  3' CGIs HUVEC normal 7 17 473 1806 0.051055748 0.66372472 
   CD14+ normal 7 17 533 1806 0.095458345 1 
   HMEC normal 5 17 437 1806 0.20972921 1 
   HSMM normal 9 17 521 1806 0.009157676 0.11904978 
   HSMMtube normal 4 17 464 1806 0.452710588 1 
   NH-A normal 8 17 467 1806 0.0151013 0.19631689 
   NHDF-Ad normal 7 17 471 1806 0.049889915 0.64856889 
   NHEK normal 6 17 522 1806 0.194040971 1 
   NHLF normal 5 17 453 1806 0.236397344 1 
   K562 cancer 2 17 401 1806 0.764175739 1 
   HeLa-S3 cancer 2 17 407 1806 0.773970887 1 
   HepG2 cancer 5 17 435 1806 0.206493324 1 
   Dnd41 cancer 2 17 252 1806 0.430473217 1 
  Intergenic CGIs HUVEC normal 35 65 2626 6835 0.00391671 0.05091723 
   CD14+ normal 33 65 2738 6835 0.02985051 0.38805663 
   HMEC normal 30 65 2681 6835 0.101532922 1 
   HSMM normal 39 65 3001 6835 0.003048259 0.03962737 
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   HSMMtube normal 32 65 2670 6835 0.035878191 0.46641649 
   NH-A normal 35 65 2813 6835 0.013964187 0.18153444 
   NHDF-Ad normal 32 65 2616 6835 0.026532101 0.34491731 
   NHEK normal 33 65 2876 6835 0.061037448 0.79348683 
   NHLF normal 26 65 2559 6835 0.286316305 1 
   K562 cancer 25 65 2086 6835 0.065076454 0.8459939 
   HeLa-S3 cancer 13 65 2026 6835 0.946000912 1 
   HepG2 cancer 23 65 2648 6835 0.663529081 1 
   Dnd41 cancer 11 65 1478 6835 0.776954598 1 
 CE 5'CGIs HUVEC normal 7100 8782 11399 15680 1.89E-147 2.45E-146 
   CD14+ normal 6987 8782 11296 15680 5.37E-124 6.99E-123 
   HMEC normal 7242 8782 11565 15680 2.17E-172 2.82E-171 
   HSMM normal 7472 8782 11939 15680 1.16E-193 1.50E-192 
   HSMMtube normal 7273 8782 11545 15680 2.98E-191 3.87E-190 
   NH-A normal 7282 8782 11638 15680 5.43E-174 7.05E-173 
   NHDF-Ad normal 7090 8782 11380 15680 2.60E-147 3.38E-146 
   NHEK normal 7338 8782 11718 15680 1.81E-181 2.35E-180 
   NHLF normal 7118 8782 11406 15680 2.10E-153 2.72E-152 
   K562 cancer 6164 8782 9977 15680 4.99E-83 6.49E-82 
   HeLa-S3 cancer 6293 8782 10081 15680 6.30E-105 8.18E-104 
   HepG2 cancer 6986 8782 11193 15680 6.90E-144 8.97E-143 
   Dnd41 cancer 5538 8782 8921 15680 9.48E-70 1.23E-68 
  Intragenic CGIs HUVEC normal 223 1284 441 3094 1.33E-05 0.000173 
   CD14+ normal 249 1284 533 3094 0.003209551 0.041724 
   HMEC normal 213 1284 421 3094 2.04E-05 0.000265 
   HSMM normal 251 1284 536 3094 0.002620 0.034066 
   HSMMtube normal 239 1284 529 3094 0.026758 0.347857 
   NH-A normal 233 1284 489 3094 0.001165 0.015150 
   NHDF-Ad normal 215 1284 449 3094 0.001315 0.017092 
   NHEK normal 247 1284 494 3094 1.28E-05 0.000167 
   NHLF normal 217 1284 432 3094 3.16E-05 0.000411 
   K562 cancer 197 1284 388 3094 3.24E-05 0.000422 
   HeLa-S3 cancer 215 1284 456 3094 0.003546 0.046092 
   HepG2 cancer 219 1284 461 3094 0.002013 0.026163 
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   Dnd41 cancer 104 1284 230 3094 0.104339 1.000000 
  3' CGIs HUVEC normal 265 911 473 1806 0.001972 0.025633 
   CD14+ normal 295 911 533 1806 0.002973 0.038650 
   HMEC normal 247 911 437 1806 0.001453 0.018893 
   HSMM normal 283 911 521 1806 0.015761 0.204890 
   HSMMtube normal 249 911 464 1806 0.048052 0.624682 
   NH-A normal 250 911 467 1806 0.054213 0.704768 
   NHDF-Ad normal 247 911 471 1806 0.143967 1.000000 
   NHEK normal 290 911 522 1806 0.002365 0.030749 
   NHLF normal 242 911 453 1806 0.064310 0.836025 
   K562 cancer 207 911 401 1806 0.277121 1.000000 
   HeLa-S3 cancer 220 911 407 1806 0.043409 0.564319 
   HepG2 cancer 227 911 435 1806 0.187133 1.000000 
   Dnd41 cancer 129 911 252 1806 0.373133 1.000000 
  Intergenic CGIs HUVEC normal 959 1686 2626 6835 3.57E-71 4.64E-70 
   CD14+ normal 929 1686 2738 6835 1.40E-47 1.83E-46 
   HMEC normal 979 1686 2681 6835 1.05E-73 1.37E-72 
   HSMM normal 1090 1686 3001 6835 1.42E-87 1.85E-86 
   HSMMtube normal 1001 1686 2670 6835 2.46E-85 3.20E-84 
   NH-A normal 1069 1686 2813 6835 3.90E-101 5.07E-100 
   NHDF-Ad normal 944 1686 2616 6835 8.36E-66 1.09E-64 
   NHEK normal 1052 1686 2876 6835 2.19E-84 2.85E-83 
   NHLF normal 933 1686 2559 6835 1.71E-67 2.23E-66 
   K562 cancer 725 1686 2086 6835 9.25E-37 1.20E-35 
   HeLa-S3 cancer 731 1686 2026 6835 2.02E-44 2.62E-43 
   HepG2 cancer 962 1686 2648 6835 5.75E-70 7.47E-69 
   Dnd41 cancer 536 1686 1478 6835 2.78E-30 3.61E-29 
H3K27ac HIR 5'CGIs HUVEC normal 1019 1535 9179 15680 1.34E-11 1.74E-10 
   CD14+ normal 964 1535 8858 15680 5.52E-08 7.18E-07 
   HMEC normal 986 1535 9036 15680 1.18E-08 1.53E-07 
   HSMM normal 962 1535 8902 15680 3.40E-07 4.42E-06 
   HSMMtube normal 931 1535 8631 15680 1.33E-06 1.72E-05 
   NH-A normal 996 1535 9121 15680 6.37E-09 8.28E-08 
   NHDF-Ad normal 1041 1535 9597 15680 6.52E-09 8.48E-08 
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   NHEK normal 993 1535 9128 15680 2.05E-08 2.67E-07 
   NHLF normal 1028 1535 9402 15680 1.06E-09 1.37E-08 
   K562 cancer 976 1535 8778 15680 8.33E-11 1.08E-09 
   HeLa-S3 cancer 1013 1535 9136 15680 2.77E-11 3.61E-10 
   HepG2 cancer 921 1535 8417 15680 6.61E-08 8.59E-07 
   Dnd41 cancer 969 1535 8945 15680 1.48E-07 1.93E-06 
  Intragenic CGIs HUVEC normal 21 235 340 3094 0.825340008 1 
   CD14+ normal 38 235 583 3094 0.842215063 1 
   HMEC normal 10 235 225 3094 0.96411323 1 
   HSMM normal 19 235 357 3094 0.951734634 1 
   HSMMtube normal 23 235 411 3094 0.94253385 1 
   NH-A normal 14 235 322 3094 0.990235294 1 
   NHDF-Ad normal 31 235 519 3094 0.927750484 1 
   NHEK normal 11 235 280 3094 0.993154904 1 
   NHLF normal 22 235 398 3094 0.945532767 1 
   K562 cancer 27 235 320 3094 0.234423785 1 
   HeLa-S3 cancer 26 235 271 3094 0.081292371 1 
   HepG2 cancer 19 235 229 3094 0.28507305 1 
   Dnd41 cancer 62 235 662 3094 0.023544976 0.30608469 
  3' CGIs HUVEC normal 29 143 306 1806 0.112093913 1 
   CD14+ normal 40 143 435 1806 0.109799288 1 
   HMEC normal 24 143 239 1806 0.07918861 1 
   HSMM normal 29 143 296 1806 0.07962582 1 
   HSMMtube normal 32 143 311 1806 0.037860326 0.49218424 
   NH-A normal 31 143 268 1806 0.007863803 0.10222944 
   NHDF-Ad normal 32 143 403 1806 0.444516291 1 
   NHEK normal 25 143 299 1806 0.327921437 1 
   NHLF normal 35 143 353 1806 0.051481078 0.66925402 
   K562 cancer 35 143 340 1806 0.030860906 0.40119177 
   HeLa-S3 cancer 29 143 293 1806 0.071328609 0.92727191 
   HepG2 cancer 28 143 249 1806 0.016271937 0.21153517 
   Dnd41 cancer 40 143 420 1806 0.069747718 0.90672033 
  Intergenic CGIs HUVEC normal 139 509 1488 6835 0.000874217 0.01136483 
   CD14+ normal 129 509 1464 6835 0.011784574 0.15319946 
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   HMEC normal 129 509 1352 6835 0.000586642 0.00762634 
   HSMM normal 124 509 1357 6835 0.004001398 0.05201818 
   HSMMtube normal 116 509 1354 6835 0.0366927 0.4770051 
   NH-A normal 145 509 1456 6835 2.63E-05 0.00034234 
   NHDF-Ad normal 145 509 1669 6835 0.012381231 0.160956 
   NHEK normal 123 509 1395 6835 0.013652571 0.17748343 
   NHLF normal 141 509 1511 6835 0.00083107 0.0108039 
   K562 cancer 152 509 1472 6835 1.75E-06 2.28E-05 
   HeLa-S3 cancer 133 509 1458 6835 0.003006324 0.03908221 
   HepG2 cancer 104 509 1130 6835 0.006804828 0.08846277 
   Dnd41 cancer 146 509 1591 6835 0.00137856 0.01792129 
 5LSR 5'CGIs HUVEC normal 165 233 9179 15680 3.51E-05 0.00045644 
   CD14+ normal 161 233 8858 15680 2.64E-05 0.00034381 
   HMEC normal 159 233 9036 15680 0.000315168 0.00409718 
   HSMM normal 163 233 8902 15680 1.14E-05 0.00014858 
   HSMMtube normal 161 233 8631 15680 3.67E-06 4.78E-05 
   NH-A normal 169 233 9121 15680 1.63E-06 2.13E-05 
   NHDF-Ad normal 178 233 9597 15680 2.49E-07 3.23E-06 
   NHEK normal 163 233 9128 15680 7.39E-05 0.00096055 
   NHLF normal 165 233 9402 15680 0.000200651 0.00260846 
   K562 cancer 156 233 8778 15680 0.000225235 0.00292805 
   HeLa-S3 cancer 157 233 9136 15680 0.001610201 0.02093262 
   HepG2 cancer 154 233 8417 15680 4.10E-05 0.00053364 
   Dnd41 cancer 150 233 8945 15680 0.009089806 0.11816747 
  Intragenic CGIs HUVEC normal 2 19 340 3094 0.348214888 1 
   CD14+ normal 5 19 583 3094 0.130980652 1 
   HMEC normal 1 19 225 3094 0.40713897 1 
   HSMM normal 2 19 357 3094 0.378242878 1 
   HSMMtube normal 1 19 411 3094 0.740205766 1 
   NH-A normal 2 19 322 3094 0.316466195 1 
   NHDF-Ad normal 7 19 519 3094 0.008014574 0.10418946 
   NHEK normal 1 19 280 3094 0.523921693 1 
   NHLF normal 0 19 398 3094 0.927517473 1 
   K562 cancer 0 19 320 3094 0.8751593 1 
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   HeLa-S3 cancer 1 19 271 3094 0.505735219 1 
   HepG2 cancer 0 19 229 3094 0.769030044 1 
   Dnd41 cancer 10 19 662 3094 0.000550209 0.00715272 
  3' CGIs HUVEC normal 0 17 306 1806 0.958059567 1 
   CD14+ normal 3 17 435 1806 0.6148087 1 
   HMEC normal 1 17 239 1806 0.679660247 1 
   HSMM normal 2 17 296 1806 0.544954337 1 
   HSMMtube normal 3 17 311 1806 0.333942024 1 
   NH-A normal 3 17 268 1806 0.237498468 1 
   NHDF-Ad normal 3 17 403 1806 0.546503105 1 
   NHEK normal 0 17 299 1806 0.954585865 1 
   NHLF normal 2 17 353 1806 0.674970273 1 
   K562 cancer 0 17 340 1806 0.971657448 1 
   HeLa-S3 cancer 1 17 293 1806 0.789669019 1 
   HepG2 cancer 0 17 249 1806 0.920669554 1 
   Dnd41 cancer 2 17 420 1806 0.794178512 1 
  Intergenic CGIs HUVEC normal 24 65 1488 6835 0.001599445 0.02079279 
   CD14+ normal 16 65 1464 6835 0.213562803 1 
   HMEC normal 14 65 1352 6835 0.295865386 1 
   HSMM normal 14 65 1357 6835 0.301130624 1 
   HSMMtube normal 10 65 1354 6835 0.766900317 1 
   NH-A normal 14 65 1456 6835 0.410492354 1 
   NHDF-Ad normal 23 65 1669 6835 0.016222041 0.21088653 
   NHEK normal 13 65 1395 6835 0.459301223 1 
   NHLF normal 16 65 1511 6835 0.255970976 1 
   K562 cancer 11 65 1472 6835 0.771856722 1 
   HeLa-S3 cancer 10 65 1458 6835 0.847682447 1 
   HepG2 cancer 11 65 1130 6835 0.387009036 1 
   Dnd41 cancer 13 65 1591 6835 0.677252021 1 
 CE 5'CGIs HUVEC normal 5730 8782 9179 15680 6.30E-83 8.19E-82 
   CD14+ normal 5402 8782 8858 15680 7.92E-47 1.03E-45 
   HMEC normal 5652 8782 9036 15680 4.85E-83 6.31E-82 
   HSMM normal 5642 8782 8902 15680 2.17E-101 2.82E-100 
   HSMMtube normal 5495 8782 8631 15680 4.29E-102 5.58E-101 
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   NH-A normal 5749 8782 9121 15680 1.86E-97 2.42E-96 
   NHDF-Ad normal 5979 8782 9597 15680 7.38E-89 9.60E-88 
   NHEK normal 5702 8782 9128 15680 6.54E-83 8.50E-82 
   NHLF normal 5849 8782 9402 15680 3.86E-82 5.02E-81 
   K562 cancer 5457 8782 8778 15680 3.17E-69 4.12E-68 
   HeLa-S3 cancer 5732 8782 9136 15680 4.33E-90 5.62E-89 
   HepG2 cancer 5260 8782 8417 15680 5.68E-70 7.38E-69 
   Dnd41 cancer 5496 8782 8945 15680 1.20E-56 1.56E-55 
  Intragenic CGIs HUVEC normal 155 1284 340 3094 0.046864792 0.60924229 
   CD14+ normal 256 1284 583 3094 0.087398419 1 
   HMEC normal 110 1284 225 3094 0.008335083 0.10835608 
   HSMM normal 153 1284 357 3094 0.270251272 1 
   HSMMtube normal 179 1284 411 3094 0.168309867 1 
   NH-A normal 141 1284 322 3094 0.173400386 1 
   NHDF-Ad normal 230 1284 519 3094 0.070208194 0.91270652 
   NHEK normal 137 1284 280 3094 0.00352142 0.04577846 
   NHLF normal 178 1284 398 3094 0.073442963 0.95475851 
   K562 cancer 155 1284 320 3094 0.00339791 0.04417282 
   HeLa-S3 cancer 142 1284 271 3094 5.93E-05 0.00077143 
   HepG2 cancer 102 1284 229 3094 0.149102077 1 
   Dnd41 cancer 270 1284 662 3094 0.646128785 1 
  3' CGIs HUVEC normal 171 911 306 1806 0.0156651 0.2036463 
   CD14+ normal 231 911 435 1806 0.091926603 1 
   HMEC normal 128 911 239 1806 0.134999356 1 
   HSMM normal 155 911 296 1806 0.215723479 1 
   HSMMtube normal 160 911 311 1806 0.32585844 1 
   NH-A normal 145 911 268 1806 0.086013542 1 
   NHDF-Ad normal 223 911 403 1806 0.011107431 0.1443966 
   NHEK normal 158 911 299 1806 0.165554665 1 
   NHLF normal 191 911 353 1806 0.055333839 0.71933991 
   K562 cancer 173 911 340 1806 0.405200056 1 
   HeLa-S3 cancer 162 911 293 1806 0.030181149 0.39235494 
   HepG2 cancer 132 911 249 1806 0.173234529 1 
   Dnd41 cancer 222 911 420 1806 0.117934346 1 
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  Intergenic CGIs HUVEC normal 579 1686 1488 6835 1.45E-44 1.88E-43 
   CD14+ normal 515 1686 1464 6835 4.77E-25 6.20E-24 
   HMEC normal 523 1686 1352 6835 1.96E-38 2.55E-37 
   HSMM normal 529 1686 1357 6835 3.86E-40 5.02E-39 
   HSMMtube normal 542 1686 1354 6835 1.32E-45 1.72E-44 
   NH-A normal 579 1686 1456 6835 2.50E-48 3.26E-47 
   NHDF-Ad normal 614 1686 1669 6835 2.98E-38 3.87E-37 
   NHEK normal 514 1686 1395 6835 7.31E-31 9.51E-30 
   NHLF normal 576 1686 1511 6835 7.18E-41 9.34E-40 
   K562 cancer 514 1686 1472 6835 4.17E-24 5.43E-23 
   HeLa-S3 cancer 563 1686 1458 6835 8.78E-42 1.14E-40 
   HepG2 cancer 463 1686 1130 6835 4.99E-41 6.48E-40 
   Dnd41 cancer 563 1686 1591 6835 9.92E-29 1.29E-27 
H3K36me3 HIR 5'CGIs HUVEC normal 669 1535 6558 15680 0.067210303 0.87373394 
   CD14+ normal 519 1535 4950 15680 0.022188677 0.28845281 
   HMEC normal 660 1535 6669 15680 0.338733884 1 
   HSMM normal 848 1535 8023 15680 0.000343315 0.00446309 
   HSMMtube normal 677 1535 6641 15680 0.068423821 0.88950968 
   NH-A normal 613 1535 5938 15680 0.037534781 0.48795215 
   NHDF-Ad normal 748 1535 7065 15680 0.001082305 0.01406997 
   NHEK normal 769 1535 7533 15680 0.042381947 0.55096531 
   NHLF normal 769 1535 7437 15680 0.012882143 0.16746786 
   K562 cancer 784 1535 6949 15680 9.51E-09 1.24E-07 
   HeLa-S3 cancer 735 1535 6665 15680 3.46E-06 4.50E-05 
   HepG2 cancer 668 1535 6288 15680 1.91E-03 0.02482775 
   Dnd41 cancer 818 1535 7612 15680 4.04E-05 0.0005256 
  Intragenic CGIs HUVEC normal 86 235 1280 3094 0.930798207 1 
   CD14+ normal 64 235 1188 3094 0.999875172 1 
   HMEC normal 85 235 1232 3094 0.868747145 1 
   HSMM normal 100 235 1436 3094 0.878324946 1 
   HSMMtube normal 107 235 1577 3094 0.952244821 1 
   NH-A normal 76 235 1056 3094 0.700477153 1 
   NHDF-Ad normal 86 235 1250 3094 0.878795401 1 
   NHEK normal 90 235 1338 3094 0.936758049 1 
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   NHLF normal 91 235 1495 3094 0.998680813 1 
   K562 cancer 62 235 1044 3094 0.992814645 1 
   HeLa-S3 cancer 92 235 1119 3094 0.144614695 1 
   HepG2 cancer 91 235 1313 3094 0.870864711 1 
   Dnd41 cancer 84 235 1301 3094 0.976081611 1 
  3' CGIs HUVEC normal 77 143 770 1806 0.001885221 0.02450787 
   CD14+ normal 63 143 662 1806 0.023435846 0.304666 
   HMEC normal 77 143 736 1806 0.000363765 0.00472894 
   HSMM normal 75 143 854 1806 0.084591729 1 
   HSMMtube normal 80 143 861 1806 0.015766181 0.20496035 
   NH-A normal 65 143 608 1806 0.000841661 0.01094159 
   NHDF-Ad normal 73 143 754 1806 0.007669583 0.09970458 
   NHEK normal 71 143 828 1806 0.149517063 1 
   NHLF normal 77 143 876 1806 0.077955821 1 
   K562 cancer 61 143 630 1806 0.017800492 0.23140639 
   HeLa-S3 cancer 64 143 643 1806 0.007287572 0.09473843 
   HepG2 cancer 72 143 679 1806 0.000441824 0.00574371 
   Dnd41 cancer 71 143 771 1806 0.033247076 0.43221198 
  Intergenic CGIs HUVEC normal 59 509 678 6835 0.084698387 1 
   CD14+ normal 56 509 605 6835 0.03471042 0.45123546 
   HMEC normal 67 509 791 6835 0.109272568 1 
   HSMM normal 100 509 1177 6835 0.060238262 0.7830974 
   HSMMtube normal 83 509 873 6835 0.006546956 0.08511043 
   NH-A normal 58 509 600 6835 0.014536252 0.18897127 
   NHDF-Ad normal 72 509 818 6835 0.052539249 0.68301023 
   NHEK normal 79 509 898 6835 0.044882391 0.58347108 
   NHLF normal 86 509 1026 6835 0.097838329 1 
   K562 cancer 93 509 846 6835 2.50E-05 0.00032537 
   HeLa-S3 cancer 73 509 814 6835 0.035945814 0.46729558 
   HepG2 cancer 68 509 737 6835 0.024010632 0.31213821 
   Dnd41 cancer 85 509 957 6835 0.031571295 0.41042684 
 5LSR 5'CGIs HUVEC normal 104 233 6558 15680 0.172649457 1 
   CD14+ normal 84 233 4950 15680 0.061356652 0.79763648 
   HMEC normal 106 233 6669 15680 0.161545556 1 
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   HSMM normal 129 233 8023 15680 0.087179711 1 
   HSMMtube normal 101 233 6641 15680 0.35234683 1 
   NH-A normal 101 233 5938 15680 0.036374095 0.47286323 
   NHDF-Ad normal 127 233 7065 15680 0.001448573 0.01883145 
   NHEK normal 120 233 7533 15680 0.129029023 1 
   NHLF normal 122 233 7437 15680 0.056614077 0.73598301 
   K562 cancer 133 233 6949 15680 3.14E-05 0.00040782 
   HeLa-S3 cancer 138 233 6665 15680 8.41E-08 1.09E-06 
   HepG2 cancer 112 233 6288 15680 0.005409569 0.0703244 
   Dnd41 cancer 127 233 7612 15680 0.02870035 0.37310455 
  Intragenic CGIs HUVEC normal 13 19 1280 3094 0.004338901 0.05640571 
   CD14+ normal 11 19 1188 3094 0.024852816 0.32308661 
   HMEC normal 9 19 1232 3094 0.180989517 1 
   HSMM normal 13 19 1436 3094 0.014809112 0.19251846 
   HSMMtube normal 13 19 1577 3094 0.037843282 0.49196267 
   NH-A normal 12 19 1056 3094 0.002324823 0.03022271 
   NHDF-Ad normal 13 19 1250 3094 0.003339216 0.04340981 
   NHEK normal 12 19 1338 3094 0.023605472 0.30687114 
   NHLF normal 13 19 1495 3094 0.022335542 0.29036204 
   K562 cancer 8 19 1044 3094 0.15460513 1 
   HeLa-S3 cancer 12 19 1119 3094 0.004203321 0.05464317 
   HepG2 cancer 13 19 1313 3094 0.005729294 0.07448082 
   Dnd41 cancer 10 19 1301 3094 0.121440184 1 
  3' CGIs HUVEC normal 4 17 770 1806 0.914714111 1 
   CD14+ normal 4 17 662 1806 0.807536039 1 
   HMEC normal 6 17 736 1806 0.577857379 1 
   HSMM normal 7 17 854 1806 0.601613746 1 
   HSMMtube normal 4 17 861 1806 0.962937018 1 
   NH-A normal 3 17 608 1806 0.876651482 1 
   NHDF-Ad normal 3 17 754 1806 0.966503609 1 
   NHEK normal 6 17 828 1806 0.734532897 1 
   NHLF normal 5 17 876 1806 0.910791987 1 
   K562 cancer 7 17 630 1806 0.208742787 1 
   HeLa-S3 cancer 6 17 643 1806 0.401362869 1 
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   HepG2 cancer 10 17 679 1806 0.020970127 0.27261166 
   Dnd41 cancer 7 17 771 1806 0.447979481 1 
  Intergenic CGIs HUVEC normal 13 65 678 6835 0.003946679 0.05130682 
   CD14+ normal 5 65 605 6835 0.520344185 1 
   HMEC normal 5 65 791 6835 0.779037215 1 
   HSMM normal 16 65 1177 6835 0.045130092 0.5866912 
   HSMMtube normal 6 65 873 6835 0.741106363 1 
   NH-A normal 4 65 600 6835 0.68637612 1 
   NHDF-Ad normal 8 65 818 6835 0.374187104 1 
   NHEK normal 8 65 898 6835 0.487839491 1 
   NHLF normal 7 65 1026 6835 0.779964351 1 
   K562 cancer 4 65 846 6835 0.918251224 1 
   HeLa-S3 cancer 5 65 814 6835 0.802508545 1 
   HepG2 cancer 4 65 737 6835 0.844410487 1 
   Dnd41 cancer 8 65 957 6835 0.569155962 1 
 CE 5'CGIs HUVEC normal 4076 8782 6558 15680 4.75E-40 6.18E-39 
   CD14+ normal 3025 8782 4950 15680 7.66E-19 9.96E-18 
   HMEC normal 4138 8782 6669 15680 7.80E-40 1.01E-38 
   HSMM normal 4994 8782 8023 15680 6.16E-59 8.01E-58 
   HSMMtube normal 4104 8782 6641 15680 1.65E-36 2.15E-35 
   NH-A normal 3729 8782 5938 15680 1.81E-41 2.35E-40 
   NHDF-Ad normal 4479 8782 7065 15680 1.06E-64 1.38E-63 
   NHEK normal 4684 8782 7533 15680 3.02E-51 3.93E-50 
   NHLF normal 4653 8782 7437 15680 2.91E-56 3.79E-55 
   K562 cancer 4335 8782 6949 15680 2.69E-47 3.49E-46 
   HeLa-S3 cancer 4211 8782 6665 15680 2.55E-55 3.31E-54 
   HepG2 cancer 3903 8782 6288 15680 1.65E-36 2.15E-35 
   Dnd41 cancer 4723 8782 7612 15680 4.25E-50 5.53E-49 
  Intragenic CGIs HUVEC normal 590 1284 1280 3094 5.68E-06 7.38E-05 
   CD14+ normal 505 1284 1188 3094 0.17447696 1 
   HMEC normal 590 1284 1232 3094 1.85E-09 2.40E-08 
   HSMM normal 648 1284 1436 3094 6.02E-05 0.00078251 
   HSMMtube normal 704 1284 1577 3094 0.000128638 0.0016723 
   NH-A normal 494 1284 1056 3094 7.78E-06 0.00010115 
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   NHDF-Ad normal 570 1284 1250 3094 6.04E-05 0.00078514 
   NHEK normal 612 1284 1338 3094 1.26E-05 0.00016395 
   NHLF normal 677 1284 1495 3094 1.53E-05 0.00019919 
   K562 cancer 473 1284 1044 3094 0.000966049 0.01255863 
   HeLa-S3 cancer 529 1284 1119 3094 4.00E-07 5.20E-06 
   HepG2 cancer 550 1284 1313 3094 0.339310805 1 
   Dnd41 cancer 565 1284 1301 3094 0.02933107 0.38130392 
  3' CGIs HUVEC normal 420 911 770 1806 0.001124399 0.01461718 
   CD14+ normal 353 911 662 1806 0.02796486 0.36354318 
   HMEC normal 408 911 736 1806 0.000178937 0.00232618 
   HSMM normal 469 911 854 1806 0.000130139 0.0016918 
   HSMMtube normal 475 911 861 1806 5.15E-05 0.000669 
   NH-A normal 341 911 608 1806 0.000260584 0.00338759 
   NHDF-Ad normal 418 911 754 1806 0.000133994 0.00174192 
   NHEK normal 463 911 828 1806 7.36E-06 9.56E-05 
   NHLF normal 485 911 876 1806 1.97E-05 0.00025634 
   K562 cancer 343 911 630 1806 0.005544192 0.07207449 
   HeLa-S3 cancer 357 911 643 1806 0.00055535 0.00721955 
   HepG2 cancer 377 911 679 1806 0.00033387 0.00434031 
   Dnd41 cancer 411 911 771 1806 0.015801376 0.20541789 
  Intergenic CGIs HUVEC normal 303 1686 678 6835 6.49E-34 8.43E-33 
   CD14+ normal 227 1686 605 6835 5.94E-14 7.72E-13 
   HMEC normal 329 1686 791 6835 1.59E-29 2.06E-28 
   HSMM normal 467 1686 1177 6835 5.80E-37 7.53E-36 
   HSMMtube normal 347 1686 873 6835 1.08E-26 1.41E-25 
   NH-A normal 266 1686 600 6835 6.49E-29 8.43E-28 
   NHDF-Ad normal 354 1686 818 6835 2.54E-36 3.30E-35 
   NHEK normal 373 1686 898 6835 1.14E-33 1.48E-32 
   NHLF normal 428 1686 1026 6835 7.80E-40 1.01E-38 
   K562 cancer 341 1686 846 6835 1.53E-27 1.99E-26 
   HeLa-S3 cancer 336 1686 814 6835 1.96E-29 2.54E-28 
   HepG2 cancer 302 1686 737 6835 1.19E-25 1.55E-24 
   Dnd41 cancer 364 1686 957 6835 8.89E-24 1.16E-22 
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Supplementary table 3.4: Raw data used to calculate CGIs enriched with H3K4me3, H3K27ac and H3K36me3 in different cell lines according to the CGIs evolutionary 
model. 
Histone mark 
Signature of 
selective 
pressure 
CGIs according to 
evolutionary model Cell lines Category 
No.of CGIs with peaks 
under 
 selective pressure (k) 
No.of CGIs under 
selective pressure (n) 
No. of CGIs with 
peaks (M) 
Total no. of 
CGIs (N) 
Hyper- 
geometric  
P-value 
bonferroni  
P-value 
H3K4me3 HIR Hypodeaminated CGIs HUVEC normal 731 907 6957 9091 0.000834 0.01083714 
   CD14+ normal 720 907 6935 9091 0.008619 0.11204396 
   HMEC normal 735 907 7063 9091 0.004263 0.05542167 
   HSMM normal 766 907 7317 9091 0.000487 0.0063369 
   HSMMtube normal 717 907 7007 9091 0.061529 0.79987202 
   NH-A normal 737 907 7158 9091 0.021772 0.28303785 
   NHDF-Ad normal 718 907 6952 9091 0.018996 0.24695346 
   NHEK normal 756 907 7254 9091 0.0018 0.02339949 
   NHLF normal 715 907 6910 9091 0.015368 0.19978297 
   K562 cancer 632 907 6002 9091 0.00609 0.07916973 
   HeLaS3 cancer 621 907 5934 9091 0.014696 0.19104443 
   HepG2 cancer 703 907 6754 9091 0.008171 0.10622555 
   Dnd41 cancer 551 907 5169 9091 0.005585 0.07261111 
  BGC CGIs HUVEC normal 129 345 1204 4782 6.40E-08 8.32E-07 
   CD14+ normal 131 345 1341 4782 1.27E-05 1.65E-04 
   HMEC normal 122 345 1162 4782 6.10E-07 7.92E-06 
   HSMM normal 135 345 1370 4782 5.10E-06 6.63E-05 
   HSMMtube normal 125 345 1294 4782 4.09E-05 5.32E-04 
   NH-A normal 124 345 1203 4782 1.36E-06 1.77E-05 
   NHDF-Ad normal 134 345 1220 4782 5.28E-09 6.87E-08 
   NHEK normal 128 345 1259 4782 1.83E-06 2.38E-05 
   NHLF normal 117 345 1174 4782 1.84E-05 2.40E-04 
   K562 cancer 113 345 1112 4782 1.07E-05 1.39E-04 
   HeLaS3 cancer 126 345 1286 4782 1.78E-05 2.32E-04 
   HepG2 cancer 128 345 1302 4782 1.22E-05 1.58E-04 
   Dnd41 cancer 103 345 853 4782 4.35E-09 5.65E-08 
 5LSR Hypodeaminated CGIs HUVEC normal 108 138 6957 9091 0.283012 1 
   CD14+ normal 102 138 6935 9091 0.715888 1 
   HMEC normal 109 138 7063 9091 0.324192 1 
   HSMM normal 117 138 7317 9091 0.078514 1 
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   HSMMtube normal 114 138 7007 9091 0.044844 0.58296702 
   NH-A normal 109 138 7158 9091 0.437416 1 
   NHDF-Ad normal 113 138 6952 9091 0.050077 0.65100448 
   NHEK normal 112 138 7254 9091 0.310684 1 
   NHLF normal 106 138 6910 9091 0.379269 1 
   K562 cancer 83 138 6002 9091 0.914782 1 
   HeLaS3 cancer 83 138 5934 9091 0.881381 1 
   HepG2 cancer 97 138 6754 9091 0.838183 1 
   Dnd41 cancer 75 138 5169 9091 0.697099 1 
  BGC CGIs HUVEC normal 9 28 1204 4782 0.142858 1 
   CD14+ normal 6 28 1341 4782 0.708068 1 
   HMEC normal 8 28 1162 4782 0.221869 1 
   HSMM normal 9 28 1370 4782 0.262014 1 
   HSMMtube normal 10 28 1294 4782 0.10857 1 
   NH-A normal 7 28 1203 4782 0.407707 1 
   NHDF-Ad normal 10 28 1220 4782 0.07636 0.99267721 
   NHEK normal 8 28 1259 4782 0.304875 1 
   NHLF normal 8 28 1174 4782 0.231545 1 
   K562 cancer 6 28 1112 4782 0.485857 1 
   HeLaS3 cancer 8 28 1286 4782 0.329635 1 
   HepG2 cancer 8 28 1302 4782 0.344566 1 
   Dnd41 cancer 6 28 853 4782 0.220868 1 
 CE Hypodeaminated CGIs HUVEC normal 3913 4881 6957 9091 4.90E-19 6.38E-18 
   CD14+ normal 3851 4881 6935 9091 1.26E-10 1.63E-09 
   HMEC normal 3974 4881 7063 9091 1.73E-20 2.25E-19 
   HSMM normal 4119 4881 7317 9091 2.10E-24 2.73E-23 
   HSMMtube normal 3986 4881 7007 9091 1.59E-29 2.07E-28 
   NH-A normal 4012 4881 7158 9091 1.73E-18 2.25E-17 
   NHDF-Ad normal 3877 4881 6952 9091 3.51E-13 4.56E-12 
   NHEK normal 4055 4881 7254 9091 2.00E-17 2.59E-16 
   NHLF normal 3872 4881 6910 9091 6.47E-16 8.41E-15 
   K562 cancer 3373 4881 6002 9091 1.03E-11 1.34E-10 
   HeLaS3 cancer 3418 4881 5934 9091 4.88E-25 6.35E-24 
   HepG2 cancer 3820 4881 6754 9091 4.78E-21 6.22E-20 
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   Dnd41 cancer 2994 4881 5169 9091 6.24E-21 8.11E-20 
  BGC CGIs HUVEC normal 438 1338 1204 4782 5.89E-14 7.66E-13 
   CD14+ normal 454 1338 1341 4782 9.32E-09 1.21E-07 
   HMEC normal 418 1338 1162 4782 2.59E-12 3.37E-11 
   HSMM normal 472 1338 1370 4782 1.69E-10 2.20E-09 
   HSMMtube normal 443 1338 1294 4782 2.69E-09 3.50E-08 
   NH-A normal 428 1338 1203 4782 9.06E-12 1.18E-10 
   NHDF-Ad normal 418 1338 1220 4782 9.05E-09 1.18E-07 
   NHEK normal 446 1338 1259 4782 5.43E-12 7.06E-11 
   NHLF normal 417 1338 1174 4782 2.66E-11 3.46E-10 
   K562 cancer 412 1338 1112 4782 1.64E-14 2.13E-13 
   HeLaS3 cancer 448 1338 1286 4782 1.02E-10 1.32E-09 
   HepG2 cancer 461 1338 1302 4782 1.99E-12 2.59E-11 
   Dnd41 cancer 320 1338 853 4782 8.18E-12 1.06E-10 
H3k27ac HIR Hypodeaminated CGIs HUVEC normal 562 907 5346 9091 0.018869 0.24530313 
   CD14+ normal 534 907 5121 9091 0.047821 0.62167341 
   HMEC normal 549 907 5298 9091 0.068502 0.89053238 
   HSMM normal 534 907 5148 9091 0.069877 0.90840636 
   HSMMtube normal 504 907 4982 9091 0.300404 1 
   NH-A normal 556 907 5288 9091 0.019826 0.25773606 
   NHDF-Ad normal 575 907 5632 9091 0.16347 1 
   NHEK normal 548 907 5335 9091 0.124198 1 
   NHLF normal 569 907 5446 9091 0.030535 0.39695404 
   K562 cancer 557 907 5159 9091 0.001202 0.01562905 
   HeLaS3 cancer 561 907 5304 9091 0.01066 0.1385841 
   HepG2 cancer 522 907 4831 9091 0.002206 0.02867685 
   Dnd41 cancer 558 907 5186 9091 0.001766 0.02295731 
  BGC CGIs HUVEC normal 117 345 985 4782 6.59E-10 8.57E-09 
   CD14+ normal 121 345 1289 4782 0.000227 2.95E-03 
   HMEC normal 98 345 801 4782 5.81E-09 7.55E-08 
   HSMM normal 108 345 933 4782 1.91E-08 2.49E-07 
   HSMMtube normal 111 345 995 4782 9.53E-08 1.24E-06 
   NH-A normal 98 345 870 4782 4.56E-07 5.93E-06 
   NHDF-Ad normal 121 345 1165 4782 1.29E-06 1.68E-05 
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   NHEK normal 99 345 892 4782 8.17E-07 1.06E-05 
   NHLF normal 109 345 1005 4782 6.14E-07 7.98E-06 
   K562 cancer 116 345 971 4782 5.58E-10 7.25E-09 
   HeLaS3 cancer 106 345 942 4782 1.33E-07 1.73E-06 
   HepG2 cancer 91 345 824 4782 3.30E-06 4.30E-05 
   Dnd41 cancer 141 345 1377 4782 2.21E-07 2.87E-06 
 5LSR Hypodeaminated CGIs HUVEC normal 88 138 5346 9091 0.099486 1 
   CD14+ normal 84 138 5121 9091 0.120714 1 
   HMEC normal 81 138 5298 9091 0.427491 1 
   HSMM normal 82 138 5148 9091 0.226076 1 
   HSMMtube normal 81 138 4982 9091 0.155651 1 
   NH-A normal 85 138 5288 9091 0.181833 1 
   NHDF-Ad normal 98 138 5632 9091 0.009766 0.12695304 
   NHEK normal 80 138 5335 9091 0.535547 1 
   NHLF normal 87 138 5446 9091 0.199408 1 
   K562 cancer 74 138 5159 9091 0.746042 1 
   HeLaS3 cancer 77 138 5304 9091 0.701113 1 
   HepG2 cancer 70 138 4831 9091 0.687313 1 
   Dnd41 cancer 75 138 5186 9091 0.712584 1 
  BGC CGIs HUVEC normal 8 28 985 4782 0.103776 1 
   CD14+ normal 11 28 1289 4782 0.050066 0.65085246 
   HMEC normal 7 28 801 4782 0.082873 1 
   HSMM normal 9 28 933 4782 0.033046 0.42959758 
   HSMMtube normal 9 28 995 4782 0.049244 0.64017842 
   NH-A normal 7 28 870 4782 0.121137 1 
   NHDF-Ad normal 12 28 1165 4782 0.008794 0.11431614 
   NHEK normal 7 28 892 4782 0.135173 1 
   NHLF normal 6 28 1005 4782 0.37191 1 
   K562 cancer 6 28 971 4782 0.336307 1 
   HeLaS3 cancer 7 28 942 4782 0.17026 1 
   HepG2 cancer 6 28 824 4782 0.195344 1 
   Dnd41 cancer 13 28 1377 4782 0.014165 0.18414148 
 CE Hypodeaminated CGIs HUVEC normal 3092 4881 5346 9091 1.08E-21 1.41E-20 
   CD14+ normal 2916 4881 5121 9091 7.06E-13 9.18E-12 
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   HMEC normal 3069 4881 5298 9091 4.09E-22 5.31E-21 
   HSMM normal 3040 4881 5148 9091 3.87E-32 5.03E-31 
   HSMMtube normal 2953 4881 4982 9091 2.34E-32 3.04E-31 
   NH-A normal 3085 4881 5288 9091 4.02E-26 5.23E-25 
   NHDF-Ad normal 3212 4881 5632 9091 1.53E-16 1.99E-15 
   NHEK normal 3076 4881 5335 9091 6.46E-20 8.40E-19 
   NHLF normal 3124 4881 5446 9091 3.82E-18 4.97E-17 
   K562 cancer 2966 4881 5159 9091 3.47E-17 4.51E-16 
   HeLaS3 cancer 3109 4881 5304 9091 2.81E-29 3.66E-28 
   HepG2 cancer 2830 4881 4831 9091 8.99E-24 1.17E-22 
   Dnd41 cancer 2994 4881 5186 9091 2.15E-19 2.79E-18 
  BGC CGIs HUVEC normal 368 1338 985 4782 2.09E-13 2.72E-12 
   CD14+ normal 456 1338 1289 4782 3.41E-12 4.43E-11 
   HMEC normal 314 1338 801 4782 1.51E-14 1.96E-13 
   HSMM normal 345 1338 933 4782 8.67E-12 1.13E-10 
   HSMMtube normal 366 1338 995 4782 3.50E-12 4.55E-11 
   NH-A normal 330 1338 870 4782 5.91E-13 7.69E-12 
   NHDF-Ad normal 418 1338 1165 4782 4.14E-12 5.38E-11 
   NHEK normal 332 1338 892 4782 9.48E-12 1.23E-10 
   NHLF normal 366 1338 1005 4782 1.79E-11 2.32E-10 
   K562 cancer 371 1338 971 4782 2.69E-15 3.49E-14 
   HeLaS3 cancer 365 1338 942 4782 3.68E-16 4.79E-15 
   HepG2 cancer 331 1338 824 4782 2.69E-17 3.50E-16 
   Dnd41 cancer 469 1338 1377 4782 1.55E-09 2.02E-08 
H3K36me3 HIR Hypodeaminated CGIs HUVEC normal 370 907 3612 9091 0.234017 1 
   CD14+ normal 299 907 2750 9091 0.028395 0.36912887 
   HMEC normal 363 907 3702 9091 0.66087 1 
   HSMM normal 465 907 4497 9091 0.11927 1 
   HSMMtube normal 361 907 3630 9091 0.518084 1 
   NH-A normal 338 907 3260 9091 0.166704 1 
   NHDF-Ad normal 397 907 3833 9091 0.142562 1 
   NHEK normal 417 907 4154 9091 0.414611 1 
   NHLF normal 403 907 4029 9091 0.456648 1 
   K562 cancer 426 907 3867 9091 0.00204 0.0265251 
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   HeLaS3 cancer 402 907 3736 9091 0.017354 0.22560689 
   HepG2 cancer 374 907 3435 9091 0.011137 0.14477735 
   Dnd41 cancer 460 907 4143 9091 0.00047 0.006111 
  BGC CGIs HUVEC normal 125 345 1682 4782 0.31221 1 
   CD14+ normal 115 345 1591 4782 0.463909 1 
   HMEC normal 129 345 1630 4782 0.080941 1 
   HSMM normal 153 345 1943 4782 0.065207 0.84769658 
   HSMMtube normal 140 345 1997 4782 0.656461 1 
   NH-A normal 103 345 1329 4782 0.170709 1 
   NHDF-Ad normal 132 345 1622 4782 0.034679 0.45082273 
   NHEK normal 148 345 1824 4782 0.026442 0.34374195 
   NHLF normal 140 345 1996 4782 0.653451 1 
   K562 cancer 124 345 1489 4782 0.020572 0.26743116 
   HeLaS3 cancer 124 345 1504 4782 0.028093 0.36521405 
   HepG2 cancer 128 345 1686 4782 0.210546 1 
   Dnd41 cancer 143 345 1915 4782 0.270525 1 
 5LSR Hypodeaminated CGIs HUVEC normal 54 138 3612 9091 0.520706 1 
   CD14+ normal 43 138 2750 9091 0.367571 1 
   HMEC normal 45 138 3702 9091 0.970201 1 
   HSMM normal 75 138 4497 9091 0.107167 1 
   HSMMtube normal 56 138 3630 9091 0.401315 1 
   NH-A normal 48 138 3260 9091 0.566845 1 
   NHDF-Ad normal 66 138 3833 9091 0.074836 0.97287081 
   NHEK normal 59 138 4154 9091 0.729331 1 
   NHLF normal 63 138 4029 9091 0.342154 1 
   K562 cancer 60 138 3867 9091 0.376061 1 
   HeLaS3 cancer 66 138 3736 9091 0.044661 0.58058869 
   HepG2 cancer 55 138 3435 9091 0.27483 1 
   Dnd41 cancer 62 138 4143 9091 0.525789 1 
  BGC CGIs HUVEC normal 14 28 1682 4782 0.034768 0.45198332 
   CD14+ normal 12 28 1591 4782 0.101961 1 
   HMEC normal 14 28 1630 4782 0.026147 0.33991207 
   HSMM normal 18 28 1943 4782 0.003222 0.04187976 
   HSMMtube normal 15 28 1997 4782 0.072655 0.94451966 
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   NH-A normal 13 28 1329 4782 0.010215 0.13279852 
   NHDF-Ad normal 16 28 1622 4782 0.003253 0.04229248 
   NHEK normal 15 28 1824 4782 0.031639 0.41131271 
   NHLF normal 15 28 1996 4782 0.072339 0.94041122 
   K562 cancer 14 28 1489 4782 0.011017 0.14322697 
   HeLaS3 cancer 14 28 1504 4782 0.012161 0.15808916 
   HepG2 cancer 15 28 1686 4782 0.014433 0.18762763 
   Dnd41 cancer 14 28 1915 4782 0.102705 1 
 CE Hypodeaminated CGIs HUVEC normal 2187 4881 3612 9091 5.42E-27 7.04E-26 
   CD14+ normal 1623 4881 2750 9091 7.57E-12 9.84E-11 
   HMEC normal 2230 4881 3702 9091 1.00E-25 1.30E-24 
   HSMM normal 2665 4881 4497 9091 1.99E-26 2.59E-25 
   HSMMtube normal 2201 4881 3630 9091 7.82E-28 1.02E-26 
   NH-A normal 1986 4881 3260 9091 1.39E-25 1.81E-24 
   NHDF-Ad normal 2369 4881 3833 9091 1.03E-40 1.34E-39 
   NHEK normal 2502 4881 4154 9091 5.62E-31 7.31E-30 
   NHLF normal 2429 4881 4029 9091 6.74E-30 8.76E-29 
   K562 cancer 2312 4881 3867 9091 3.72E-24 4.83E-23 
   HeLaS3 cancer 2256 4881 3736 9091 3.37E-27 4.38E-26 
   HepG2 cancer 2094 4881 3435 9091 6.73E-28 8.74E-27 
   Dnd41 cancer 2525 4881 4143 9091 1.69E-37 2.19E-36 
  BGC CGIs HUVEC normal 674 1338 1682 4782 2.55E-42 3.31E-41 
   CD14+ normal 602 1338 1591 4782 1.22E-26 1.58E-25 
   HMEC normal 646 1338 1630 4782 1.23E-37 1.60E-36 
   HSMM normal 729 1338 1943 4782 4.06E-34 5.28E-33 
   HSMMtube normal 750 1338 1997 4782 5.40E-36 7.02E-35 
   NH-A normal 541 1338 1329 4782 3.20E-33 4.16E-32 
   NHDF-Ad normal 639 1338 1622 4782 5.90E-36 7.67E-35 
   NHEK normal 720 1338 1824 4782 1.04E-43 1.35E-42 
   NHLF normal 766 1338 1996 4782 5.09E-42 6.61E-41 
   K562 cancer 566 1338 1489 4782 4.65E-25 6.04E-24 
   HeLaS3 cancer 586 1338 1504 4782 5.36E-30 6.96E-29 
   HepG2 cancer 618 1338 1686 4782 5.99E-23 7.78E-22 
   Dnd41 cancer 716 1338 1915 4782 1.84E-32 2.39E-31 
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List of abbreviations 
 
DNMTs        :     DNA methyltransferases 
CGIs             :     CpG islands  
H3K4me3    :      Histone H3 lysine 4 trimethylation 
H3K27ac      :      Histone H3 lysine 27acetylation 
H3K36me3  :      Histone H3 lysine 36 trimethylation 
NuRD           :      Nucleosome remodelling and deacetylation complex 
SETD2          :      SET domain containing protein 2 (Histone-lysine N-methyltransferase) 
JHDM3A      :      Jumonji C (JmjC)-domain-containing Histone Demethylase 3A  
Cfp1             :      CxxC finger protein 1 
MBDs           :      Methyl CpG Binding Domain Proteins 
HDAC           :      Histone Deacetylase  
PRC1            :      Polycomb Repressive Complex 1 
PRC2            :      Polycomb Repressive Complex 2 
iHS                :      Integrated Haplotype Score 
HIR               :      High iHS Regions 
S score         :      Selective sweep scan score 
5LSR             :      5% Lowest S Regions 
CE                 :      Conserved Elements 
CT                 :     Cancer Transformed  
EBV               :     Epstein Barr Virus transformed  
NU                :      Normal Untransformed  
TSS                :     Transcription Start Sites 
UCSC GB      :      University of California Santa Cruz Genome Browser  
ENCODE       :     Encyclopedia of DNA Elements  
PS                  :     Peaks Signal 
BGC               :     Biased Gene Conversion  
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